Text

Attachment 12 to Enclosure, Calculation GEN-PI-083, Rev. 0, LRA Analysis Titled, Locked Rotor Accident (LRA) Analysis Using Ast.
	ML093160590
Person / Time
Site:	Prairie Island
Issue date:	09/09/2009
From:	Gita Patel; Xcel Energy
To:	; Office of Nuclear Reactor Regulation
References
	L-PI-09-114 GEN-PI-083, Rev 0
	Download: ML093160590 (129)
	v • d • e

ATTACHMENT 12 to ENCLOSURE LRA Analysis titled, "Locked Rotor Accident (LRA) Analysis Using AST" 128 Pages Follow

OF-0549 (FP-E-CAL-01), Rev. 3 Page 1 of 128

'C.# xcelSnerCy- CaRculationsignature Sheet Document Information NSPM Calculation (Doc) No: GEN-PI-083 [ Revision: 0

Title:

Locked Rotor Accident (LRA) Analysis Using AST Facility: l MT Z PI I Unit: Z 1 M 2 Safety Class: Z SR [1 Aug Q 0I Non SR Special Codes: r] Safeguards [I- Proprietary Type: Ca1c Sub-Type:

ii

[NOTE: Print and sign name in signature blocks, as required.

Major Revisions EC Number: 13720 [-] Vendor Calc Vendor Name or Code: Vendor Doc No:

Description of Revision: Initial Issue Prepared by: Gopal J. Patel V Date: o*/09 /o o0!

Reviewed by: Thomas J. Msci , . e: <A . o ) _9 Type of Review: ER Design Verific ion LI Review I] Vendor Acceptance Method Used (For.DVO*): Z Review L] Alternate Calc L] Test Approved b3JTJ z-ý'-* (t Date: t6//5//

Minor Revisions EC No: I Vendor Calc:

Minor Rev. No:

Description of Change:

Pages Affected:

Prepared by: Date:

Reviewed by:/ Date:

Type of Review: EL Design Verification I- Tech Review LI Vendor Acceptance Method Used (For DV Only): LI Review EL Alternate CalcIr Test Approved by: LLDate:

(continued on next page)

Record Retention: Retain this form with the associated calculation for the life of the plant.

()F-0549 (FP-E-CAL-01), Rev. 3 Page 2 of 128 XceiEnergy Calculation "Signature Sheet EC No: El Vendor Calc:

Minor Rev. No:

Description of Change:

Pages Affected:

Prepared by: Date:

Reviewed by: Date:

Type of Review: E- Design Verification E] Tech Review -] Vendor Acceptance Method Used (For DV Only): -li Review El- Alternate Calc L- Test Approved by: Date:

EC No: E Vendor Calc:

Minor Rev. No:

Description of Change:

Pages Affected:

Prepared by: Date Reviewed by:I Date:

Type of Review: E] Design Verification -- Tech Review -- Vendor Acceptance Method Used (For DV Only): E Review L] Alternate Calc [:] Test Approved by: Date:

EC No: El Vendor Calc:

Minor Rev. No:

Description of Change:

Pages Affected:

Prepared by: D ate:

Reviewed by: Date:

Type of Review: E] Design Verification E] Tech Review [-] Vendor Acceptance Method Used (For DV Only): [E Review E] Alternate Calc El Test Approved by: Date:

Record Retention: Retain this form with the associated calculation for the life of the plant.

QF-0549 (FP-E-CAL-01), Rev. 3 Page 3 of 128 XcelEnergy- Calculation Signature Sheet NOTE: This reference table is used for data entry into the PassPort Controlled Documents Module, reference tables (C012 Panel). It may also be used as the reference section of the calculation. The input documents, output documents and other references should all be listed here. Add additional lines as needed.

Reference Documents (PassPort C012 Panel from C020)

Controlled* Document Name Document Doc Rev Ref Type**

Doc? + Type Number (if known) 1.183 July 2000 ZInput [--Output 1 E 1

RG

_____RG Alternative Radiological Source Terms for Evaluating Design Basis Accidents at Nuclear Power Reactors 2 F-- DOC A Simplified Model for Radionuclide Transport and NUREG/CR-6604 Dec 1997 ZInput L--Output Removal and Dose Estimation 3 Z TRNS LR Input Parameters DIT No. 13720-09 0 ZInput L--Output 4 Z TRNS Control Room Input Parameters DIT No. 13720-07 1 ZInput -]Output 5 M TRNS Meteorological Input Parameters DIT No. 13720-03 0 Zlnput -]Output 6 Z STD Accident Source Term 10 CFR 50.67 ZInput -- Output 7 Z CALC PI Control Room Atmospheric Dispersion Factors GEN-PI-049 Add 2Input 0, including 2 -]Output UI/U2 Zinput --Output 8 Z Tech Spec PINGP Units 1 & 2, Definition of Rated Thermal Power 1.1 Amendment 158/149 UI/U2 Zinput [-]Output 9 Z Tech Spec PINGP Units 1 & 2, Definition of Dose Equivalent 1-131 1.1 Amendment 158/149 U1.U2 Aoutput Input PINGP Units 1 & 2, Definition of E-bar Average 10 Z Tech Spec Disintegration Energy 177/167 U1/U2 ZInput L--]Output 11 Z Tech Spec PINGP Units 1 & 2 LCO for Secondary Specific Activity 3.7.14 Amendment

_ _158/149

Paae 4 of 128 OF-0549 (FP-E-CAL-01') Rev. 3 Pa~f2 Xcel~ergyCalculation Signa'ture Sheet Controlled* Document Name Document Doc Rev Ref Type**

Doc? + Type Number (if known)

UI/U2 MInput -lOutput 12 Z Tech Spec PINGP Units 1 & 2 LCO for RCS Specific Activity 3.4.17 Amendment 167/157 PINGP Units I & 2 LCO for Control Room Special U1/U2 ZInput Foutput 13 M Tech Spec Ventilation System (CRSVS) 3.7.10 Amendment 158/149 UI/U2 ZInput ElOutput 14 [* Tech Spec PINGP Units 1 & 2 LCO for RCS Operational Leakage 3.4.14 Amendment 158/149 U1/U2 ZInput LOutput PINGP Units 1 & 2 Specification for Ventilation Filter 5.5.9 Amendment 15 ] Tech Spec Testing Program (VFTP) 186/176 Ul/U2 Mlnput DOutput PINGP Units 1 & 2 LCO for Control Room Special Amendment 16 Z Tech Spec PNP3.3.6 A 158/n149 Ventilation System (CRSVS) Actuation Instrumentation 17 E- FGR Federal Guidance Report 11 EPA-520/1-88-020 [Input L--lOutput 18 F-- FGR Federal Guidance Report 12 EPA-402-R-93-081 [ZInput [:]Output Westinghouse Letter - Nuclear Management Company ZInput E--Outpiut 19 Z LTR Prairie Island Units I & 2, MUR Power Uprate Program, NSP-07-59 11/02/2007 Core Activity Inventory and Coolant Activity LTR-PEP-07-26 Concentrations 20 L STD Laboratory Testing of Nuclear-Grade Activated Charcoal GL 99-02 6/3/99 ZInput -- Output ASME Steam Tables Sixth Edition IInput L-Output 21 E-- DOC 15.0.1 0 ZInput L--Output 22 m NUREG-0800, Standard Review Plan, "Radiological 22

-Consequence Analyses Using Alternative Source Terms 23 IZ CALC Post-LOCA EAB, LPZ, and CR Doses - AST GEN-PI-079 0 [Input []-Output 24 Z USAR Steam Generator Design Data Table 4.1-5 27 NInput L--Output 12400604-UR(B)- 0 Ellnput [Output 25 Z CALC Locked Rotor Accident Dose Consequences 002

QF-0549 (FP-E-CAL-01), Rev. 3 Paqe 5 of 128 XceIEnergy- Calculation Signature Sheet

Controlled* Document Name Document Doc Rev Ref Type**

Doc? + Type Number (if known) 26 [ STD Deletion of E Bar Definition and Revision to RCS Specific TSTF-490 0 ZInput L--]Output Activity Tech Spec 27 1 PROC Natural Circulation Cooldown With CRDM Fans 1ES-0.3A 14 ZInput [-Output 28 Z PROC Natural Circulation Cooldown Without CRDM Fans 1ES-0.3B 11 ZInput [:]Output NF-39603-1, Rev 29 Z DRAW Admin Bldg, Screen House, & Control RM Flow Diagram 76, Including T- 76 ZInput -Output Mod EC 14090 LAR to Revise the Loss of Coolant Accident (LOCA) and ZInput [:]Output 30 N LAR Main Steam Line Break Accident (MSLB) Dose LPI-08-052 06/26/2008 Consequences Analyses and Affected Technical Specifications (TS) 31 Z USAR PINGP USAR Appendix D - Activity In Fuel Gap Section D.2 27 ZInput [-]Output 32 Z CALC FHA Fission Product Inventories for AST Assessments GEN-PI-047 0, Add I Zinput --Output PINGP Amendment Nos. 166 and 156 to Operating Z*nput E-Output 33 License Nos. DPR-42 and DPR-60, respectively, Selective LA # 166 & 156 33 LA Implementation Of Alternate Source Term For Fuel Handling Accidents 34 Z USAR Steam Generators Section 4.3.2.1.1 29 ZInput --otiput Design, Testing, and Maintenance Criteria for Post 35 Accident Engineered-Safety-Feature Atmosphere Cleanup 1.52 2 Zlnput [:Output System Air Filtration and Adsorption Units of Light-Water-Cooled Nuclear Power Plants

Controlled Doc checkmark means the reference can be entered on the C012 panel in black. Unchecked lines will be yellow. If checked, also list the Doc Type, e.g., CALC, DRAW, VTM, PROC, etc.)

- Corresponds to these PassPort "Ref Type" codes: Inputs/Both = ICALC, Outputs = OCALC, Other/Unknown = blank)

QF-0549 ('FP-E-CAL-01), Rev. 3 Paae 6 of 128 XceI Energy- Calculation Signature Sheet Other Pass Port Data Associated System (PassPort C011, first three columns) OR Equipment References (PassPort C025, all five columns):

Facility Unit System Equipment Type Equipment Number PI 0 ZN FILTER 069-241 PI 0 ZN FILTER 069-242 PI 1 MS CV CV-31084 PI 2 MS CV CV-31102 PI 1 MS CV CV-31089 PI 2 MS CV CV-31107 PI 1 MS CV CV-31085 PI 1 MS CV CV-31086 PI 1 MS CV CV-31090 PI 1 MS CV CV-31091 Pi 2 MS CV CV-31103 Pi 2 MS CV CV-31104 PI 2 MS CV CV-31108 Pi 2 MS CV CV-31109 Pi 1 MS RFV RS-21-1 PI 1 MS RFV RS-21-2 PI I MS RFV RS-21-3 PI I MS RFV RS-21-4 PI 1 MS RFV RS-21-5 PI 1 MS RFV RS-21-6 PI I MS RFV RS-21-7 PI I MS RFV RS-21-8 PI 1 MS RFV RS-21-9 PI I MS RFV RS-21-10 PI 2 MS RFV RS-21-11 PI 2 MS RFV RS-21-12 PI 2 MS RFV RS-21-13 PI 2 MS RFV RS-21-14

QF-0549 (FP-E-CAL-01), Rev. 3 Paae 7 of 128 XcelEnergy- Calculation Signature Sheet.

Facility Unit System Equipment Type Equipment Number PI 2 MS RFV RS-21-15 PI 2 MS RFV RS-21-16 PI 2 MS RFV RS-21-17 PI 2 MS RFV RS-21-18 PI 2 MS RFV RS-21-19 PI 2 MS RFV RS-21-20 PI 0 RD RM RM-23 PI 0 RD RM RM-24 PI 1 SG GEN 134-011 P1 1 SG GEN 134-012 PI 2 SG GEN 234-011 PI 2 SG GEN 234-012 Superseded Calculations (PassPort C019):

Facility Calc Document Number Title Description Codes - Optional (PassPort C018):

Code Description (optional) Code Description (optional)

Notes (Nts) - Optional (PassPort X293 from C020):

Topic Notes Text E-l Calc introduction Z* Copy directly from the calculation Intro Paragraph or 0 See write-up below The purpose of this calculation is to determine the Exclusion Area Boundary (EAB), Low Population Zone (LPZ), and Control Room (CR) doses due to a Locked Rotor Accident (LRA) using the Alternative Source Term (AST) methodology, the total effective dose equivalent (TEDE) dose criteria, and the plant-specific bounding design information applicable to the PINGP Units 1 & 2 steam generators (SGs). The dose consequences are representative of an LRA occurring in either Unit 1 or Unit 2.

El (Specify)

q XceEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No.8 of 128 Sheet of DOCUMENT NUMBER/ TITLE: GEN-PI-083/ Locked Rotor Accident (LRA) Analysis Using AST REVISION: 0 DATE:

REVIEWER'S COMMENTS PREPARER'S REVIEWER'S RESOLUTION DISPOSITION Minor editorial comments made in document Incorporated. Accepted 07/22/09 text, Section 2.1 states that the Prairie Island fuel The comparison of the plant-specific Accepted 07/22/09 management program can result in some fuel GAP fraction with the RG 1.183, gap assemblies being exposed to a maximum fraction in Table 3 indicates that the LHGR that exceeds 6.3 kw/hr at fuel burnups calculated gap fraction for the most between 54 and 62 GWD/MTU. There limiting 1-131 is at least two times should be a statement of what the calculated lower than that in RG 1.183, Table 3.

LHGR is, and how many assemblies are affect Therefore, the tacking of number of ted. This will potentially eliminate RAI assemblies exceeding LHGR of 6.3 questions. kw/hr is essential because it provides a large margin for the same.

Section 2.1 makes reference to the normalized Since the NIF and RFT files are Accepted 07/22/09 default nuclide inventory file (NIF) reproduced by the RADTRAD code in "Pwr-def.nif', which is modified based on the the output files, therefore, they are not PINGP plant-specific isotopic core inventory, provided in the attachment. The It also states that there are two modified NIF modified DCF is added.

files "PILRA lodin def.txt" and "PILRALiq def.txt" are used in the analysis.

However none of these files are included in the calculation. All .nif, .rft, and any modified .inp files should be included.

Design Input Table item 5.3.1: There should Incorporated. Accepted 07/22/09 be something that says that 1683 MWt includes the 102% as used in section 5.3.5.

Section 7.3.2 (CRSVS HEPA Filter The PINGP Ventilation Filter Testing Accepted 07/22/09 Efficiency) states that Generic Letter 99-02 Program, Section 5.5.9.a, shows that requires a safety factor of at least 2 to be used the inplace DOP test for the HEPA to determine the filter efficiencies to be shows a penetration and system bypass credited in the design basis accident. < 0.05%, Therefore, a safety factor of 2 Although this true for charcoal laboratory is conservatively applied. The word testing, RG 1.52 states that if the in-place "system bypass" is added for filter penetration and bypass test results are completeness.

less than or equal to 0.05%, then an efficiency of 99% can be assigned.

Tables 8 & 9 should have the names of the Incorporated. Accepted 07/22/09

.NIF files that are associated with them for clarity.

XceIEnergy Design Review Comment Fr Caculation No. GEN-PI-083 Revision No. 0 Page No. 9 of 128 Xce E°'nergy-Sheet of DOCUMENT NUMBER/ TITLE: GEN-PI-083/ Locked Rotor Accident (LRA) Analysis Using AST REVISION: 0 DATE:

ITEM REVIEWER'S COMMENTS PREPARER'S REVIEWER'S

RESOLUTION DISPOSITION 7 Tables 12 & 13 should have some tie-in to the Section 5.5.17 is added to establish a Accepted 07/22/09 RADTRAD inputs. It is difficult to follow the link for the X/Qs used in the analysis RADTRAD input file to see where the values came from.

END Reviewer: Thomas Mscisz Date: 05/17/2009 Preparer: Gopal J. Patel Date: 07/15/2009

4

6 Xce IEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 10 of 128 REVISION HISTORY Revision Description 0 Initial issue

/

XcelEnergy ICalculation No. GEN-PI-083 Revision No. 0 I Page No. 11 of 128 1 SHEET REVISION INDEX SHEET REV SHEET REV 1 0 31 0 2 0 32 0 3 0 33 0 4 0 34 0 5 0 35 0 6 0 36 0 7 0 37 0 8 0 38 0 9 0 39 0 10 11 0

0 40 41 0

0 I

12 0 42 0 13 0 43 0 14 0 44 0 15 0 45 0 16 0 46 0 17 0 47 0 18 0 48 0 19 0 49 0 20 0 50 0 21 0 51 0 22 0 Attachment 13.1 0 23 0 Attachment 13.2 0 24 0 Attachment 13.3 0 25 0 Attachment 13.4 0 26 0 27 0 28 0 29 0 30 0

9/l XceIEnergy* Calculation No. GEN-PI-083 Revision No. 0 Page No. 12 of 128 TABLE OF CONTENTS Section Sheet No.

Cover Sheet 1 Revision History 10 Sheet Revision Index 11 Table of Contents 12 1.0 Purpose And Summary Report 13 2.0 Methodology 13 3.0 Acceptance Criteria 19 4.0 Assumptions 20 5.0 Design Inputs 26 6.0 Computer Codes & Compliance With Regulatory Requirements 33 7.0 Calculations 34 8.0 Results Summary And Conclusions 38 9.0 References 39 10.0 Tables 41 11.0 Figures 49 12.0 Affected Documents 51 13.0 Attachment 51 13.1 RADTRAD Output File PLRINIDO1 .oO 52 13.2 RADTRAD Output File PLRAINGO1.oO 74 13.3 RADTRAD Output File PLRATNLQ01 .oO 93 13.4 Modified RADTRAD Dose Conversion File PINGP fg 11 & 12.txt 113 I

9~XceIEnerg y' Calculation No. GEN-PI-083 Revision No. 0 Page No. 13 of 128 1.0 PURPOSE AND

SUMMARY

REPORT:

1.1 Purpose The purpose of this calculation is to determine the Exclusion Area Boundary (EAB), Low Population Zone (LPZ), and Control Room (CR) doses due to a Locked Rotor Accident (LRA) using the Alternative Source Term (AST) methodology, the total effective dose equivalent (TEDE) dose criteria, and the plant-specific bounding design information applicable to the PINGP Units I & 2 steam generators (SGs). The dose consequences are representative of an LRA occurring in either Unit I or Unit 2.

1.2 Summary Report The resulting post-LRA doses are shown in Section 8.0. These doses comply with the applicable regulatory allowable dose limits.

2.0 METHODOLOGY

The PINGP operating licenses are proposed to amend to implement the full scope AST methodology in lieu of the TID-14844 source term methodology. The TEDE offsite dose acceptance criteria specified in Table 6 of Regulatory Guide 1.183 (Ref. 9.1) is implemented in lieu of the whole body and thyroid dose guidelines provided in 10 CFR 100.11. In addition, the 5 rem TEDE control room dose acceptance criterion specified in 10 CFR 50.67 (Ref. 9.4) is implemented in lieu of the 5 rem whole body and equivalent organ dose guidelines provided in 10 CFR 50 Appendix A GDC 19.

The design basis locked rotor accident is analyzed using a conservative set of assumptions and as-built design inputs. The numeric values of the critical design inputs are conservatively selected to assure an appropriate prudent safety margin against unpredicted events in the course of an accident and compensate for large uncertainties in facility parameters, accident progression, radioactive material transport, and atmospheric dispersion. The LRA analysis is performed using the guidance in Regulatory Guide 1.183 and its Appendix G (Ref. 9.1).

This analysis uses Version 3.02 of the RADTRAD computer code (Ref. 9.2) to calculate the potential radiological consequences of the LRA. The validation and verification (V&V) of the RADTRAD code is addressed in Section 6.

The LRA dose consequences are determined by summing together the results from the primary-to-secondary (P-T-S) leakage iodine activity release, the P-T-S leakage noble gas activity release, and the secondary liquid iodine release.

2.1 Failed Fuel Gap Inventory The principal radiation source term for the LRA is the fuel gap activity in the failed fuel caused by the transient of the accident. The PINGP plant-specific LRA analysis predicted that no more than 20% of the fuel in the core will fail (Ref. 9.3.1, Item #3). Consistent with the guidance in Regulatory Guide 1.183 (Ref. 9.1, Appendix G, Section 3), the failed fuel rod gap activity is assumed to be released instantaneously and homogenously through the primary coolant (i.e., reactor coolant system [RCS]) at the start of the event.

The fuel gap isotopic activity release fractions are in accordance with RG 1.183 (Ref. 9.1, Table 3).

Footnote 11 to Table 3 of RG 1.183 requires that the maximum linear heat generation (LHGR) does not

XceIEnergy* Calculation No. GEN-PI-083 Revision No. 0 Page No. 14 of 128 exceed 6.3 kw/ft peak rod average power for burnups exceeding 54 GWD/MTU. The Prairie Island fuel management program can result in some fuel assemblies being exposed to a maximum LHGR that exceeds 6.3 kw/hr at fuel burnups between 54 and 62 GWD/MTU (Ref. 9.20). To account for the higher LHGR a site-specific analysis was performed in Reference 9.21 and a computer code, "GAP" was developed and qualified using methodology presented in ANSI/ANS-5.4-1982 to perform the site-specific gap fraction analysis. The NRC reviewed the GAP code during approval of the PINGP license amendment for implementing selective implementation of AST for FHA (Ref. 9.22, Section 3.2) and determined that the analytical approach is consistent with the ANSI/ANS-5.4-1982 model, and that the GAP code is acceptable for analyzing the gap release fraction. The plant-specific gap fractions are compared with the RG 1.183 gap fractions in Table IA, which indicates that the gap fractions in Table 3 of RG 1.183 are bounding for the PINGP fuel assemblies exceeding the maximum LHGR of 6.3 kw/ft.

The exclusion of iodine spiking is consistent with the guidance presented in RG 1.183 (Ref. 9.1, Appendix E, Footnote 2), which states that the activity assumed in the analysis should be based on the activity associated with the projected fuel damage or the maximum technical specification values, whichever maximizes the radiological consequences. Since the RCS activity associated with 20% failed fuel is greater than that of an iodine spike, the iodine spike is not included with the failed fuel activity release.

Per Regulatory Guide 1.183 (Ref. 9.1, Section 3.2), for non-LOCA events (such as an LRA), the fractions of the core inventory assumed to be in the fuel rod gap space for the various radionuclides are given in RG 1.183 Table 3. Per RG 1.183 Table 3, the isotopes present in the gap are noble gases, iodine and alkali metals. Per RG 1.183 Section 3.4 and Table 5, noble gases are Xenon and Krypton isotopes, halogens are Iodine and Bromine isotopes, and alkali metals are Cesium and Rubidium isotopes.

The alkali metals (Cs, Rb) present in the source term are omitted from the RADTRAD analysis since they have a negligible impact on the analysis results, primarily because the dose contribution from alkali metals is insignificant compared to the dose contribution from noble gases which are released directly to the environment without hold-up.

In an intact steam generator in which the tubes are covered by liquid for the event duration, the release of alkali metals is facilitated solely by steam generator moisture carryover of no more than 0.25% (Ref.

9.23) (i.e., a factor of 400 less than the noble gas release rate). In addition, the alkali metals introduced into both intact SGs are diluted within the SG space of approximately 3400 cubic feet (per Section 7.1.2), and then gradually released as this SG liquid volume is steamed to the environment at a rate of no more than 40 cfm (per Section 7.2.2, without consideration of iodine PC of 100). This release rate of approximately 0.0 12 SG volumes per minute (= 40 cfm / 3400 cf) is 85 times lower than the noble gas release rate to the environment. Combining the moisture carryover and hold-up effect indicates that the alkali metal release rate is approximately 34,000 times (= 400 x 85) lower than the noble gas release rate to the environment. This hold-up of the alkali metal within the intact SG significantly reduces the alkali metal activity released to the environment in comparison to the noble gas activity released to the environment.

In addition, the control room dose contribution from alkali metals is further minimized by their removal via the 99% efficient control room HEPA recirculation filter (Ref. 9.3.2, Item #14), which would reduce the alkali metal CR dose contribution by an additional factor of 100.

The activity released during the vent contributes to the external dose (whole body gamma - DDE) and internal dose (inhaled - CEDE). All alkali isotopes including the daughters are naturally beta emitters; therefore, they do not contribute to any external dose. The inhaled dose conversion factors for the rubidium and cesium isotopes are calculated in Table 14, which shows that the alkali isotopes are

c XeInergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 15 of 128 inherently low thyroid inhalation dose contributors. These dose characteristics combined with the extremely low fractional release of less than 1/34,000 will result in inconsequential CR and offsite doses, which will be eliminated as being less than the significant figure rounding error.

Westinghouse Letter NSP-07-59, LTR-PEP-07-26 (Ref. 9.9, Table 2-1) presents the PINGP Units I and 2 core inventory at a core thermal power level of 1683 MWt at reactor shutdown. This core inventory is bounding for the 422V+ (Heavy Bundle or HB) core and OFA core (Ref. 9.9, Section 2.0).

The core activity is based on a core thermal power of 1,683 MWt (= 1,650 MWt x 1.02) including the 2% power level measuring instrument uncertainty, fuel enrichment of 5.0%, and cycle burnup of 25,000 MWD/MTU (Ref. 9.9, Table 6-1). For conservatism and to bound possible core inventory increases associated with a 10% Power Uprate, the Table I core inventory is used in this analysis with the core thermal power level of 1,852 MWt (= 1.10 x 1,683 MWt).

NUREG/CR-6604 (Ref. 9.2, Section 1.4.3.2 and Table 1.4.3.2-2) provides the normalized default nuclide inventory file (NIF) "Pwr def.nif', which is modified based on the PINGP plant-specific isotopic core inventory. Modified NIF files "PILRAlodindef.txt" and "PILRALiqdef.txt" are used in the analysis.

The design basis core iodine and noble gas activity releases from the 20% failed fuel are calculated in Table I using the gap release fractions in RG 1.183, Table 3. Consistent with RG 1.183 (Appendix G, Section 3), the activity released from the failed fuel is assumed to be instantaneously and homogeneously mixed through the primary coolant.

2.2 RCS Iodine Inventory Westinghouse Letter NSP-07-59, LTR-PEP-07-26 (Ref. 9.9, Table 2-2, HB x 1.04 scenario) provides the PINGP Units I and 2 RCS iodine activity concentrations based on a 1% fuel defect level. Table 4 converts the iodine activity concentration profile based on this 1% fuel defect level into its corresponding Dose Equivalent Iodine-] 31 (DE 1-131) activity concentration using the thyroid inhalation dose conversion factors listed in Table 2. Technical Specification 1.1 defines Dose Equivalent 1-131 as that concentration of 1-131 that alone would produce the same thyroid dose as the quantity and isotopic mixture of 1-131, 1-132, 1-133, 1-134 and 1-135 actually present. Technical Specification 1.1 defines Dose Equivalent 1-131 in terms of the thyroid dose conversion factors listed in Table III of TID-14844. In this calculation, consistent with RG 1.183 methodology (Ref. 9.1, Section 4.1.2), DE 1-131 is defined in terms of the committed effective dose equivalent (CEDE) iodine inhalation dose conversion factors of FGR- I I (Ref. 9.7). The revision to use of FGR dose conversion factors in the Technical Specification 1.1 definition for DE 1-131 will be included in the AST license amendment request. The iodine inhalation dose conversion factors are calculated in Table 2 and used in Table 3 to establish a scaling factor based on 0.50 V.Ci/gram DE 1-131 to calculate Tech Spec iodine concentration in Table 4. The total isotopic iodine activities are conservatively calculated using the 1%

failed fuel iodine concentration instead of 0.50 pCi/gram DE 1-131 concentration and RCS mass (per Section 7.1.1) in Table 5.

2.3 Noble Gas Inventory Per Technical Specification LCO 3.4.17 (Ref. 9.6.5), the maximum permitted equilibrium RCS non-iodine concentration is I O1/E-BAR. The parameter E-BAR is defined in Technical Specification Section 1.1 (Ref. 9.6.3) as the average (weighted in proportion to the concentration of each radionuclide in the reactor coolant at the time of sampling) of the sum of the average beta and gamma energies per

XceInergy-

Calculation No. GEN-PI-083 Revision No. 0 Page No. 16 of 128 disintegration (in MeV) for isotopes, other than iodines, with half lives greater than 15 minutes, making up at least 95% of the total non-iodine activity in the coolant.

The PINGP licensing proposes the deletion of the E-BAR definition and revision of the RCS Specific Activity Tech Specification to utilize a new indicator, Dose Equivalent Xenon-133, instead of the current indicator known as E-BAR. The current limits on primary coolant gross specific activity will be replaced with limits on primary coolant noble gas activity. The noble gas activity would be based on DOSE EQUIVALENT XE- 133 and would take into account only the noble gas aciivity in the primary coolant. The determination of Dose EquivalentXe-133 will be performed in a similar manner to that currently used in determining DE 1-131, except that the calculation of Dose Equivalent Xe-133 is based on the acute dose to the whole body and considers the noble gases which are significant in terms of contribution to whole body dose. Some noble gas isotopes are not included due to low concentration, short half-life, or small dose conversion factor.

Per TSTF-490 traveler (Ref. 9.16), the DOSE EQUIVALENT XE-133 shall be that concentration of Xe- 133 (ltCi/g) that alone would produce the same acute dose to the whole body as the combined activities of noble gas nuclides [Kr-85m, Kr-85, Kr-87, Kr-88, Xe-131m, Xe-133m. Xe-133, Xe-135m, Xe-135, and Xe-138] actually present. The determination of DOSE EQUIVALENT XE-133 shall be performed using effective dose conversion factors for air submersion listed in Table 111.1 of EPA Federal Guidance Report No. 12, 1993. "External Exposure to Radionuclides in Air, Water, and Soil" or the average gamma disintegration energies as provided in ICRP Publication 38, "Radionuclide Transformations" or similar source.

The XE- 133 Dose Equivalent concentration is established in Table 6 as defined in the TSTF-490 design specification using effective dose conversion factors for air submersion listed in Table 111. 1 of EPA Federal Guidance Report No. 12 (Ref. 9.8) and 1% failed fuel noble gas isotopic concentrations in Reference 9.9, Table 2-2 for HB x 1.04. The proposed XE-133 Dose Equivalent concentration limit for noble gas activity is calculated to be 580 tCi/g XE-133 DE (Table 6), and is used in this analysis with the noble gas isotopic concentrations in Table 7.

2.4 RCS Alkali Metal Inventory Westinghouse Letter NSP-07-59, LTR-PEP-07-26 (Ref. 9.9, Table 2-2) presents the PINGP Units 1 and 2 RCS non-iodine activity concentrations based on a 1% fuel defect level. As discussed in Section 2.1, all alkali metals are omitted from the RADTRAD analysis. This analysis considers only the iodine and noble gas isotopes present in the modified Nuclide Inventory Files "PILRAlodindef.txt" and "PILRALiq_def.txt" that are described in Section 2.1.

Table 8 determines the post-LRA total iodine and noble gas activity initially present in the RCS by summing the RCS activity introduced by the 20% fuel failure from Table I with the initial RCS activity at the 1 percent fuel defect level from Tables 5 and 7. This RCS activity inventory is input into RADTRAD Nuclide Inventory File "PILRA lodindef.txt.

2.5 Secondary Coolant Liquid Iodine Inventory Per Technical Specification LCO 3.7.14 (Ref. 9.6.4) the secondary coolant iodine concentration is limited to 0.1 jiCi/gram DE 1-131. This is one-fifth of theproposed Specification LCO 3.4.17 RCS iodine concentration limit of 0.50 WtCi/gram DE 1-131. In Table 9, the RCS iodine concentration profile at the 1% fuel defect level (which is conservatively greater than 0.50 ýtCi/gm DE 1-13 1) is multiplied by the secondary to primary limits (0.1/0.5) to determine the secondary coolant iodine concentration profile. Table 9 scales this secondary coolant iodine activity concentration profile by the coolant mass in both intact steam generators (per Section 7.1.2) to calculate the total secondary coolant iodine

XcelEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 17 of 128 inventory. This secondary coolant iodine activity inventory is input into RADTRAD Nuclide Inventory File "PILRALiq_def.txt".

2.6 Post-LRA Releases 2.6.1 Primary to Secondary (P-T-S) Leakage Rate This analysis models the RCS operational leakage limit of 150 gallons/day of primary to secondary (P-T-S) leakage through each steam generator (SG) at 70'F (i.e., 300 gpd through both SGs) as specified in Technical Specification LCO 3.4.14 (Ref. 9.6.7).

Consistent with RG 1.183 (Ref. 9.1, Appendix G, Section 5.3) the primary-to-secondary leakage is assumed to continue until the primary system pressure is less than the secondary system pressure, or until the temperature of the leakage is less than 2121F, and the release of radioactivity is assumed to continue until shutdown cooling is in operation and releases from the steam generator have terminated.

In this analysis the RCS is assumed to leak into the SGs for 45.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months at which time the Residual Heat Removal (RHR) system is initialized (Ref. 9.3.1, Item #25).

2.6.2 RCS Iodine Release Trough P-T-S Leakage The SG tubes are expected to be submerged in the intact SGs coolant during the LRA, with no tube uncovery (Ref. 9.3.1, Item #22). The iodine activity in the P-T-S leakage is assumed to mix with SG coolant without flashing during period of submergence (Ref. 9.1, Appendix E, Section 5.5.1) and iodine partition coefficient of 100 is assumed (Ref. 9.1, Appendix E, Section 5.5.1 and Ref. 9.3.1, Item #22).

The RCS iodine release continues until the RHR system is initialized at 45.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months (Ref. 9.3.1, Item #25).

The doses from the LRA RCS iodine release are summarized in Section 8.1.

2.6.3 RCS Noble Gas Release Trough P-T-S Leakage Noble gases present in the P-T-S leakage are released directly to the environment without dilution or retention in the intact SGs. The RCS noble gas release continues until the RHR system is initialized at 45.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months (Ref. 9.3.1, Item #25).

The doses from the LRA RCS noble gas release are summarized in Section 8.1.

2.6.4 Secondary Liquid Iodine Release to the Environment The iodine activity in the bulk water in the SG is assumed to become vapor and is directly released to the environment in proportion to the steam release rate, with credit taken for iodine partitioning in the SG liquid. For the secondary liquid iodine release from the SGs, an iodine partition coefficient of 100 is assumed as recommended in Regulatory Guide 1.183 (Ref. 9.1, Appendix G, Section 5.6 and Appendix E, Section 5.5.4).

The secondary coolant iodine release continues until the RHR system is initialized at 45.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months (Ref. 9.3.1, Item #25).

The doses from the LRA secondary liquid iodine release are summarized in Section 8.1.

XceI Energy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 18 of 128 2.7 Steam Release Atmospheric Dispersion to the Control Room The activity during the LRA releases to the atmosphere via following two distinct plant-specific release paths:

I. Intact SG Steaming Via Safety & Power Operated Relief Valve (PORV) Group I and Group 2 Release

2. Intact SG Steaming via Turbine Driven Auxiliary Feed Water (TDAFW) Pump Exhaust Steam Release 2.7.1 Intact SG Via Safety & Power Operated Relief Valve (PORV) Group I Release Following the event the intact SGs.are used to cooldown the RCS. The mass of the steam released and the release location during the cooldown are important considerations due. to the total 300 gpd P-T-S leakage assumed for the intact SGs (maximum allowed by Technical Specification 3.4.14) (Ref. 9.6.7).

Assuming a loss of off-site power, the unit would be cooled down using procedure ES-0.3A or ES-0.3B (Ref. 9.17) for cooling down using natural circulation. Per either procedure, the preferred means to release steam for the cooldown is by dumping steam to the condenser. If this path is not available, then the SG PORV is used (Ref. 9.17.1, Step 8 and Ref. 9.17.2, Step 7). The time dependent steaming rates through the intact SGs are shown in Table 10. The apportioned P-T-S leakage rates used in this analysis are based on the steam mass flow rate distribution through the intact SGs as shown in Table 11.

2.7.2 Turbine Driven Auxiliary Feedwater (TDAFW) Pump Exhaust Steam Release An additional steam release path from the intact SGs is through the Turbine Driven Auxiliary Feedwater (TDAFW) Pump steam exhaust. Assuming a single failure of the motor driven AFW Pump, the TDAFW Pump would be used for the cooldown. Steam mass flow rates to drive the TDAFW Pump for given time periods are shown in Table 10.

The intact steam generator releases steam to the environment through three potential release paths, namely via the TDAFW pump exhaust, Group I PORV and Group 2 PORV. To eliminate a large number of RADTRAD computer runs, an average set of atmospheric dispersion factors (x/Qs) are conservatively established by picking the limiting sets of X/Qs from Unit I or Unit 2, instead of mixing and matching X/Qs from the two units, which is both unrealistic and not credible. The sets of X/Qs for the three potential release paths Unit I and from Unit 2 are compared to pick the most limiting sets of X/Qs from which will be determined the average set of X/Qs for the post-LRA intact SG steam mass releases. Tables 12 and 13 calculate the average set of X/Qs for Units I and 2, respectively. The calculation begins by calculating an average set of X/Qs for the intact SG PORV release, represented by 60% and 40% releases through the Group 1 PORV and Group 2 PORV sets, respectively. The calculation finishes by calculating the average set of x/Qs by applying the Table 10 fractional steam mass releases to the TDAFW and PORV x/Qs. The review of Tables 12 and 13 indicates that the Unit 2 steam release paths provide the higher sets of X/Qs in comparison to the Unit 1 steam release paths for the 0 to 45.5 hour5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months release duration. The average Unit 2 X/Qs from Table 13 are used in the analysis with the iodine, noble gas, and SG liquid iodine release rates shown in Table 11.

The post-LRA activity transport and CR response models are shown in Figures 1 and 2, which are used to determine the post-LRA radiological consequences using the plant-specific as-built design inputs and assumptions listed in Sections 4 & 5.

XcelcErergy I Calculation No. GEN-PI-083 Revision No. 0 Page No. 19 of 128 2.8 CR Intake Monitor Response Post-LRA Xe-133 activity in the CR @ 0.0833 hr (5 minutes)

= 0.58225 Ci (RADTRAD Run PLRAINGOI .o0) 3 3 3 Control room volume 61,315 ft (Section 5.5.1) = 61,315 ft / (3.28 ft/m) = 1,737.58 m 3

Xe-133 activity concentration in the CR @ 0.0036 hr (0.22 minute)

= 0.58225 Ci / 1,737.58 m3 = 3.351 E-04 Ci/m 3 = 3.351 E-04 pCi/cc, which exceeds CR monitor setpoint of IE-05 [iCi/cc for Xe-133 (Section 5.5.19).

Since the Xe-133 activity in the CR is circulated by the CR recirculation flow through the CR air supply duct (Ref. 9.19), the monitor setpoint is instantly exceeded. Therefore, the CR actuation delay of 5 minutes following a LRA is considered extremely conservative, and does not require any further justification.

3.0 ACCEPTANCE CRITERIA:

The following NRC regulatory requirement and guidance documents are applicable to this PINGP Alternative Source Term LRA Calculation:

Regulatory Guide 1.183 (Ref. 9.1)

10 CFR 50.67 (Ref. 9.4)

Standard Review Plan section 15.0.1 (Ref. 9.12)

Dose Acceptance Criteria are:

Regulatory Dose Limits Dose Type Control Room (rem) EAB and LPZ (rem)

TEDE Dose 5 2.5

XcelEnergy- ICalculation No. GEN-PI-083 Revision No. 0 Page No. 20 of 128

4.0 ASSUMPTIONS

Regulatory Guide 1.183 (Ref. 9.1) provides guidance on modeling assumptions that are acceptable to the NRC staff for the evaluation of the radiological consequences of a LRA. The following sections address the applicability of these modeling assumptions to the PINGP Units I and 2 LRA analysis. These assumptions are incorporated as design inputs in Sections 5.3 through 5.6. There are no unverified assumptions used in this analysis.

The radioactivity material releases and radiation levels used in the control room dose analysis are determined using the same source term, transport, and release assumptions used for determining the exclusion area boundary (EAB) and the low population zone (LPZ) TEDE values (Ref 9.1, Section 4.2.2).

4.1 Source Term For conservatism and to bound possible fuel failure increases associated with a Power) Uprate, this analysis assumes that 20% of the fuel in the core has failed (Ref. 9.3.1, Item #3). Per RG 1.183 (Ref. 9.1, Appendix G, Section 2), since fuel damage is postulated for the limiting event, a radiological analysis is required.

4.1.1 Core Inventory It is assumed that the inventory of fission products in the reactor core is based on the maximum power level of 1,852 MWt corresponding to 110% of 1,683 MWt. The power level of 1,683 MWt is 1.02 times the PINGP current licensed rated thermal power of 1,650 MWt (Ref. 9.6.1).

4.1.2 Activity Release from the Fuel into the Primary Coolant It is assumed consistent with RG 1.183 (Ref. 9.1, Appendix G, Section 3), that the activity released from the fuel is assumed to be released instantaneously and homogeneously through the primary coolant (i.e., the Reactor Coolant System).

4.1.3 Iodine Chemical Form It is assumed consistent with RG 1.183 (Ref. 9.1, Appendix G, Section 4), that the chemical form of iodine releases from the steam generators to the environment is 97% elemental and 3% organic. These fractions apply to iodine releases from the primary-to-secondary (P-T-S) leakage and the secondary liquid.

4.2 Transport 4.2.1 Primary-to-Secondary Leak Rates This analysis assumes the primary-to-secondary (P-T-S) leakage is at the RCS operational leakage limit of 150 gallons/day through any one SG (i.e., 300 gpd through both SGs) as specified in Technical Specification LCO 3.4.14 (Ref. 9.6.7).

4.2.2 Primary-to-Secondary Leak Primary Coolant Density It is assumed consistent with RG 1.183 (Ref. 9.1, Appendix G, Section 5.2), that the primary coolant (i.e., RCS) density used in converting the volumetric primary-to-secondary leak rates (e.g., gpm) to mass leak rates (e.g.,

lb/hr) is 1.0 gm/cc (62.4 lb/ft3 ).

SXceInergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 21 of 128 4.2.3 Primary-to-Secondary Leak Duration It is assumed consistent with RG 1.183 (Ref. 9.1, Appendix G, Section 5.3), that the primary-to-secondary leakage continues until the primary system pressure is less than the secondary system pressure, or until the temperature of the leakage is less than 212 0 F, and the release of radioactivity is assumed to continue until shutdown cooling is in operation and releases from the steam generator have terminated. In this analysis RCS is conservatively assumed to leak into the SGs for 45.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months until the RHR system is initialized (Ref. 9.3.1, Item #25).

4.2.4 Release of Fission Products It is assumed consistent with RG 1.183 (Ref. 9.1, Appendix G, Section 5.4), that the release of fission products from the secondary system is evaluated with the assumption of a coincident loss of offsite power (LOOP). The offsite power is assumed to be lost so that the main steam condensers are not available for removal of the decay heat.

4.2.5 Noble Gas Releases to the Environment It is assumed consistent with RG 1.183 (Ref. 9.1, Appendix G, Section 5.5), that all noble gas radionuclides released from the primary system (via the primary-to-secondary leak) are released to environment without reduction or mitigation.

4.2.6 Transport Model RG 1.183 (Ref. 9.1, Appendix G, Section 5.6) states that the main steam line break (MSLB) accident transport model of RG 1.183, Appendix E, Sections 5.5 and 5.6 should be utilized for iodine and particulates. RG 1.183 Appendix E Sections 5.5 and 5.6 present the following transport model for use in evaluating releases from steam generators:

STEAM GENERATOR TRANSPORT MODEL In this analysis, no credit is taken for iodine scrubbing, only for iodine partitioning. It is assumed consistent with RG 1.183 (Appendix E, Section 5.5.4), that the iodine activity in the bulk water of the two intact steam generators (consisting of the initial secondary coolant iodine activity and the iodine activity introduced via primary-to-secondary leakage) becomes vapor at a rate that is a function of the steaming rate and assumed iodine partition coefficient of 100.

X'cel Energy' Calculation No. GEN-PI-083 Revision No. 0 Page No. 22 of 128 For the primary-to-secondary leakage iodine release from the SGs, the SG tubes are expected to be submerged in the SGs liquid during the event, and consequently iodine introduced into the two intact SGs via the P-T-S leakage is assumed to be released to the environment with an iodine partitioning coefficient of 100 as recommended in RG 1.183 (Ref. 9.1, Appendix G, Section 5.6 and Appendix E, Section 5.5.4 and Ref. 9.3.1, Item #22).

For the secondary liquid iodine release from the SGs, an iodine partition coefficient of 100 is assumed (Ref. 9.3.1, Item #22), consistent with the value of 100 recommended in Regulatory Guide 1.183 (Ref. 9.1, Appendix G, Section 5.6 and Appendix E, Section 5.5.4).

4.3 Offsite Dose Consequences Regulatory Guide 1.183 (Ref. 9.1, Section 4.1) provides guidance to be used in determining the total effective dose equivalent (TEDE) for persons located at the exclusion area boundary (EAB) and at the outer boundary of the low population zone (LPZ). The following sections address the applicability of this guidance to the PINGP Units 1 and 2 LRA analyses. These assumptions are incorporated as design inputs in Section 5.6.

4.3.1 Modeling of Parent and Daughter Isotopes It is assumed consistent with RG 1.183 (Ref. 9.1, Section 4.1.1), that the dose calculation determines the TEDE, which is the sum of the committed effective dose equivalent (CEDE) from inhalation and the deep dose equivalent (DDE) from external exposure. It is assumed that the CEDE and DDE components of the TEDE consider all radionuclides, including progeny from the decay of parent radionuclides that are significant with regard to dose consequences and the released radioactivity. These isotopes are listed in Section 5.3.

4.3.2 CEDE (Inhalation) Dose Conversion Factors It is assumed consistent with RG 1.183 (Ref. 9.1, Section 4.1.2), that the exposure-to-CEDE factors for inhalation of radioactive material are derived from the data provided in ICRP Publication 30, "Limits for Intakes of Radionuclides by Workers". This calculation models the CEDE dose conversion factors (DCFs) in the column headed "effective" yield doses in Table 2.1 of Federal Guidance Report I1, "Limiting Values of Radionuclide Intake and Air Concentration and Dose Conversion Factors for Inhalation, Submersion, and Ingestion" (Ref. 9.7).

4.3.3 Offsite Breathing Rates It is assumed consistent with RG 1.183 .Ref. 9.1, Section 4.1.3), that for the first 8 hours9.259259e-5 days 0.00222 hours 1.322751e-5 weeks 3.044e-6 months , the breathing rate of persons offsite is assumed to be 3.5x10 cubic meters per second. From 8 to 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months following the accident, the breathing rate is assumed to be 1.8 x 10-4 cubic meters per second. After that and until the end of the accident, the rate is assumed to be 2.3x 10-4 cubic meters per second. These offsite breathing rates are listed in Section 5.6.

4.3.4 DDE (Immersion) Dose Conversion Factors It is assumed consistent with RG 1.183 (Ref. 9.1, Section 4.1.4), that the deep dose equivalent (DDE) is calculated assuming submergence in semi-infinite cloud assumptions with appropriate credit for attenuation by body tissue. The DDE is nominally equivalent to the effective dose equivalent (EDE) from external exposure if the whole body is irradiated uniformly. Since this is a reasonable assumption for submergence exposure

I Xcel Energy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 23 of 128 situations, EDE is used in lieu of DDE in determining the contribution of external dose to the TEDE. This calculation models the EDE dose conversion factors in the column headed "effective" in Table 111.1 of Federal Guidance Report 12, "External Exposure to Radionuclides in Air, Water, and Soil" (Ref. 9.8).

4.3.5 ,. Exclusion Area Boundary Dose Acceptance Criteria It is assumed for the LRA that the postulated EAB dose should not exceed 2.5 Rem TEDE (per Section 3.2).

Per RG 1.183 Table 6, the LRA event release duration is until cold shutdown is established. In this analysis, the LRA event ends when shutdown cooling is placed into operation at 45.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months (Ref. 9.3.1, Item #25).

The RADTRAD Code (Ref. 9.2) used in this analysis determines the maximum two-hour TEDE by calculating the postulated dose for a series of small time increments and performing a "sliding" sum over the increments for successive two-hour periods. The time increments appropriately reflect the progression of the accident to capture the peak dose interval between the start of the event and the end of radioactivity release.

4.3.6 Low Population Zone Outer Boundary Dose Acceptance Criteria It is assumed for the LRA that the postulated LPZ dose should not exceed 2.5 Rem TEDE (per Section 3.3). Per RG 1.183 Table 6, the LRA event release duration is until cold shutdown is established. In this analysis, the LRA event ends when shutdown cooling is placed into operation at 45.5.hours (Ref. 9.3.1, Item #25).

4.3.7 Effluent Plume Depletion It is assumed consistent with RG 1.183 (Ref. 9.1, Section 4.1.7), that no correction is made for depletion of the effluent plume by deposition on the ground.

4.4 Control Room Dose Consequences Regulatory Guide 1.183 (Ref. 9.1, Section 4.2) provides guidance to be used in determining the total effective dose equivalent (TEDE) for persons located in the control room (CR). The following sections address the applicability of this guidance to the PINGP Units I and 2 LRA analyses.. These assumptions are incorporated as design inputs in Section 5.5.

4.4.1 Control Room Operator Dose Contributors It is assumed consistent with RG 1.183 (Ref. 9.1, Section 4.2.1), the CR TEDE analysis considers the following sources of radiation that will cause exposure to control room personnel:

0 Contamination of the control room atmosphere by the filtered CR ventilation inflow through the CR air intake and by unfiltered inleakage of the radioactive material contained in the post-accident radioactive plume released from the facility, 0 Contamination of the control room atmosphere by filtered CR ventilation inflow via the CR air intake and by unfiltered inleakage of airborne radioactive material from areas and structures adjacent to the control room envelope,

Radiation shine from the external radioactive plume released from the facility (i.e., external airborne cloud shine dose),

Xcei nergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 24 of 128 Radiation shine from radioactive material in the reactor containment (i.e., containment shine dose). This form of radiation shine is not applicable to a LRA in which the activity is not released into the containment air space, and

Radiation shine from radioactive material in systems and components inside or external to the control room envelope (e.g., radioactive material buildup in CR intake and recirculation filters [i.e., CR filter shine dose]).

Note: The external airborne cloud shine dose and the CR filter shine dose due to a LRA are expected to be less than those due to a LOCA as a result of source term differences (i.e., the LOCA releases significantly more activity from failed fuel than does the LRA event per RG 1.183 [Ref. 9.1, Table 2 for LOCA compared to Ref. 9. 1, Table 3 for LRA]). Therefore, the post-LOCA external airborne cloud and CR filter shine doses are conservatively applied to the LRA in Section 8.1.

4.4.2 Control Room Source Term It is assumed consistent with RG 1.183 (Ref. 9. 1, Section 4.2.2), that the radioactive material releases and radiation levels used in the control room dose analysis are determined using the same source term, transport, and release assumptions used for determining the EAB and the.LPZ TEDE values. The parameters assumed for determining the EAB and LPZ TEDE values also result in conservative dose projections to the control room personnel.

4.4.3 Control Room Transport It is assumed consistent with RG 1.183 (Ref. 9.1, Section 4.2.3), that the models used to transport radioactive material into and through the control room, and the shielding models used to determine radiation dose rates from external sources, are structured to provide suitably conservative estimates of the exposure to control room personnel. These conservative assumptions include conservative values for unfiltered inleakage, minimum clean-up air flow rates, and minimum filter efficiencies. The shielding models are not developed to determine radiation dose rates from external sources because their dose contributions are insignificant compared to those from a LOCA (Section 4.4.1).

4.4.4 Control Room Response It is assumed consistent with RG 1.183 (Ref. 9.1, Section 4.2.4), that engineered safety features (ESF) are credited in mitigating airborne radioactive material within the control room. Such features include control room recirculation filtration. The CR isolation is actuated by radiation monitors (RMs). The Xe-133 concentration at the CR air intake instantaneously exceeds CR monitor setpoint of 1.OE-05 tCi/ml following a LRA (see Section 2.8). Therefore, a delay of 5 minutes for the CR isolation to be fully operational is considered to be conservative and no further sensitivity of delay time is required.

4.4.5 Control Room Operator Use of Dose Mitigating Devices It is assumed consistent with RG 1.183 (Ref. 9.1, Section 4.2.5), that credit is not taken for the use of personal protective equipment (e.g., protective beta radiation resistant clothing, eye protection, or self-contained breathing apparatus) or prophylactic drugs (i.e., potassium iodide [KI] pills).

& XceIEnergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 25 of 128 4.4.6 Control Room Occupancy Factors and Breathing Rates It is assumed consistent with RG 1.183 (Ref. 9.1, Section 4.2.6), that the CR dose receptor for these analyses is the hypothetical maximum exposed individual who is present in the control room for 100% of the time during the first 24 hours2.777778e-4 days 0.00667 hours 3.968254e-5 weeks 9.132e-6 months after the event, 60% of the time between I and 4 days, and 40% of the time from 4 days to 30 days. For the duration of the event, the breathing rate of this individual should be assumed to be 3.5 x 10.4 cubic meters per second. These assumptions are incorporated as design inputs in Section 5.5.

4.4.7 Control Room Dose Conversion Factors It is assumed consistent with RG 1.183 (Ref. 9.1, Section 4.2.7), that the control room doses are calculated using the offsite dose analysis dose conversion factors identified in RG 1.183 Regulatory Position 4.1 (see preceding Sections 4.3.2 & 4.3.4). The deep dose equivalent (DDE) from photons is corrected for the difference between finite cloud geometry in the control room and the semi-infinite cloud assumption used in calculating the dose conversion.factors. The RADTRAD Code (Ref. 9.2) used in this analysis uses the following expression to correct the semi-infinite cloud dose, DDE., to a finite cloud dose, DDEfinite, where the control room is modeled as a hemisphere that has a volume, V, in cubic feet, equivalent to that of the control room:

DDEfinite = (DDE0 , x V° 338 ) / 1173 4.4.8 Control Room Operator Dose Acceptance Criteria It is assumed that for the LRA the postulated CR dose should not exceed 5 Rem TEDE (per Section 3.1).

Xcel nergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 26 of 128 5.0 DESIGN INPUTS:

5.1 General Considerations 5.1.1 Applicability of Prior Licensing Basis As discussed in RG 1.183 (Ref. 9.1, Section 5.1.4), the implementation of an AST is a significant change to the design basis of the facility and assumptions and design inputs used in the analyses. The characteristics of the AST and the revised TEDE dose calculation methodology may be incompatible with many of the analysis assumptions and methods currently used in the facility's design basis analyses. The PINGP specific design inputs and assumptions used in the TID-14844 analyses were assessed for their validity to represent the as-built condition of the plant and evaluated for their compatibility to meet the AST characteristics and TEDE methodology. The analysis in this calculation ensures that analysis assumptions, design inputs, and methods are compatible with the requirements of the AST and the TEDE criteria. There are no unvalidated assumptions used in this calculation.

5.1.2 Credit for Engineered Safety Features Credit is taken only for those accident mitigation features that are classified as safety-related, are required to be operable by technical specifications, are powered by emergency power sources, and are either automatically actuated or, in limited cases, have actuation requirements explicitly addressed in emergency operating procedures. The dose mitigation features of the Control Room Special Ventilation System (CRSVS) are credited in the analysis. This system is safety related and operable by Technical Specification LCO 3.7.10 (Ref. 9.6.6). The CRSVS HEPA particulate removal filtration efficiency, and the CRSVS charcoal iodine removal filtration efficiencies used in the analysis are verified by the Ventilation Filter Testing Program in Technical Specification 5.5.9 (Ref. 9.6.8), which comply with Generic Letter (GL) 99-02 (Ref. 9.10) as demonstrated in Section 7.3. The CRSVS air intake monitors are required to be operable by TS 3.3.6 and Table 3.3.6-1 (Ref. 9.6.9) in Modes 1, 2, 3, & 4 and during movement of irradiated fuel assemblies. The CRSVS actuation during the LRA is credited in the analysis with a 5-minute system response delay.

5.1.3 Assignment of Numeric Input Values The numeric values chosen as inputs to this analysis are compatible to AST and TEDE dose criteria and selected with the objective of maximizing the postulated dose. The loss of offsite power for the entire duration of the event disabling the condenser, single failure of the motor driven AFW pump, 60/40 split of Groups I & 2 PORV steam releases, use of more than measured CR unfiltered inleakage, 5 minutes delay for CRSVS actuation and a 10% lower CR recirculation flow rate are conservatively used to maximize the resulting doses.

5.1.4 Meteorology Considerations The control room atmospheric dispersion factors (x,/Qs) are developed in Reference 9.5 using the NRC sponsored ARCON96 computer code. The release points for activity released to the environment are the Units 1 or 2 turbine driven auxiliary feedwater (TDAFW) pump exhaust and the Groups I & 2 PORV release locations (Ref. 9.3.1, Item #20).

Per the AST LOCA Calculation GEN-PI-079 (Ref. 9.13, Sections 2.4.1 & 2.4.2), the use of the CR air intake X/Qs are conservative for the CR unfiltered inleakage and are modeled for both the CR makeup flow during 0 to 5 minutes and the unfiltered inleakage for greater than 5 minutes.

XceI Energy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 27 of 128 The EAB and LPZ X/Qs used in this analysis were originally developed for the plant operating license and were accepted by the staff in the previous licensing proceedings.

5.2 Accident-Specific Desi2n Inputs/Assumptions The design inputs and assumptions utilized in this EAB, LPZ, and CR dose consequence analysis are listed in the following sections. The design inputs are compatible with the requirements of the AST characteristics and TEDE dose criteria and the assumptions are consistent with those identified in Section 4 and Appendix G of RG 1.183 (Ref. 9.1). The design inputs and assumptions in the following sections represent the as-built design of the plant.

XceI Energy, Calculation No. GEN-PI-083 RevisionNo. 0 Page No. 28 of 128 Design Input Parameter Value Assigned Reference Locked Rotor Accident Parameters 5.3 Source Terms 5.3.1 Licensed reactor core 1,650 MWt 9.6.1 thermal power level 1,683 MWt ( 102% of 1,650 MWt) 10% EPU Power Level Used in 1,852 MWt ( 110% of 1,683 MWt) the analysis 5.3.2 Proposed LCO for RCS 1.0 [tCi/gm DE Iodine-131 9.6.2, 9.6.5, & 9.18 iodine specific activity Modeled as 0.50 liCi/gm DE 1-131 per Ref. 9.18 5.3.3 Reactor Coolant System 100 / E-bar 9.6.3 (non-iodine) specific activity in 580 pCi/gm DE of Xe-133 Proposed limit is used in the the Technical Specifications analysis Section 2.3, Tables 6 & 7, Used in the analysis 5.3.4 Secondary coolant (iodine) 0. 1 iCi/gm DE lodine-131 9.6.2 & 9.6.4 specific activity in the Technical Specifications 5.3.5 Core activity inventory at 1683 MWt 9.9, Table 2-1 Isotope Activity (Ci) Isotope Activity (Ci) Isotope Activity (Ci) 1-131 4.50E+07 Kr-85 7.15E+05 Xe-133M 2.86E+06 1-132 6.51E+07 Kr-85M 1.08E+07 Xe-135 2.07E+07 1-133 9.13E+07 Kr-87 2.12E+07 Xe-135M 1.95E+07 1-134 1.02E+08 Kr-88 2.82E+07 Xe-138 7.72E+07 1-135 8.72E+07 Xe-131M 5.06E+05 Kr-83M 0.OOE+00 Xe-133 9.15E+07 5.3.6 RCS iodine activity concentration based on 1% fuel defects 9.9, Table 2-2 for HB x 1.04 Isotope Activity Isotope Activity (pCi/gm) Isotope Activity (tCi/gm) _ (ACi/gm) 1-131 2.55E+00 1-134 5.82E-01 1-132 2.80E+00 1-135 2.20E+00 1-133 3.88E+00 5.3.7 RCS noble )as activity concentration based on I%fuel defects 9.9, Table 2-2 for HB x 1.04 Isotope Activity Isotope Activity (gCi/gm) Isotope Activity (4Ci/gm) (WCi/gm)

Kr-83M 3.92E-01 Kr-88 2.89E+00 Xe-135 8.24E+00 Kr-85 1.09E+01 Xe-131M 2.05E+00 Xe-135M 5.02E-01 Kr-85M '1.59E+00 Xe-133 2.60E+02 Xe-138 6.09E-01 Kr-87 1.03E+00 Xe-133M 3.65E+00 5.3.8 Post-LRA failed fuel 20% 9.3.1, Item #3 5.3.9 Fission product inventory in Section 2.1 Fuel Rod Gap:

1-131 0.08 Other lodines (I & Br) 0.05 Kr-85 0.10 Other Noble Gases (Kr & Xe) 0.05

XceI Energy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 29 of 128 Design Input Parameter Value Assigned Reference 5.3.10 Radionuclide Composition 9. 1, Table 5 Group Elements Noble Gases Xe, Kr lodines I, Br AlkalifMetals Cs, Rb Tellurium Group Te, Sb, Se, Ba, Sr Noble Metals Ru, Rh, Pd, Mo, Tc, Co Lanthanides La, Zr, Nd, Eu, Nb, Pm, Pr, Sm, Y, Cm, Am Cerium Ce, Pu, Np 5.4 Activity Transport Models (Figure 1) 5.4.1 RCS operational leakage 150 gpd - one intact SG 9.6.7 through any one SG 300 gpd - two intact SGs Used in the analysis 5.4.2 Primary-to-Secondary leak 45.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months 9.3.1, Item #25 duration 5.4.3 Steam mass released from Table 10 intact SGs to the environment 0 - 2 hr 226,414 Ibm 2 - 8 hr 406,952 Ibm 8 - 24 hr 796,899 Ibm 24- 45.5 hr 863,053 Ibm 5.4.4 Turbine driven auxiliary 12,000 lbm/hr 0-2 hrs Table 10 feedwater pump exhaust, steam 11,000 lbm/hr 2-8 hrs release rate 9,500 lbm/hr 8-24 hrs 9,000 Ibm/hr 24-45.5 hrs 5.4.5 Nominal Reactor Coolant 5,290 ft3 9.9, Table 6-1 System volume 5.4.6 Steam generator dilution 9.3.1, Item #10 mass:

U1 Framatome ANP Model 56/19 107,100 lb @ Full Power U2 Westinghouse Model 51 107,420 lb @ Full Power 5.4.7 SG liquid iodine partition 100 9.1, Appendix E, Section 5.5.4 coefficient for SG liquid iodine & 9.3.1, Item #22 release 5.4.8 SG liquid iodine partition 100 9.1, Appendix E, Section 5.5.4 coefficient for P-T-S leakage & 9.3.1, Item #22 5.4.9 Chemical Form of Iodine In 9.1, Appendix G, Section 4 SG Releases Elemental 97%

Organic 3%

5.4.10 Steam condition at full load 519.2 0 F and 806.8 psia - Unit 1 9.14, page 1 of 2 510.8 0 F and 750 psia - Unit 2 5.4.11 Steam generator moisture 9.23 carryover:

Unit_

Unit 2

<_ 0.10 %

< 0.25 %

XceIEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 30 of 128 Design Input Parameter Value Assigned Reference 5.5 Control Room Model Parameters (Figure 2) 5.5.1 CR Volume 61,315 ft3 9.3.2, Item #6 5.5.2 CRSVS Normal Flow Rate 1,818 cfm +/- 10% 9.3.2, Item #10 2,000 cfm < 5 minutes Used in the analysis 5.5.3 CRSVS Makeup Rate 0 cfm > 5 minutes 9.3.2, Item #4 (CR operates in a recirculation mode) 5.5.4 CRSVS Recirc Flow Rate 4,000 cfm +/- 10% 9.3.2, Item #13 3,600 cfm > 5 minutes 5.5.5 CRSVS Charcoal Filter 95% for elemental iodine Section 7.3.1 Efficiencies 95% for organic iodide 5.5.6 CRSVS HEPA Filter 99% Section 7.3.2 Efficiency 5.5.7 CR Unfiltered Inleakage 300 cfm (includes 10 cfm for ingress 9.3.2, Item #11 Determined By Tracer Gas and egress) (nominal value including Testing uncertainty) 5.5.8 CR Breathing Rate 3.5E-04 m3/sec 9.1, Section 4.2.6 5.5.9 CR Allowable Dose Limit 5 rem TEDE for the event duration 9.4 5.5.10 CR occupancy factors Time (Hr) % 9.1, Section 4.2.6 0-24 100 24-96 60 96-720 40 5.5.11 Unit I CR air intake X/Qs for Unit I ADV / Turbine Driven Aux Feedwater Pump Exhaust release Time (Hr) X/Q (sec/m 3 )

0-2 4.66E-02 9.5, Table 6, Case 12a (which has 2-8 3.62E-02 less dispersion than Case 12b) 8-24 1.55E-02 24-96 1.12E-02 96-720 9.95E-03 5.5.12 Unit 2 CR air intake X/Qs for Unit 2 ADV / Turbine Driven Aux Feedwater Pump Exhaust release Time (Hr) X/Q (sec/m 3) 0-2 9.89E-03 9.5, Table 6, Case 22b (which has 2-8 7.51 E-03 less dispersion than Case 22a) 8-24 3.29E-03 24-96 2.23E-03 96-720 1.73E-03 5.5.13 Unit I CR air intake X/Qs for Unit I Safety & Relief Valve (PORV) Group 1 Release - Intact SG Time (Hr) X/Q (sec/m 3) 9.5, Table 6, Case 13a (which has 0-2 1.87E-02 less dispersion than Case 13b) 2-8 1.31E-02 8-24 5.51E-03 24-96 3.52E-03 96-720 2.76E-03

S XcelEnerg Calculation No. GEN-PI-083 Revision No. 0 Page No.31 of 128 ]

Design Input Parameter Value Assigned Reference 5.5.14 Unit 2 CR air intake x/Qs for Unit 2 Safety & Relief Valve (PORV) Group I Release - Intact SG Time (Hr) X/Q (see/mr3) 9.5, Table 6, Case 23b (which has 0-2 3.06E-02 less dispersion than Case 23a) 2-8 2.46E-02 8-24 1.11E-02 24-96 7.76E-03 96-720 6.14E-03 5.5.15 Unit I CR air intake x/Qs forUnit 1 Safety & Relief Valve (PORV) Group 2 Release - Intact SG Time (Hr) X/Q (sec/m 3 ) 9.5, Table 7, Case 14a (which has 0-2 1.89E-03 less dispersion than Case 14b) 2-8 1.35E-03 8-24 5.33E-04 24-96 3.54E-04 96-720 2.75E-04 5.5.16 Unit 2 CR air intake x/Qs for Unit 2 Safety & Relief Valve (PORV) Group 2 Release - Intact SG Time (Hr) X/Q (sec/mr3) 9.5, Table 7, Case 24b (which has 0-2 2.47E-03 less dispersion than Case 24a) 2-8 1.97E-03 8-24 8.76E-04 24-96 5.62E-04 96-720 4.32E-04 5.5.17 Limiting Weighted Average Unit 2 X/Qs Used In Analysis for Intact Steam Release via PORV and TDAFW Time (Hr) X/Q (sec/m 3) Table 13 0-2 1.83E-02 2-8 1.42E-02 8-24 6.30E-03 24-96 4.29E-03 96-720 3.38E-03 5.5.18 PORV Mass Release 60% from the Group I PORVs 9.3.1 Distribution 40% from the Group 2 PORVs 5.5.19 CR Monitor Setpoint 1.0E-05 [iCi/mi for Xe-133 9.3.2, Item # 9 5.6 Site Boundary Release Model Parameters 5.6.1 EAB Atmospheric 6.49E-04 sec/ 3 T9.3.3, Item #2 Dispersion Factor (x/Q) 5.6.2 EAB Breathing Rate 3.49E-04 9.1, Section 4.1.3 3

(m /sec) 5.6.3 LPZ Distance 2,414 m 9.3.3, Item #3 5.6.4 LPZ atmospheric dispersion factors (T/Qs)

Time (Hr) x/Q (sec/m 3) 9.3.3, Item #3 0-8 1.77E-04 8-24 3.99E-05 24-96 7.12E-06 96'720 1.04E-06

OXF cI Energy* Calculation No. GEN-PI-083 Revision No. 0 Page No. 32 of 128 }

Design Input Parameter Value Assigned Reference 5.6.5 LPZ breathing rates (m /sec)

Time (Hr) BR (m3/sec) 9. 1, Section 4.1.3 0-8 3.5E-04 8-24 1.8E-04 24-720 2.3E-04 5.6.6 EAB allowable dose limit 2.5 rem TEDE 9.1, Table 6 5.6.7 LPZ allowable dose limit 2.5 rem TEDE 9.1, Table 6

'3

I Xce nergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 33 of 128

6. COMPUTER CODES & COMPLIANCE WITH REGULATORY REQUIREMENTS 6.1 COMPUTER CODES:

RADTRAD 3.03 (Ref. 9.2) is an NRC-sponsored code approved for use in determining control room and offsite doses from releases due to reactor accidents. This code was used by the most of the AST license amendments that have been approved by the NRC. A rigorous high quality code qualification process was adopted to develop and procure the code by testing of the program elements, verification of input/output files, and examination of design specification. Therefore the RADTRAD3.03 computer code is considered to be qualified to comply with the quality assurance requirements of 10 CFR50, Appendix B and it can be safely used to perform the design basis accident analyses.

Calculation GEN-PI-079 (Ref. 9.13, Sections 2.6 & 8.2) documents a V&V of the RADTRAD3.03 code. Suitable acceptance test cases for the PWR radiological analysis were incrementally selected, initially defining simplified cases that could verified against analytical solutions, then adding complexity (typically a control room) and comparing the results against the RADTRAD3.03 and HABIT code analyses, adding more complexity (e.g., removal by decay chain) and comparing the results with the RADTRAD3.03 and HABIT codes again. The selected PWR code cases cover all essential characteristics of an LRA AST analysis, including transportation of activity within the compartment and in the atmosphere. All radiological features of the RADTRAD3.03 code were verified and validated by running the selected PWR code cases in the Microsoft Window XP environment. The results of V&V code cases were summarized in Calculation GEN-PI-079, Section 8.2, and compared with the RADTRAD3.03 and HABIT, code results, which showed an excellent agreement.

Therefore, the RADTRAD code is considered validated for use in this PINGP AST analysis.

6.2 COMPLIANCE WITH REGULATORY REQUIREMENTS:

As discussed in Section 4.0, Assumptions, the analysis in this calculation complies with the line-by-line requirements in Regulatory Guide 1.183 including its Appendix G.

XceI Energy Calculation No. GEN-PI-083 Revision No. 0 Page No. 34 of 128

7.0 CALCULATIONS

The LRA dose consequences are determined by summing together the results from a set of three RADTRAD code analyses that separately calculate the dose contributions from the primary-to-secondary (P-T-S) leakage iodine activity release, the P-T-S leakage noble gas activity release, and the secondary liquid iodine release.

RADTRAD Nuclide Inventory File (NIF) "PILRA_iodindef.txt" models the RCS nuclide inventory of Table 8. This inventory includes iodine and noble gas activity initially present in the RCS, including the RCS activity introduced by the 20% fuel failure from Table 1, and the initial RCS activity from Tables 5 and 7.

RADTRAD NIF "PILRA Liq_def.txt" models the secondary coolant iodine inventory of Table 9.

RADTRAD Release Fraction Timing (RFT) File "PINGPIodineRFT.txt" is used for iodine release by setting the iodine release fraction to 1.0 and all other release fractions to zero. RADTRAD RFT File "PILRANG RFT.txt" is used for noble gas release by setting the noble gas release fraction to 1.0 and all other release fractions to zero.

All three RADTRAD runs use Dose Conversion File (DCF) "PINGPfgl &l 2.txt", which uses CEDE inhalation DCFs from FGR-1 1 (Ref. 9.7), and EDE immersion DCFs from FGR-12 (Ref. 9.8).

7.1 Reactor Coolant & Steam Generator Coolant Mass 7.1.1 RCS Mass:

RCS water volume = 5,290 ft3 @ 560'F and 2235 psia (Ref. 9.9, Table 6-1 & Ref. 9.3.1, Item #24)

RCS specific volume at 560'F and 2235 psia = 0.02165 ft3/lb (Ref. 9.11, page 281)

RCS density at 560'F and 2235 psia = 1 / (0.02165 ft3/ib) = 46.19 lb/ft3 RCS water density at cooled liquid conditions = 62.4 lb/ft3 (Ref. 9.1, Appendix G, Section 5.2)

The RCS mass at cooled liquid conditions is:

RCS Mass = 5,290 ft3 x 62.4 lb/ft3 x 453.6 gm/lb = 1.497E+08 gm [used in Tables 5 and 7] (a larger mass yields a greater RCS activity inventory available for leakage) 7.1.2 SG Liquid Volume and Mass:

The steam generator (SG) tubes are expected to be submerged in the intact SGs coolant during the LRA event, with no tube uncovery (Ref. 9.3.1, Item #22). The iodine activity in the P-T-S leakage is assumed to mix with SG coolant without flashing during period of submergence (Ref. 9.1, Appendix G, Section 5.6 and Appendix E, Section 5.5.1).

The Unit 1 SGs are Framatome ANP Model 56/19 with a full power liquid mass of 107,100 lb (Ref. 9.3.1, Item #10). The Unit 2 SGs are Westinghouse Model 51 with a full power liquid mass of 107,420 lb (Ref. 9.3.1, Item #10). The total intact SG liquid volume is minimized by assuming that the secondary liquid mass is at cooled liquid conditions. Minimizing the intact SGs dilution volume will maximize the intact SGs liquid activity concentrations due to P-T-S leakage. Maximizing the intact SGs liquid activity concentration will conservatively maximize the intact SGs steaming activity releases to the environment.

Total intact SG liquid mass = 107,100 lb + 107,420 lb = 214,520 lb x 453.6 gm/lb = 9.731E+07 gm Total intact SG liquid volume = 214,520 lb / 62.4 lb/ft3 = 3,438 ft3

XceIEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 35 of 128 7.2 Post-LRA Release Rates 7.2.1 P-T-S Leakage Iodine and Noble Gas Release Rate Per Design Input 5.4.1, the primary to secondary leakage through any one SG is 150 gpd.

P-T-S volumetric leakage rate into intact SGs = 0.208 gpm ([ [2 SGs x 150 gpd/SG] / [24 hr/day x 60 min/hr])

P-T-S volumetric leakage rate into intact SGs = (0.208 gal/min) x (0.13368 ft3/gal) = 0.02781 cfm Per Regulatory Guide 1.183 (Ref. 9. 1, Appendix G, Section 5.2), the density of this P-T-S leakage at the time of surveillance test measurement is assumed to be 1.0 gm/cc (62.4 lb/ft3). Therefore, the P-T-S mass leakage rate into the intact SGs at measured conditions is:

P-T-S mass leakage rate at measured conditions = (0.02781 ft 3/min) x (62.4 lb/ft3) = 1.735 lb/min Per Section 7.1. 1, at the time of the LRA the RCS is operating at 5607F and 2235 psia with an RCS specific volume of 0.02165 ft3/lb. Therefore, the iodine and noble gas P-T-S volumetric leakage rate into the intact SGs at conditions present during the LRA is:

0-45.5 hr P-T-S volumetric leakage rate during the LRA = (1.735 lb/min) x (0.02165 ft31/b) 0-45.5 hr P-T-S volumetric leakage rate during the LRA = 0.0376 cfm of RCS liquid 0-45.5 hr iodine and noble gas P-T-S leakage rate from RCS to the intact SGs = 0.0376 cfm 7.2.2 Intact SGs PORVs Steaming Rates (P-T-S Leakage):

Unit I steam temperature @ full power = 519.2 0 F and 806.8 psia (Ref. 9.14)

Unit 1 liquid specific volume @ full power = 0.02089 ft 3/lbm (Ref. 9.11, page 182)

Unit 2 steam temperature @ full power = 510.8 0 F and 750 psia (Ref. 9.14)

Unit 2 liquid specific volume @ full power = 0.02069 ft 3/lbm (Ref. 9.11, page 182)

Unit I liquid specific volume of 0.02089 ft3/lbm is conservatively used in the following section to maximize the volumetric steaming rates:

The intact SGs tubes remain covered during the LRA, the iodine partition factor of 100 (Ref. 9.1, Appendix G, Section 5.6 and Appendix E, Section 5.5.4) is credited in calculating the steaming rate from the intact SGs:

Total mass of steam released from intact SG to the environment (0 - 2 hr) = 226,414 lb (Table 10)

Intact SG steamingrate (0 - 2 hr) = 226,414 lb x 0.02089 ft3/lb x (1/100) 0.3942 cfm'of Intact SG liquid 120 minutes Total mass of steam released from intact SG to the environment (2 - 8 hr) = 406,952 (Table 10)

Intact SG steaming rate (2 - 8 hr) = 406,952 lb x 0.02089 ft3/lb x (1/100) = 0.2361 cfm of Intact SG liquid 360 minutes Total mass of steam released from intact SG to the environment (8 - 24 hrs) = 796,899 lb (Table 10)

Intact SG steaming rate (8 -24 hr) = 796,899 lb x 0.02089 ft 3/lb x (1/100) = 0.1734 cfm of Intact SG liquid 960 minutes

XceI Energy Calculation No. GEN-PI-083 Revision No. 0 Page No. 36 of 128 Total mass of steam released from intact SG to the environment (24 - 45.5 hrs) = 863,053 lb (Table 10)

Intact SG steaming rate (24 -45.5 hr) = 863,053 lb x 0.02089 ft3/lb x (1/100) = 0.1398 cfm of Intact SG liquid 1290 minutes 0 - 2 hr iodine P-T-S leakage release from intact SG to the environment = 0.3942 cfm of Intact SG liquid 2 - 8 hr iodine P-T-S leakage release from intact SG to the environment = 0.2361 cfm of Intact SG liquid 8 - 24 hr iodine P-T-S leakage release from intact SG to the environment = 0.1734 cfm of Intact SG liquid 24 - 45.5 hr iodine P-T-S leakage release from intact SG to the environment = 0.1398 cfm of Intact SG liquid 7.2.3 Intact SGs - Iodine Release Rate - Secondary Liquid The steaming rates for the secondary liquid iodine releases from the intact steam generators are the same as the intact SGs iodine release rates calculated in Section 7.2.2.

0 - 2 hr iodine secondary liquid release from intact SG to the environment = 0.3942 cfm of Intact SG liquid 2 - 8 hr iodine secondary liquid release from intact SG to the environment = 0.2361 cfm of Intact SG liquid 8 - 24 hr iodine secondary liquid release from intact SG to the environment = 0.1734 cfm of Intact SG liquid 24 - 45.5 hr iodine secondary liquid release from intact SG to the environment 0.1398 cfm of Intact SG liquid 7.3 CRSVS Charcoal / HEPA Filter Efficiencies The Control Room Special Ventilation System (CRSVS) charcoal and HEPA filter efficiencies are modeled per the following table, based on the calculations performed in the following subsections.

Safety Grade Filter Efficiency Credited (%)

Filter Aerosol Elemental Organic CRSVS 99 95 95 7.3.1 CRSVS Charcoal Filter Efficiency Laboratory penetration testing acceptance criteria for the safety related Charcoal filters are as follows:

CRSVS Charcoal Filter - in-laboratory testing methyl iodide penetration < 2.5% (Ref. 9.6.8 Section 5.5.9.c)

Generic Letter 99-02 (Ref. 9.10) requires a safety factor of at least 2 to be used to determine the filter efficiencies to be credited in the design basis accident.

Testing methyl iodide penetration (%) = (100% - Tl)/safety factor (100% - rl)/2 Where q = charcoal filter efficiency to be credited in the analysis CRSVS Charcoal Filter:

2.5% = (100% - vj)/2 5% = (100% -q) i=100% - 5% = 95%

X IEn rgy Calculation No. GEN-PI-083 Revision No. 0 Page No. 37 of 128 7.3.2 CRSVS HEPA Filter Efficiency CRSVS HEPA Filter - in-place DOP penetration and bypass < 0.05% (Ref. 9.6.8 Section 5.5.9.a)

Generic Letter 99-02 (Ref. 9. 10) requires a safety factor of at least 2 to be used to determine the filter efficiencies to be credited in the design basis accident.

Testing DOP penetration (%) = (100% - il)/safety factor = (100% -,1)/2 Where ri = HEPA filter efficiency to be credited in the analysis CRSVS HEPA Filter:

0.05% = (100% - 11)/2 0.10% = (100%- -9)

'q = 100% - 0.10% = 99.9%

Regulatory Guide 1.52 (Ref. 9.24, Regulatory Position C.5.c) states that if the in-place penetration and bypass testing results are <0.05%, the condition can be considered to warrant a 99% removal efficiency for particulates in accident dose evaluations. Therefore, a HEPA filter efficiency of 99% is used in the analysis.

Safety Grade Filter Efficiency Credited (%)

Filter Aerosol Elemental I Organic CRSVS 99 95 95 I

&W ce Energy Calculation No. GEN-PI-083 Revision No. 0 Page No. 38 of 128 8.0 RESULTS

SUMMARY

/CONCLUSIONS:

8.1 Result Summary The post-LRA EAB, LPZ, and CR doses are summarized in the following table:

Post-LRA Post-LRA TEDE Dose (Rem)

Activity Release Receptor Location Path Control Room EAB LPZ P-T-S Iodine Release ISG 3.68E+00 3.90E-01 2.14E-01 PLRINIDOI.oO (occurs @ 24 hrs)

P-T-S Noble Gas Release ISG 1.22E-01 9.57E-02 5.59E-02 PLRAINGO I.oO (occurs @ 0.0 hrs)

Liquid Iodine Release ISG 9.78E-03 1.17E-03 9.66E-04 PLRAINLQOI .oO (occurs @ 0.0 hrs)

External Cloud* 3.70E-02 0.OOE+00 0.00E+00 CR Filter Shine* 4.71E-02 0.00E+00 0.OOE+00 Total 3.90E+00 4.87E-01 2.71E-01 Allowable TEDE Limit 5.OOE+00 2.50E+00 2.50E+00 ISG = Intact SG

Post-LOCA External Cloud & CR Filter Shine Doses Used From Reference 9.13, Section 8.1 8.2 Conclusions The results of analysis in Section 8.1 indicate that the EAB, LPZ, and CR doses are within allowable limits for an LRA. The calculated doses have adequate margins over the allowable dose limits for future safe operation of the plant.

The proposed new LCO 3.4.17 for Reactor Coolant System Specific Activity is 580 ýtCi/g DE of XE-133 based on the primary coolant noble gas activity corresponding to 1% failed fuel with the following changes:

0 Delete the definition of "E-Bar," AVERAGE DISINTEGRATION ENERGY 0 Add a new definition for DOSE EQUIVALENT XE-133

Revise definition for DOSE EQUIVALENT 1-131 to refer to FGR-l I thyroid inhalation dose conversion factors

Revise LCO 3.4.17, "RCS Specific Activity, to delete references to gross specific activity 0 Reference limit on DOSE EQUIVALENT XE-133

Revise SR 3.4.16.1 to verify the limit for DOSE EQUIVALENT XE-133

XceI Energy' Calculation No. GEN-PI-083 Revision No. 0 Page No. 39 of 128

9.0 REFERENCES

1. U.S. NRC Regulatory Guide 1.183, Alternative Radiological Source Terms for Evaluating Design Basis Accidents at Nuclear Power Reactors, July 2000

2. S.L. Humphreys et. al., "RADTRAD: A Simplified Model for Radionuclide Transport and Removal and Dose Estimation," NUREG/CR-6604, USNRC, December 1997

3. Design Input Transmittal Nos.

3.1 DIT No. 13720-09, Rev. 0, LR Input Parameters 3.2 DIT No. 13720-07, Rev. 1, Control Room Input Parameters 3.3 DIT No. 13720-03, Rev. 0, Meteorological Input Parameters

4. 10 CFR 50.67, "Accident Source Term"

5. PINGP Calculation No. GEN-PI-049, Rev 0 and Addendum 2, PI Control Room Atmospheric Dispersion Factors (x/Q)

6. PINGP Units I & 2 Technical Specifications (TS):

6.1 Specification 1.1, PINGP Units I & 2, Rated Thermal Power 6.2 Specification 1.1, PINGP Units I & 2, Dose Equivalent 1-131 6.3 Specification 1.1, PINGP Units I & 2, E-bar Average Disintegration Energy 6.4 Specification 3.7.14, PINGP Units 1 & 2 Limiting Condition for Operation (LCO) for Secondary Specific Activity 6.5 Specification 3.4.17, PINGP Units I & 2 LCO for RCS Specific Activity 6.6 Specification 3.7.10, PINGP Units I & 2 LCO for Control Room Special Ventilation System (CRSVS) 6.7 Specification 3.4.14, PINGP Units 1 & 2 LCO FOR RCS Operational Leakage 6.8 Specification 5.5.9, PINGP Units I & 2 Ventilation Filter Testing Program (VFTP) 6.9 Specification 3.3.6, PINGP Units I & 2 LCO for Control Room Special Ventilation System (CRSVS) Actuation Instrumentation and Table 3.3.6-1, PINGP Unit I/Unit 2 LCO for Radiation Monitoring Instrumentation

7. Federal Guidance Report 11, EPA-520/1-88-020, Environmental Protection Agency

8. Federal Guidance Report 12, EPA-402-R-93-081, Environmental Protection Agency

9. Westinghouse Letter NSP-07-59, LTR-PEP-07-26, Nuclear Management Company, Prairie Island Units I & 2, MUR Power Uprate Program, Core Activity Inventory and Coolant Activity Concentration, November 2, 2007.

10. USNRC Generic Letter 99-02, "Laboratory Testing of Nuclear-Grade Activated Charcoal", June 3, 1999

11. ASME Steam Tables, Sixth Edition

12. NUREG-0800, Standard Review Plan, "Radiological Consequence Analyses Using Alternative Source Terms," SRP 15.0.1, Rev. 0, July 2000

13. PINGP Calculation No. GEN-PI-079, Rev 0, Post-LOCA EAB, LPZ, and CR Doses - AST

14. PINGP USAR Table 4.1-5, Rev 27, Steam Generator Design Data

XceI Energy Calculation No. GEN-PI-083 Revision No. 0 Page No. 40 of 128

15. PINGP Calculation No. 12400604-UR(B)-002, Rev 0, Locked Rotor Accident Dose Consequences

16. Technical Specification Task Force Improved Standard Technical Specifications Change Traveler TSTF-490, Rev 0, "Deletion of E Bar Definition and Revision to RCS Specific Activity Tech Spec"

17. PINGP Procedure Nos:

17.1 1ES-0.3A, Rev 14, Natural Circulation Cooldown With CRDM Fans 17.2 1ES-0.3B, Rev 11, Natural Circulation Cooldown Without CRDM Fans

18. PINGP License Amendment Request (LAR) L-PI-08-052, LAR to Revise the Loss of Coolant Accident (LOCA) and Main Steam Line Break Accident (MSLB) Dose Consequences Analyses and Affected Technical Specifications (TS), June 26, 2008

19. PINGP Flow Diagram No. NF-39603-1, Rev 76, Including T-Mod EC 14090, Admin Bldg, Screen House, & Control RM Flow Diagram

20. PINGP USAR Appendix D Section D.2, Rev 27, Activity In Fuel Gap

21. PINGP Calculation No. GEN-PI-047, Rev 0, Addendum 1, FHA Fission Product Inventories for AST Assessments

22. Prairie Island Nuclear Generating Plant Amendment Nos. 166 and 156 to Operating License Nos. DPR-42 and DPR-60, respectively, Selective Implementation Of Alternate Source Term For Fuel Handling Accidents (TAC Nos. MCI1843 and MCI1844), September 10, 2004, NRC ADAMS Accession Number ML042430504

23. PINGP USAR Section 4.3.2.1. 1, Rev 28, Steam Generators

24. U.S. NRC Regulatory Guide 1.52, Revision 2, "Design, Testing, and Maintenance Criteria for Post Accident Engineered-Safety-Feature Atmosphere Cleanup System Air Filtration and Adsorption Units of Light-Water-Cooled Nuclear Power Plants", March 1978

Xoel Energy Calculation No. GEN-PI-083 Revision No. 0 Page No. 41 of 128 10.0 TABLES:

Table I Post-LRA Design Basis Failed Fuel Gap Activity Release Isotopic Fraction of Fraction Failed Fuel

- Core Fission Failed Fuel Gap Inventory Product Activity Isotope at 1683 MWt Inventory Release (Ci) In Gap (Ci)

A B C D=AxBxC 1-131 4.50E+07 0.08 0.20 7.20E+05 1-132 6.51E+07 0.05 0.20 6.5 1 E+05 1-133 9.13E+07 0.05 0.20 9.13E+05 1-134 1.02E+08 0.05 0.20 1.02E+06 1-135 8.72E+07 0.05 0.20 8.72E+05 KR-83M 0.00E+00 0.05 0.20 0.OOE+00 KR-85 7.15E+05 0.10 0.20 1.43E-04 KR-85M 1.08E+07 0.05 0.20 1.08E+05 KR-87 2.12E+07 0.05 0.20 2.12E+05 KR-88 2.82E+07 0.05 0.20 2.82E+05 XE-131M 5.06E+05 0.05 0.20 5.06E+03 XE-133 9.15E+07 0.05 0.20 9.15E+05 XE-133M 2.86E+06 0.05 0.20 2.86E+04 XE-135 2.07E+07 0.05 0.20 2.07E+05 XE-135M 1.95E+07 0.05 0.20 1.95E+05 XE-138 7.72E+07 0.05 0.20 7.72E+05 A From Reference 9.9, Table 2-1, based on 1683 MWt per Reference 9.9, Section 1.2 B From Regulatory Guide 1.183 (Ref. 9.1, Table 3)

C From Reference 9.3.1, Item # 3 Table IA Comparison of Gap Fractional Releases for Prairies Island Fuel Rod To RG 1.183, Table 3 Radionuclide Fractional Release Or Bounding RG 1.183 Radionuclide Prairie Island Table 3 Group Result A B 1-131 0.036 0.08 Kr-85 0.056 0.10 Other Noble Gases 0.024 0.05 Other Halogens 0.013 0.05 Alkali Metals 0.072 0.12 A From Reference 9.20 B From Regulatory Guide 1.183 (Ref. 9.1, Table 3)

Xci elEnrgy- ICalculation No. GEN-PI-083 Revision No. 0 Page No. 42 of 128 Table 2 Iodine Isotopic Dose Conversion Factors Thyroid Radiation Units Thyroid Inhalation Conversion Inhalation Dose Factors Dose Isotope Conversion 11 Sv = 100 Rem] Conversion Factor 13.7E10 Bq = I Cif Factor (Sv/Bq) (rem/Ci per Sv/Bq) (rem/Ci)

A B C=AxB 1-131 2.92E-07 3.70E+12 1.08E+06 1-132 1.74E-09 3.70E+ 12 6.44E+03 1-133 4.86E-08 3.70E+12 1.80E+05 1-134 2.88E-10 3.70E+12 1.07E+03 1-135 8.46E-09 3.70E+ 12 3.13E+04 (A) From Reference 9.7, Page 136 Table 3 Iodine Scaling Factor for 1-131 Dose Equivalent 1% Fuel Defect Thyroid Iodine Inhalation Activity Dose Product Isotope Concentration Conversion Factor (gCi/gm) (rem/Ci) (liCi.rem / Ci.gm)

A B (A x B) 1-131 2.55E1+00 1.08E+06 2.76E+06 1-132 2.80E+00 6.44E+03 1 .80E+04 1-133 3.88E+00 1.80E+05 6.98E+05 1-134 5.82E-01 1.07E+03 6.20E+02 1- 135 2.20E+00 3.13E+04 6.89E+04 Total 3.54E+06 1-131 DE Based on 1% FF Iodine Concentration (ItCi/gm); (C)I 3.28E+00 Iodine Scaling Factor Based on 0.50 gCi/gm DE 1-131; (D) I.526E-01 (A) From Reference 9.9, Table 2-2 for HB x 1.04, based on 1683 MWt per Reference 9.9, Table 6-1 (C) = Total / Iodine-131 Thyroid Inhalation Dose Conversion Factor (D) = 0.50 piCi/gm DE 1-131 / C

9~XceIcnergy~ Calculation No. GEN-PI-083 Revision No. 0 Page No. 43 of 128 Table 4 RCS 0.50 gtCi/gm DE 1-131 Iodine Concentration 1% Failed Fuel Iodine 0.50 g+/-Ci/g Iodine Scaling DE 1-13 1 Isotope Activity Factor Iodine Concentration 0.50 pCi/gm Concentration (pCi/gm) DE 1-131 (PCi/gm)

A B C=AxB 1-131. 2.55E+00 1.526E-01 3.891E-01 1-132 2.80E+00 1.526E-01 4.272E-01 1-133 3.88E+00 1.526E-01 5.920E-01 1-134 5.82E-01 1.526E-01 8.880E-02 1-135 2.20E+00 1.526E-01 3.357E-01 A From Reference 9.9, Table 2-2 for HB x 1.04, based on 1683 MWt per Reference 9.9, Table 6-1 B From Table 3 Table 5 1% Failed Fuel RCS Iodine Activity 1% Fuel Defect Reactor Total RCS Iodine Coolant Pre-Accident Isotope Activity Mass RCS Iodine Concentration Activity (itCi/gm) (gin) (Ci)

A B C = (A x B)/1E6 1-131 2.55E+00 1.497E+08 3.817E+02 1-132 2.80E+00 1.497E+08 4.192E+02 1-133 3.88E+00 1.497E+08 5.808E+02 1-134 5.82E-01 1.497E+08 8.713E+01 1-135 2.20E+00 1.497E+08 3.293E+02 (A) From Reference 9.9, Table 2-2 for HB x 1.04, based on 1683 MWt per Reference 9.9, Table 6-1 (B) Reactor coolant mass from Section 7.1.1

XceI Energy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 44 of 128 Table 6 Dose Equivalent of Xenon-133 1% Failed Submersion Noble Fuel RCS Dose Product Gas Activity Coefficient Nuclide (gCi/gm) (Sv M3 / Bq s) (gtCi/gm

Sv M3 Bq s)

A B C=AxB KR-85 1.09E+01 1.19E-16 1.297E- 15 KR-85M 1.59E+00 7.48E-15 1.189E-14 KR-87 1.03E+00 4.12E- 14 4.244E-14 KR-88 2.89E+00 1.02E- 13 2.948E-13 XE-13 IM 2.05E+00 3.89E-16 7.975E-16 XE-133 2.60E+02 1.56E-15 4.056E-13 XE-133M 3.65E+00 1.37E-15 5.001E-15 XE-135 8.24E+00 1.19E-14 9.806E-14 XE-135M 5.02E-01 2.04E-14 1.024E-14 Xe-138 6.09E-01 5.77E- 14 3.514E- 14 Total (.gCi/gm

Sv / Bq s m3) 9.052E-13 Xe-133 DE Based on 1% FF NG Concentration (laCi/gm) 580 A From Reference 9.9, Table 2-2 for HB x 1.04, based on 1683 MWt per Reference 9.9, Table 6-1 (Kr-83M omitted per definition of Dose Equivalent XE-133)

B From FGR 12, Table 111.1 Table 7 Total RCS Noble Gas Activity 1% Fuel Defect Reactor Total RCS Noble Gas Coolant Pre-Accident Isotope Activity Mass RCS Noble Gas Concentration Activity jtCi/gm) (gm) (Ci)

A B C =(A x B) 1E6/

KR-83M 3.92E-01 1.497E+08 5.868E+01 KR-85 1.09E+01 1.497E+08 1.632E+03 KR-85M 1.59E+00 1.497E+08 2.380E+02 KR-87 1.03E+00 1.497E+08 1.542E+02 KR-88 2.89E+00 1.497E+08 4.326E+02 XE-131M 2.05E+00 1.497E+08 3.069E+02 XE-133 2.60E+02 1.497E+08 3.892E+04 XE-133M 3.65E+00 1.497E+08 5.464E+02 XE-135 8.24E+00 1.497E+08 1.234E+03 XE- 135M 5.02E-0 1 1.497E+08 7.515E+01 Xe-138 6.09E-01 1.497E+08 9.117E+01 (A) From Reference 9.9, Table 2-2 for HB x 1.04, based on 1683 MWt per Reference 9.9, Table 6-1 (B) Reactor coolant mass from Section 7.1.1

S XcelEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 45 of 128 Table 8 Total LRA Activity Initially Present in the RCS Failed Fuel Total Total Core RADTRAD Gap RCS Post-LRA Thermal Nuclide Activity Iodine & NG Activity Power Inventory File Isotope Release Activity In RCS Level PLRAiodindef.txt (Ci) (Ci) (Ci) (MW,) (Ci/MW,)

A B C=A+B D E 1-131 7.200E+05 3.817E+02 7.204E+05 1683 .4280E+03 1-132 6.510E+05 4.192E+02 6.514E+05 1683 .3871E+03 1-133 9.130E+05 5.808E+02 9.136E+05 1683 .5428E+03 1-134 1.020E+06 8.713E+01 1.020E+06 1683 .6061E+03 1-135 8.720E+05 3.293E+02 8.723E+05 1683 .5183E+03 KR-83M 0.OOOE+00 5,868E+01 5.868E+01 1683 .3487E-01 KR-85 1.430E+04 1.632E+03 1.593E+04 1683 - .9466E+01 KR-85M 1.080E+05 2.380E+02 1.082E+05 1683 .6431E+02 KR-87 2.120E+05 1.542E+02 2.122E+05 1683 .1261E+03 KR-88 2.820E+05 4.326E+02 2.824E+05 1683 .1678E+03 XE-131M 5.060E+03 3.069E+02 5.367E+03 1683 .3189E+01 XE-133 9.150E+05 3.892E+04 9.539E+05 1683 .5668E+03 XE-133M 2.860E+04 5.464E+02 2.915E+04 1683 .1732E+02 XE-135 2.070E+05 1.234E+03 2.082E+05 1683 .1237E+03 XE-135M 1.950E+05 7.515E+01 1.951E+05 1683 .1159E+03 Xe-138 7.720E+05 9.117E+01 7.721E+05 1683 .4588E+03 A, D From Table 1, based on 1683 MWt per Reference 9.9, Section 1.2 and Table 2-1 B, D From Tables 5 and 7, based on 1683 MWt per Reference 9.9, Table 6-1 Table 9 Total LRA Iodine Activity Initially Present in the Secondary Coolant 0.50 I1Ci/g Tech Spec Coolant Mass Total RADTRAD DE 1-131 Secondary In Both Intact Pre-Accident Nuclide Iodine Coolant Steam Secondary Inventory File Isotope Specific Coolant Concentration Activity Limit Generators Iodine Activity PILRAliqdef (gCi/gm) (unitless) (gm) (ACi) (Ci/MWt)

A B C D=(AxBxC)/0.50 E = D /(1683 x 1E6) 1-131 3.891E-01 0.10 9.731E+07 7.573E+06 .4500E-02 1-132 4.272E-01 0.10 9.731E+07 8.315E+06 .4940E-02 1-133 5.920E-01 0.10 9.731E+07 1.152E+07 .6846E-02 1-134 8.880E-02 0.10 9.731E+07 1.728E+06 .1027E-02 1-135 3.357E-01 0.10 9.73 1E+07 6.533E+06 .3882E-02 A, E From Table 4, based on 1683 MWt per Reference 9.9, Table 6-1 B From Reference 9.6.4 C From Section 7.1.2

XcelEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 46 of 128 Table 10 Steam Mass Releases From Intact SG & AFW Turbine Post-LRA Auxiliary Feedwater Turbine Intact Fraction of Steam Mass Time Steam Steam Steam SG Release Release Interval End Mass Mass Mass Mass From From Release Release Rate Release Release AFW Intact (hr) (Ibm) (Ibm/hr) (Ibm) (Ibm) Turbine SG T A B C D=A-C E=C/A F=D/A 2 226,414 12,000 24,000 202,414 0.106 0.894 8 406,952 11,000 66,000 340,952 0.162 0.838 24 796,899 9,500 152,000 644,899 0.191 0.809 45.5 863,053 9,000 193,500 669,553 0.224 0.776 A & B From Reference 9.3.1, Item #26 Table 11 Post-LRA Intact SG Release P-T-S intact SG Release Release Leakage To Iodine, Noble gas, & SG Liquid Iodine Release Intact SG Category (cfm) (cfm) (cfm) (cfm) (cfm)

A B C D E Iodine 0.0376 0.3942 0.2361 0.1734 0.1398 Release 0-45.5 hr 0-2 hr 2-8 hr 8-24 hr 24-45.5 hr Noble Gas 0.0376 0.0376 Release 0-45.5 hr 0-45.5 hr SG Liquid N/A 0.3942 0.2361 0.1734 0.1398 Iodine Release 0-2 hr 2-8 hr 8-24 hr 24-45.5 hr Release Points Safety & PORV Groups I & 2 Release Points and TDAFW Point A For Iodine Release From Section 7.2.1 A For Noble Gas Release From Section 7.2.1 B Through E For Iodine & Noble Gas Releases From 7.2.2 B Through E For SG Liquid Iodine Release From 7.3.3

Xcelnergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 47 of 128 Table 12 Average Unit 1 Atmospheric Dispersion Factor (x/Q) for Intact Steam Release via PORV and TDAFW Unit 1 Steam Release Location Fraction of Steam Mass Steam ADV/AFW Group I Group 2 Average Release Release Mass Release Time Exhaust PORV PORV PORV From From Averaged Interval X/Qs x/Qs X/Qs X/Qs AFW Intact X/Qs (hr) 3 (s/m ) (s/m )3 (s/m )3 3 (s/m ) Turbine SG PORV (s/m 3)

A B C D= 0.6B + 0.4C E F G=AxE+D*F 0-2 4.66E-02 1.87E-02 1.89E-03 1.20E-02 0.106 0.894 1.56E-02 2-8 3.62E-02 1.31E-02 1.35E-03 8.40E-03 0.162 0.838 1.29E-02 8 -24 1.55E-02 5.51E-03 5.33E-04 3.52E-03 0.191 0.809 5.81E-03 24 -96 1.12E-02 3.52E-03 3.54E-04 2.25E-03 0.224 0.776 4.26E-03 96 -720 9.95E-03 2.76E-03 2.75E-04 1.77E-03 0.224 0.776 3.60E-03 A from Reference 9.5, Table 6, Case 12a B from Reference 9.5, Table 7, Case 13a C from Reference 9.5, Table 8, Case 14a D from Reference 9.3.1 E & F from Table 10; 96 to 720 hours0.00833 days 0.2 hours 0.00119 weeks 2.7396e-4 months data set to 24 - 96 hours0.00111 days 0.0267 hours 1.587302e-4 weeks 3.6528e-5 months data with no impact since release stops at 45.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months Table 13 Average Unit 2 Atmospheric Dispersion Factor (XTQ) for Intact Steam Release via PORV and TDAFW Unit 2 Steam Release Location Fraction of Steam Mass Steam ADV/AFW Group I Group 2 Average Release Release Mass Release Time Exhaust PORV PORV PORV From From Averaged Interval X/Qs X/Qs X/Qs X/Qs AFW Intact X/Qs (hr) (s/m 3) (s/m 3 ) (s/m 3) (s/m 3) Turbine SG PORV (s/m 3)

A B C D = 0.6B + 0.4C E F G=AxE+D*F 0-2 9.89E-03 3.06E-02 2.47E-03 1.93E-02 0.106 0.894 1.83E-02 2- 8 7.51E-03 2.46E-02 1.97E-03 1.55E-02 0.162 0.838 1.42E-02 8-24 3.29E-03 1.I1E-02 8.76E-04 7.01E-03 0.191 0.809 6.30E-03 24 - 96 2.23E-03 7.76E-03 5.62E-04 4.88E-03 0.224 0.776 4.29E-03 96- 720 1.73E-03 6.14E-03 4.32E-04 3.86E-03 0.224 0.776 3.38E-03 A from Reference 9.5, Table 6, Case 22b B from Reference 9.5, Table 7, Case 23b C from Reference 9.5, Table 8, Case 24b D from Reference 9.3.1 E & F from Table 10; 96 to 720 hours0.00833 days 0.2 hours 0.00119 weeks 2.7396e-4 months data set to 24 - 96 hours0.00111 days 0.0267 hours 1.587302e-4 weeks 3.6528e-5 months data with no impact since release stops at 45.5 hours5.787037e-5 days 0.00139 hours 8.267196e-6 weeks 1.9025e-6 months

XceIEnergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 48 of 128 Table 14 Alkali Inhaled Isotopic Dose Conversion Factors Isotopic Conversion Iodine Fractional Dose Factor Dose Iodine Isotope Conversion Conversion Dose Factor Factor Conversion Factor (Sv/Bq) (rem/Ci/Sv/Bq) (rem/Ci)

A B C=AxB D=C/1.08E+06 1-131 2.92E-07 3.70E+12 1.08E+06 1.00E+00 Rb-86 1.33E-09 3.70E+ 12 4.92E+03 4.56E-03 Rb-88 1.37E-12 3,70E+12 5.07E+00 4.69E-06 Rb-89 1.61E-12 3,70E+12 5.96E+00 5.52E-06 Cs-134 1.11E-08 3.70E+12 4.11E+04 3.80E-02 -

Cs-136 1.73E-09 3.70E+12 6.40E+03 5.93E-03 Cs-137 7.93E-09 3.70E+12 2.93E+04 2.72E-02 Cs-138 3.57E-12 3.70E+12 1.32E+01 1.22E-05 A From Reference 9.7. Table 2.1

XceI Energy. Calculation No. GEN-PI-083 Revision No. 0 Page No. 49 of 128 11.0 FIGURES:

Noble Gas Release 0.0376 cfm 0- 45.5 hrs

4 Reactor Coolant System V=5,290 ft3 Figure 1: RADTRAD Nodalization For Post-LRA Iodine & Noble Gas Releases

-P-T-S Leakage and Intact SG Secondary Liquid Iodine Release

-. _ P-T-S Leakage Noble Gas Release

XceIEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 50 of 128 CR Unfiltered Inflow 2,000 cfm < 5 min r 300 cfm > 5 min 2,000 cfm < 5 min iN CONTROL ROOM CR Unfiltered Inleakage 300 cfm > 5 min V = 61,315 ft3 HEPA T1= 99%

Charcoal I= 95%

Figure 2 - RADTRAD Nodalization For Control Room Response

Xce Energy Calculation No. GEN-PI-083 Revision No. 0 Page No.51 of 128 12.0 AFFECTED DOCUMENTS:

Upon approval of the AST Licensing Change Request, the following documents will be revised or superseded:

12.1 PINGP Calculation No. 12400604-UR(B)-002, Rev 0, Locked Rotor Accident Dose Consequences 13.0 ATTACHMENTS: 3.1 - RADTRAD Output File PLRINIDO1 .oO 3.2 - RADTRAD Output File PLRAINGO1 .oO 3.3 - RADTRAD Output File PLRAINLQOI.oO 3.4 - Modified RADTRAD Dose Conversion File PINGPfg 11 & 12.txt I

S Xcelnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 52 of 128 Attachment 13.1 RADTRAD Output File PLRINID01.oO

1. 1. 1. 1. 4######*##ý################################4#######################

RADTRAD Version 3.03 (Spring 2001) run on 5/25/2009 at 2:06:20 4####4##4#########4##########4##44############44#4###f~4##4#####4#####

File information

1. 1. 1. 1. 4##########################################

Plant file = G:\Radtrad 3.03\Input\PI\GEN-PI-083\PLRINIDOl.psf Inventory file = g:\radtrad 3.03\defaults\pilra iodin def.txt Release file = g:\radtrad 3.03\defaults\pingp iodine rft.txt Dose Conversion file g:\radtrad 3.03\defaults\pingp fgll&12.txt J

4. # # 4# 4 #

4 4 #4# ~ 4

1. 1. 1. #### # # # 4 #####

4# # # ## 4

# # 4 ## # # #

1. 1. 1. 4 4 # # #

Radtrad 3.03 4/15/2001 PINGP 1 & 2 Locked Rotor Accident AST Analysis - P-T-S Leakage Iodine Release From Intact SG Nuclide Inventory File:

g:\radtrad 3.03\defaults\pilra iodin def.txt Plant Power Level:

1.8520E+03 Compartments:

4 Compartment 1:

RCS 3

5.2900E+03 0

0 0

Compartment 2:

Environment 2

0.OOOOE+00 0

0 0

Compartment 3:

Control Room

XceI Energy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 53 of 128 1

6. 1315E+04 0

0 1

0 0

Compartment 4:

Intact SG 3

3.4380E+03 0

0 0

Pathways:

4 Pathway 1:

RCS to Intact SG 1

4 2

Pathway 2:

Environment to Control Room 2

3 2

Pathway 3:

Control Room to Environment 3

2 2

Pathway 4:

Intact SG to Environment 4

2 2

End of Plant Model File Scenario Description Name:

Plant Model Filename:

Source Term:

1 1 1.OOOOE+00 g:\radtrad 3.03\defaults\pingpfgll&12.txt g:\radtrad 3.03\defaults\pingpiodine rft.txt o.0000E+00 1

0.OOOOE+00 9.7000E-01 3.OOOOE-02 1.0000E+00 Overlying Pool:

0 0.OOOOE+00 0

0 0

0 Compartments:

4

XceI Eergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 54 of 128 Compartment 1:

0 1

0 0

0 Compartment 2:

0 1

0 0

0 Compartment 3:

1 1

0 0

1

3. 6000E+03 3

0.OOOOE+00 0.OOOOE+00 0.0000E+00 o.OOOOE+00 8 .3300E-02 9. 9000E+01 9. 5000E+01 9. 5000E+01

7. 2000E+02 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0

0 Compartment 4:

0 1

0 0

Pathways:

4 Pathway 1:

0 0

0 1

2

0. OOOOE+00 3.7600E-02 0.OOOOE+00 0.OOOOE+00 O.OOOOE+00 4 .5500E+01 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 O.OOOOE+00 0

0 0

XceIfnergy ICalculation No. GEN-PI-083 Revision No. 0 Page No. 55 of 128 0

0 0

Pathway 2:

0 0

3

0. OOOOE+O0 2.OOOOE+03 0.OOOOE+00 0.OOOOE+00 o.OOOOE+00

8. 3300E-02 3.OOOOE+02 o.OOOOE+00 0.OOOOE+00 o.OOOOE+00 7 .2000E+02 I0.OOOOE+00 o.OOOOE+00 0.OOOOE+00 0o0000E+00 0

0 0

0 Pathway 3:

0 0

0 3

o .OOOOE+00 2.OOOOE+03 o.OOOOE+00 0.OOOOE+00 o.OOOOE+00 8.3300E-02 3.OOOOE+02 0.OOOOE+00 o.OOOOE+00 o.OOOOE+00 7.2000E+02 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0

0 0

Pathway 4:

0 0

0~

1 5

0. OOOOE+00 3. 9420E-01 0.OOOOE+00 0.OOOOE+00 o.OOOOE+00

2. OOOOE+00 2. 3610E-01 0.OOOOE+00 0.OOOOE+00 o.OOOOE+00

8. OOOOE+00 1.7340E-01 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00

2. 4000E+01 1. 3980E-01 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00

4. 5500E+01 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0

0 0

0 Dose Locations:

3 Location 1:

Exclusion Area Boundary

XceI Eergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 56 of 128 2

1 2

o.OOOOE+00 6.4900E.-04 7.2000E+02 0.0000E+00 1

2 o.'0000E+00 3.5000E-04 7.2000E+02 o.0000E+00 0

Location 2:

Low Population Zone 2

1 5

0.0000E+00 1.7700E-04 8.0000E+00 3.9.900E-05 2.4000E+01 7.1200E-06

9. 6000E+01 1.0400E-06 7.2000E+02 0.0000E+00 1

4 0.0000E+00 3.5000E-04 8.0000E+00 1.8000E-04 2 .4000E+01 2.3000E-04 7.2000E+02 o.0000E+00 0

Location 3:

Control Room 3

0 1

2 0.0000E+00 3.5000E-04 7.2000E+02 0.0000E+00 1

4 0.OOOOE+00 1.0000E+00 2.4000E+QI 6.0000E-01 9.6000E+01 4.OOOOE-01 7.2000E+02 0.OOOE+00 Effective Volume Location:

1 I 6

0.OOOOE+00 1.8300E-02 2.OOOOE+00 *1.4200E-02 8.0000E+00 6.3000E-03 2.4000E+01 4.2900E-03 9.6000E+01 3.3800E-03 7.2000E+02 0.0000E+00 Simulation Parameters:

6 0.OOOOE+00 1.0000E-01 2.0000E+00 5.OOOOE-01 8.0000E+00 1.0000E+00 2.4000E+01 2.0000E+00 9.6000E+01 4.OOOOE+00 7.2000E+02 0.0000E+00 Output Filename:

G:\Radtrad 3.o63

XceIEnergy ICalculation No. GEN-PI-083 Revision No. 0 Page No. 57 of 128 1

1 1

0 0

End of Scenario File

9 XeIEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 58 of 128 RADTRAD Version 3.03 (Spring 2001) run on 5/25/2009 at 2:06:20

1. 1. 4#################################################################4##

Plant Description

1. 1. 1. 1. ý#################################################################

Number of Nuclides = 60 Inventory Power = 1.OOOOE+00 MWth Plant Power Level = 1.8520E+03 MWth Number of compartments = 4 Compartment information Compartment number 1 (Source term fraction = 1.OOOOE+00 Name: RCS Compartment volume = 5.2900E+03 (Cubic feet)

Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: RCS to Intact SG Compartment number 2 Name: Environment Compartment type is Environment Pathways into and out of compartment 2 Inlet Pathway Number 3: Control Room to Environment Inlet Pathway Number 4: Intact SG to Environment Exit Pathway Number 2: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume = 6.1315E+04 (Cubic feet)

Compartment type is Control Room Removal devices within compartment:

Filter(s)

Pathways into and out of compartment 3 Inlet Pathway Number 2: Environment to Control Room Exit Pathway Number 3: Control Room to Environment Compartment number 4 Name: Intact SG Compartment volume = 3.4380E+03 (Cubic feet)

Compartment type is Normal Pathways into and out of compartment 4 Inlet Pathway Number 1: RCS to Intact SG Exit Pathway Number 4: Intact SG to Environment Total number of pathways = 4

Xce Energy, Calculation No. GEN-PI-083 Revision No. 0 Page No. 59 of 128

1. 1. 1. 1. O###############*###4#####

RADTRAD Version 3.03 (Spring 2001) run on 5/25/2009 at 2:06:20

1. 1. 1. 4###################################################################

1. 1. 1. 1. 4###############0######4#######4###########################

Scenario Description

1. 1. 1. 1. 4###

Radioactive Decay is enabled Calculation of Daughters is enabled Release Fractions and Timings GAP EARLY IN-VESSEL LATE RELEASE RELEASE MASS 0.003600 hr 0.0000 hrs 0.0000 hrs (gm)

NOBLES 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 IODINE 1.OOOOE+00 0.OOOOE+00 0.OOOOE+00 7.666E+00 CESIUM 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 TELLURIUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 STRONTIUM 0.00O0E+00 0.OOOOE+00 0.OOOOE+00 0.00OE+00 BARIUM 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOE+00 RUTHENIUM 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOE+00 CERIUM 0.OOOOE+00 0.OOOOE+00 O.OOOOE+00 0.OOOE+00 LANTHANUM 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOE+00 Inventory Power = 1852. MWt Nuclide Group Specific half Whole Body Inhaled Inhaled Name Inventory life DCF Thyroid Effective (Ci/MWt) (s) (Sv-m3/Bq-s) (Sv/Bq) (Sv/Bq) 1-131 2 4.280E+02 6. 947E+05 1.820E-14 2.920E-07 8.890E-09 1-132 2 3.871E+02 8.280E+03 1.120E-13 1.740E-09 1.030E-10 1-133 2 5.428E+02 7.488E+04 2.940E-14 4.860E-08 1.580E-09 1-134 2 6.061E+02 3. 156E+03 1.300E-13 2.880E-10 3.550E-Il 1-135 2 5.183E+02 2. 380E+04 8.294E-14 8.460E-09 3.320E-10 Nuclide Daughter Fraction Daughter Fraction Daughter Fraction Kr-85m Kr-85 0.21 none 0.00 none 0.00 Kr-87 Rb- 87 1.00 none 0.00 none 0.00 Kr-88 Rb-88 1.00 none 0.00 none 0.00 1-131 Xe-131m 0.01 none 0.00 none 0.00 1-133 Xe-133m 0.03 Xe-133 0 .97 none 0.00 1-135 Xe-135m 0.15 Xe-135 0.85 none 0.00 Xe-133m Xe-133 1.00 none 0.00 none 0.00 Xe-135 Cs-135 1.00 none 0.00 none 0.00 Xe-135m Xe-135 1.00 none 0.00 none 0.00 Xe-138 Cs-138 1 .00 none 0.00 none 0.00 Iodine fractions Aerosol = 0.OOOOE+00 Elemental 9. 7000E-01 Organic 3.OOOOE-02 COMPARTMENT DATA Compartment number 1: RCS Compartment number 2: Environment Compartment number 3: Control Room

XceI Energy Calculation No. GEN-PI-083 Revision No. 0 Page No. 60 of 128 Compartment Filter Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aero sol Elemental Or ganic 0.0000E+00 3.6000E+03 0.000(0E+00 0.OOOOE+00 0.0 OOOE+00 8.3300E-02 3.6000E+03 9.900( )E+01 9.5000E+01 9.5 000E+01 7.2000E+02 3.6000E+03 0.0000)E+00 0.OOOOE+00 0.0 000E+00 Compartment number 4: Intact SG PATHWAY DATA Pathway number 1: RCS to Intact SG Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies %)

(c fm) Aerosol Elemental Organic 0.000OE+00 3.7600E-02 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 4.5500E+01 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Pathway number 2: Environment to Control Room Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 0.OOOOE+00 2.OOOOE+03 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 8.3300E-02 3.OOOOE+02 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 7.2000E+02 0.OOOOE+00 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 Pathway number 3: Control Room to Environment Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(c fm) Aero3 ol Elemental Organic 0.000OE+00 2.OOOOE+03 0.OCOCE +00 0.OOOOE+00 0.OOOOE+00 8.3300E-02 3.0000E+02 0.0000E +00 0.OOOOE+00 O.OOOE+00 7.2000E+02 0.OOOOE+00 0. OOOOE +00 0.OOOOE+00 O.OOOOE+00 Pathway number 4: Intact SG to Environment Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies M%)

(cfm) Aerosol Elemental Organic 0.OOOOE+00 3. 9420E-01 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 2.OOOOE+00 2. 3610E-01 0.OOOOE+00 0.OOOOE+00 0.0000E+00 8.OOOOE+00 1.7340E-01 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 2.4000E+01 1..3980E-01 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 4.5500E+01 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 LOCATION DATA Location Exclusion Area Boundary is in compartment 2 Location X/Q Data Time (hr) X/Q (s

m^-3) 0.OOOOE+00 6.4900E-04

@ Energy calculation No. GEN-PI-083 Page No. 61 of 128 7.2000E+02 0.OOOOE+00 Location Breathing Rate Data Time (hr) Breathing Rate (m^3

sec^-l) 0.OOOOE+00 3.5000E-04 7.2000E+02 O.OOOOE+00 Location Low Population Zone is in compartment 2 Location X/Q Data Time (hr) X/ Q (s

m^-3) o.OOOOE+00 1.7700E-04 8.OOOOE+00 3.9900E-05 2.4000E+01 7.1200E-06 9.6000E+01 1.0400E-06 7.2000E+02 0.0000E+00 Location Breathing Ralte Data Time (hr) Br*eathi ng Rate (m^3

sec^-l) 0.0000E+00 3.5000E-04 8.OOOOE+00 1.8000E-04 2.4000E+01 2.3000E-04 7.2000E+02 0.OOOOE+00 Location Control Room is in compartment 3 Location X/Q Data Time (hr) X/ Q (s

m^-3) 0.0000E+00 1.8300E-02 2.OOOOE+00 1.4200E-02 8.0000E+00 6.3000E-03 2.4000E+01 4.2900E-03 9.6000E+01 3.3800E-03 7.2000E+02 o.OOOOE+00 Location Breathing Ralte Data Time (hr) Br eathing Rate (mW3

sec^-l)

O.0000E+00 3.5000E-04 7.2000E+02 O.OOOOE+00 Locati'on Occupancy Factor Data Time (hr) Occupancy Factor O.OOOOE+00 1.OOOOE+00 2.4000E+01 6.OOOOE-01 9.6000E+01 4.OOOOE-01 7.2000E+02 O.OOOOE+00 USER SPECIFIED TIME STEP DATA - SUPPLEMENTAL TIME STEPS Time Time step o.OOOOE+00 1.OOOOE-01 2.OOOOE+00 5. OOOOE-01 8.OOOOE+00 1.0000E+00 2.4000E+01 2.OOOOE+00

9. 6000E+01 4.0OO0E+00 7.2000E+02 0.OOOOE+00

XcelEnergy Cculation No. GEN-P-083 Revision No. P Page No. 62 of 128

1. 1. 1. 1. A######5#####################2##############################

RADTRAD Version 3.03 (Spring 2001) run on 5/25/2009 at 2:06:20 4############ ###########################################################

# # # # # # # #. 8

~ # # 8 # ##### # 8 8 8 #8 8 # 8

# # 8 8 # # # #

1. 1. 1. 8#### # #8 Dose, Detailed model and Detailed Inventory Output

1. 1. 1. 1. c#########o####D###############

Exclusion Area Boundary Doses:

Time (h) = 0.0036 Whole Body Thyroid TEDE Delta dose (rem) 5.3209E-09 1.5446E-06 5. 3614E-08 Accumulated dose (rem) 5.3209E-09 1.5446E-06 5.3614E-08 Low Population Zone Doses:

Time (h) = 0.0036 Whole Body Thyroid TEDE Delta dose (rem) 1.4511E-09 4.2125E-07 1.4622E-08 Accumulated dose (rem) 1.4511E-09 4.2125E-07 1.4622E-08 Control Room Doses:

Time (h) = 0.0036 Whole Body Thyroid TEDE Delta dose (rem) 1.3395E-11 1.0987E-07 3.4487E-09 Accumulated dose (rem) 1.3395E-Il 1.0987E-07 3.4487E-09 Control Room Compartment Nuclide Inventory:

Time (h) = 0.0036 Ci kg Atoms Decay 1-131 8. 6614E-08 6. 9864E-16 3. 2117E+09 2.8927E+04 1-132 7.8253E-08 7. 5811E-18 3.4586E+07 2.614 4E+04 1-133 1.0983E-07 9.6957E-17 4. 3901E+08 3.6683E+04 1-134 1.2231E-07 4. 5848E-18 2.0605E+07 4.0888E+04 1-135 1.0485E-07 2. 9856E-17 1. 3318E+08 3. 5021E+04 Xe-133 1. 8071E-12 9. 6542E-21 4. 3713E+04 1. 1564E-01 Xe-135 2. 0941E-11 8.2000E-21 3.6579E+04 1*.3398E+00 Control Room Transport Group Inventory:

Time (h) = 0.0036 Atmosphere Sump Noble gases (atoms) 8.8435E+04 0.0000E+00 Elemental I (atoms) 3.7239E+09 0.OOOOE+00 Organic I (atoms) 1.1517E+08 0.OOOOE+00 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 6.2502E-17 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 7.4645E-17 Total I (Ci) 5. 0186E-07

XceIEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 63 of 128 Deposition Recirculating Time (h) = 0.0036 Surfaces Filter Noble gases (atoms) 0.0000E+00 0.OOOOE+00 Elemental I (atoms) 0.0000E+00 0.0000E+00 Organic I (atoms) 0.0000E+00 0.OOOOE+00 Aerosols (kg) 0.0000E+00 jD.0000E+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 0.0036 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.6486E+04 Elemental I (atoms) 0.OOOOE+00 3.7306E+09 Organic I (atoms) 0.OOOOE+00 1.1538E+08 Aerosols (kg) O.OOOOE+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 0.0036 Filtered Transported Noble gases (atoms) 3.5133E+01 0.OOOOE+00 Elemental I (atoms) 7.0627E+06 0.0000E+00 Organic I (atoms) 2.1843E+05 0.OOOOE+00 Aerosols (kg) 0.0-000E+00 0.00OOE+00 Exclusion Area Boundary Doses:

Time (h) = 0.0833 Whole Body Thyroid TEDE Delta dose (rem) 8.1673E-06 2.3732E-03 8.2367E-05 Accumulated dose (rem) 8.1726E-06 2.3747E-03 8.2421E-05 Low Population Zone Doses:

Time (h) = 0.0833 Whole Body Thyroid TEDE Delta dose (rem) 2.2274E-06 6.4723E-04 2.2464E-05 Accumulated dose (rem) 2.2289E-06 6.4765E-04 2.2478E-05 Control Room Doses:

Time (h) = 0.0833 Whole Body Thyroid TEDE Delta dose (rem) 6.0394E-07 4.9586E-03 1.5564E-04 Accumulated dose (rem) 6.0395E-07 4.9588E-03 1.5564E-04 Control Room Compartment Nuclide Inventory:

Time (h) = 0.0833 Ci kg Atoms Decay 1-131 1.2655E-04 1. 0207E-12 4. 6924E+12 1.3436E+09 1-132 1.1165E-04 1.0817E-14 4. 9347E+10 1.1997E+09 1-133 1.6009E-04 1.4132E-13 6. 3990E+1l 1.7018E+09 1-134 1.6783E-04 6. 2914E-15 2. 8274E+10 1. 8391E+09 1-135 1.5196E-04 4. 3270E-14 1. 9302E+lI 1.6200E+09 Xe-131m 2.7860E-10 3.3262E-18 1. 5291E+07 9. 8804E+01 Xe-133 7.0602E-08 3.7718E-16 1.7079E+09 2.5065E+04 Xe-133m 5.0598E-09 1.1276E-17 5.1058E+07 1.7958E+03 Xe-135 8.1641E-07 3. 1970E-16 1.4261E+09 2.8961E+05 Xe-135m 5. 1006E-06 5.5994E-17 2.4978E+08 1.6426E+06 Control Room Transport Group Inventory:

Time (h) = 0.0833 Atmosphere Sump

XcelEnergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 64 of 128 Noble gases (atoms) 3.4501E+09 0.0000E+00 Elemental I (atoms) 5.4349E+12 0.OOOOE+00 Organic I (atoms) 1.6809E+II 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 9.1246E-14 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 1.0878E-13 Total I (Ci) 7.1808E-04 Deposition Recirculating Time (h) = 0.0833 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 0.0833 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.2174E+08 Elemental I (atoms) 0.OOOOE+00 5.7356E+12 Organic I (atoms) 0.OOOOE+00 1.7739E+11 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 0.0833 Filtered Transported Noble gases (atoms) 6.1637E+06 0.OOOOE+00 Elemental I (atoms) 2.8979E+11 0.OOOOE+00 Organic I (atoms) 8.9625E+09 0.OOOOE+00 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Exclusion Area Boundary Doses:

Time (h) = 2.0000 Whole Body Thyroid TEDE Delta dose (rem) 3.1860E-03 1.3953E+00 4.6622E-02 Accumulated dose (rem) 3.1941E-03 1.3977E+00 4.6704E-02 Low Population Zone Doses:

Time (h) = 2.0000 Whole Body Thyroid TEDE Delta dose (rem) 8.6890E-04 3.8053E-01 1.2715E-02 Accumulated dose (rem) 8.7113E-04 3.8118E-01 1.2737E-02 Control Room Doses:

Time (h) = 2.0000 Whole Body Thyroid TEDE Delta dose (rem) 1.9804E-04 2.4534E+00 7. 6561E-02 Accumulated dose (rem) 1.9865E-04 2.4584E+00 7. 6717E-02 Control Room Compartment Nuclide Inventory:

Time (h) = 2.0000 Ci kg Atoms Decay 1-131 2 .8146E-03 2. 2703E-.1 1.0437E+14 3. 5599E+ll 1-132 1 4033E-03 1. 3595E-13 6.2024E+ll 2.1618E+11 1-133 3. 3635E-03 2.9692E-12 1.3444E+13 4.3349E+I1 1-134 8 .2581E-04 3. 0956E-14 1.3912E+11 1. 8388E+lI 1-135 2 .7835E-03 7. 9261E-13 3.5357E+12 3. 7566E+l1 Xe-131m 4 1506E-07 4 . 9553E-15 2 .2780E+10 3.1144E+07

V, XcelEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 65 of 128 Xe-133 1.0240E-04 5.4706E-13 2.4770E+12 7.7288E+09 Xe-133m 7.2732E-06 1. 6209E-14 7 . 3394E+10 5.5009E+08 Xe-135 1.1949E-03 4. 6791E-13 2 .0873E+12 9. 1613E+10 Xe-135m 8.8735E-04 9.7412E-15 4. 3454E+10 1.0266E+ll Control Room Transport Group Inventory:

Time (h) = 2.0000 Atmosphere Sump Nobl e gases (atoms) 4.7040E+12 0.OOOE+00 Elemental I (atoms) 1.1844E+14 0.OOOOE+00 Organic I (atoms) 3.6632E+12 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 1. 9953E-12 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 2. 3095E-12 Total I (Ci) 1. 1191E-02 Deposition Recirculating Time (h) = 2.0000 Surfaces Filter Noble gases (atoms) 0.0000E+00 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 3.5810E+14 Organic I (atoms) 0.OOOOE+00 1.1075E+13 Aerosols (kg) 0.OOOOE+00 0.0000E+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 2.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 4.7264E+12 Elemental I (atoms) 0.OOOOE+00 5.0978E+14 Organic I (atoms) 0.OOOOE+00 1.5766E+13 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 2.0000 Filtered Transported Noble gases (atoms) 7.3573E+ll 0.OOOOE+00 Elemental I (atoms) 3.1702E+13 0.OOOOE+00 Organic I (atoms) 9.8048E+ll 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Exclusion Area Boundary Doses:

Time (h) = 8.0000 Whole Body Thyroid TEDE Delta dose (rem) 1.3740E-02 1. 1902E+01 3.8190E-01 Accumulated dose (rem) 1.6934E-02 1 . 3299E+01 4. 2860E-01 Low Population Zone Doses:

Time (h) = 8.0000 Whole Body Thyroid TEDE Delta dose (rem) 3.7472E-03 3.2459E+00 1. 0415E-01 Accumulated dose (rem) 4.6184E-03 3.6270E+00 1. 1689E-01 Control Room Doses:

Time (h) = 8.0000 Whole Body Thyroid TEDE Delta dose (rem) 9.4842E-04 2. 0251E+01 6.2740E-01 Accumulated dose (rem) 1.1471E-03 2 .2709E+01 7.0412E-01 Control Room Compartment Nuclide Inventory:

9~XceIfnergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 66 of 128 Time (h) 8.0000 Ci kg Atoms Decay 1-131 5.6688E-03 4.5726E-11 2 .1020E+14 3.2394E+12 1-132 4.7347E-04 4.5869E-14 2. 0927E+ll 7.8169E+11 1-133 5.6675E-03 5. 0030E-12 2 .2653E+13 3. 5369E+12 1-134 1.4792E-05 5.5450E-16 2. 4920E+09 3. 0556E+1l 1-135 3.0534E-03 8. 6944E-13 3.8784E+12 2. 3927E+12 Xe-131m 7.7649E-06 9.2703E-14 4 .2616E+lI 2.4468E+09 Xe-l33 1.7634E-03 9. 4206E-12 4 .2656E+13 5.7044E+l1 Xe-133m 1.2169E-04 2. 7119E-13 1 .2279E+12 3. 9717E+10 Xe-135 1.3674E-02 5.3545E-12 2 . 3885E+13 5. 0712E+12 Xe-135m 1.0676E-03 1. 1720E-14 5 .2279E+10 8. 1174E+11 Control Room Transport Group Inventory:

Time (h) = 8.0000 Atmosphere Sump Noble gases (atoms) 6.8248E+13 0.OOOOE+00 Elemental I (atoms) 2.2984E+14 0.OOOOE+00 II Organic I (atoms) 7.1084E+12 0.0000E+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 3. 8609E-12 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 4.2938E-12 Total I (Ci) 1.4878E-02 Deposition Recirculating Time (h) = 8.0000 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 3.3159E+15 Organic I (atoms) 0.OOOOE+00 1.0255E+14 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 8.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.1823E+14 Elemental I (atoms) 0.OOOOE+00 3.8469E+15 Organic I (atoms) 0.OOOOE+00 1.1898E+14 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 8.0000 Filtered Transported Noble gases (atoms) 5.0300E+13 .0.0000E+00 Elemental I (atoms) 2.9116E+14 0.OOOOE+00 Organic I (atoms) 9.0049E+12 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.0000E+00 Exclusion Area Boundary Doses:

Time (h) = 24.0000 Whole Body Thyroid TEDE Delta dose (rem) 3.9363E-02 6. 6538E+01 2.0845E+00 Accumulated dose (rem) 5.6297E-02 7.9837E+01 2. 5131E+00 Low Population Zone Doses:

Time (h) = 24.0000 Whole Body Thyroid TEDE Delta dose (rem) 2.4200E-03 2. 1038E+00 6.7083E-02 Accumulated dose (rem) 7.0383E-03 5.,7308E+00 1. 8397E-01 Control Room Doses:

XceI nergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 67 of 128 Time (h) = 24.0000 Whole Body Thyroid TEDE Delta dose (rem) 1.7605E-03 5.2186E+01 1.6059E+00 Accumulated dose (rem) 2.9076E-03 7.4895E+01 2. 3100E+00 Control Room Compartment Nuclide Inventory:

Time' (h) = 24.0000 Ci kg Atoms Decay 1-131 5.2286E-03 4 .2175E-11 1.9388E+14 1. 1172E+13 1-132 3.7241E-06 3. 6079E-16 1.6460E+09 8.8698E+ll 1-133 3.2485E-03 2 8676E-12 1.2984E+13 9.6361E+12 1-135 5. 5714E-04 1. 5865E-13 7. 0770E+11 4 .2785E+12 Xe-131m 3.2155E-05 3. 8389E-13 1.7648E+12 3.7089E+10 Xe-133 5.8276E-03 3. 1133E-11 1. 4097E+14 7. 3889E+12 Xe-133m 3.7277E-04 8 .3076E-13 3.7616E+12 4 .8881E+11 Xe-135 1.4659E-02 5. 7402E-12 2. 5606E+13 3.2601E+13 Xe-135m 3. 1535E-04 3 4619E-15 1. 5443E+10 1.8134E+12 Control Room Transport Group Inventory:

Time (h) = 24.0000 Atmosphere Sump Noble gases (atoms) 1.7212E+14 0.OOOOE+00 Elemental I (atoms) 2.0135E+14 0.0000E+00 Organic I (atoms) 6.2272E+12 0.0000E+00 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 3. 3322E-12 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 3. 5383E-12 Total I (Ci) 9.0380E-03 Deposition Recirculating Time (h) = 24.0000 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) 0.0000E+00 1.1014E+16 Organic I (atoms) 0.0000E+00 3.4065E+14 Aerosols (kg) O.OOOOE+00 O.O000E+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 24.0000 Filtered Transported Noble gases (atoms) 0.0000E+00 7.1839E+14 Elemental I (atoms) 0.0000E+00 1.2208E+16 Organic I (atoms) 0.OOOOE+00 3.7756E+14 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 24.0000 Filtered Transported Noble gases (atoms) 5.2028E+14 0.0000E+00 Elemental I (atoms) 9.6645E+14 0.OOOOE+00 Organic I (atoms) 2.9890E+13 0.0000E+00 Aerosols (kg) 0.OOOOE+00 0.0000E+00 Exclusion Area Boundary Doses:

Time (h) = 45.5000 Whole Body Thyroid TEDE Delta dose (rem) 4.6343E-02 1.3549E+02 4.1922E+00 Accumulated dose (rem) 1.0264E-01 2.1532E+02 6.7053E+00 Low Population Zone Doses:

9 XIeEnergy' Calculation No. GEN-PI-083 Revision No. 0 Page No. 68 of 128 Time (h) = 45.5000 Whole Body Thyroid TEDE Delta dose (rem) 5.0842E-04 9. 7677E-01 3.0397E-02 Accumulated dose (rem) 7.5468E-03 6.7076E+00 2. 1437E-01 Control Room Doses:

Time (h) = 45.5000 Whole Body Thyroid TEDE Delta dose (rem) 8.7814E-04 4. 3651E+01 1.3366E+00 Accumulated dose (rem) 3.7857E-03 1. 1855E+02 3.6466E+00 Control Room Compartment Nuclide Inventory:

Time (h) = 45.5000 Ci kg Atoms Decay 1-131 4.9330E-03 3.9790E-11 1.8292E+14 2.2627E+13 1-132 5.8252E-09 5. 6434E-19 2. 5747E+06 8. 8803E+ll 1-133 1.6173E-0.3 1 .4277E-12 6.4644E+12 1. 4753E+13 1-135 5.9578E-05 1. 6965E-14 7. 5678E+10 4.7328E+12 Xe-131m 6.6293E-05 7. 9145E-13 3.6384E+12 1. 5937E+II Xe-133 8.8987E-03 4.7541E-11 2. 1526E+14 2.6003E+13 Xe-133m 5. 1098E-04 1 . 1388E-12 5.1563E+12 1. 6127E+12 Xe-135 4.8893E-03 1.9146E-12 8.5406E+12 5. 4818E+13 Xe-135m 3.2956E-05 3.6178E-16 1 . 6139E+09 2.124 6E+12 Control Room Transport Group Inventory:.

Time (h) = 45.5000 Atmosphere Sump Noble gases (atoms) 2.3260E+14 0.0000E+0 0 Elemental I (atoms) 1.8377E+14 0.OOOOE+0 0 Organic I (atoms) 5.6837E+12 0.0000E+0 0 Aerosols (kg) 0.OOOOE+00 0.OOOOE+0 0 Dose Effective (Ci/cc) 1-131 (Thyroid) 2 . 9972E-12 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 3. 0930E-12 Total I (Ci) 6.6099E-03 Deposition Recirculat ing Time (h) = 45.5000 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.OOOOE+0 0 Elemental I (atoms) 0.o0oOE+00 2.1770E+1 6 Organic I (atoms) 0.0000E+00 6.7331E+1 4 Aerosols (kg) 0.0000E+00 0.0000E+0 0 Environment to Control Room Transport.Group Inventory: I Pathway Time (h) = 45.5000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.9242E+15 Elemental I (atoms) 0.OOOOE+00 2.3974E+16 Organic I (atoms) 0.0000E+00 7.4145E+14 Aerosols (kg) 0.0000E+00 0.0000E+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 45.5000 Filtered Transported Noble gases (atoms) 1.6303E+15 0.OOOOE+00 Elemental I (atoms) 1.9100E+15 0.OOOOE+00 Organic I (atoms) 5.9071E+13 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.0000E+00 Exclusion Area Boundary Doses:

X eEnergy I Calculation No. GEN-PI-083 Revision No. 0 Page No. 69 of 128 Time (h) = 96.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 1.0264E-01 2.1532E+02 6.7053E+00 Low Population Zone Doses:

Time (h) = 96.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.0000E+00 0.OOOOE+00 0.0000E+00 Accumulated dose (rem) 7.5468E-03 6.7076E+00 2.1437E-01 Control Room Doses:

Time (h) = 96.0000 Whole Body Thyroid TEDE Delta dose (rem) 4.3463E-05 9. 1958E-01 2.8141E-02 Accumulated dose (rem) 3.8292E-03 1 .1947E+02 3.6747E+00 Control Room Compartment Nuclide Inventory:

Time (h) = 96.0000 Ci kg Atoms Decay Xe-131m 2. 1373E-11 2. 5517E-19 1. 1730E+06 1.8532E+Il Xe-133 2.4881E-09 1. 3293E-17 6:0188E+07 2. 9453E+13 Xe-133m 9. 5611E-11 2.1308E-19 9. 6481E+05 1. 8057E+12 Xe-135 3.7891E-I1 1.4837E-20 6. 6187E+04 5. 6351E+13 Control Room Transport Group Inventory:

Time (h) = 96.0000 Atmosphere Sump Noble gases (atoms) 6.2392E+07 0.OOOOE+00 Elemental I (atoms) 2.1604E-66 0.OOOOE+00 Organic I (atoms) 6.6817E-68 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 3.4742E-92 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 3.4995E-92 Total I (Ci) 6.3953E-83 Deposition Recirculating Time (h) = 96.0000 Surfaces Filter Noble gases (atoms). 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 2.1906E+16 Organic I (atoms) 0.OOOOE+00 6.7749E+14 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 96.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.9242E+15 Elemental I (atoms) 0.OOOOE+00 2.3974E+16 Organic I (atoms) 0.OOOOE+00 7 .4145E+14 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 96.0000 Filtered Transported Noble gases (atoms) 1.8579E+15 0.OOOOE+00 Elemental I (atoms) 1.9218E+15 0.OOOOE+00 Organic I (atoms) 5.9438E+13 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00

XceI EnergyI Calculation No. GEN-PI-083 Revision No. 0 Page No. 70 of 128 Exclusion Area Boundary Doses:

Time (h) = 720.0000 Whole Body Thyroid TEDE Delta dose (rem) .0.0000E+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 1.0264E-01 2.1532E+02 6.7053E+00 Low Population Zone Doses:

Time (h) = 720.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 7.5468E-03 6.7076E+00 2. 1437E-01 Control Room Doses:

Time (h) = 720.0000 Whole Body Thyroid TEDE Delta dose (rem) 1.6125E-12 9. 9676E-81 1. 6125E-12 Accumulated dose (rem) 3.8292E-03 1. 1947E+02 3.6747E+00 Control Room Compartment Nuclide Inventory:

Time (h) = 720.0000 Ci kg Atoms Decay Control Room Transport Group Inventory:

Time (h) = 720.0000 Atmosphere Sump Noble gases (atoms) 6.2467E-74 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) O.OOOOE+00 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) O.OOOOE+00 Total I (Ci) O.OOOOE+00 Deposition Recirculating Time (h) = 720.0000 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 2.1906E+16 Organic I (atoms) 0.000OE+00 6.7749E+14 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 720.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 1.9242E+15 Elemental I (atoms) 0.OOOOE+00 2.3974E+16 Organic I (atoms) 0.OOOOE+00 7.4145E+14 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 720.0000 Filtered Transported Noble gases (atoms) 1.8579E+15 0.OOOOE+00 Elemental I (atoms) 1.9218E+15 0.OOOOE+00 Organic I (atoms.) 5.9438E+13 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 840

9 e IEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 71 of 128 1-131 Summary RCS Environment Control Room Time (hr) 1-131 (Curies) 1-131 (Curies) 1-131 (Curies) 0.000 1.2232E+05 1.8461E-08 3.1880E-10 0,.004 7.9265E+05 5 .0231E-06 8.6614E-08 0.083 7.9239E+05 7.7209E-03 1.2655E-04 0.400 7.9138E+05 1.8399E-01 3. 4453E-04 0.700 7.9043E+05 5.6483E-01 7. 4494E-04 1.000 7.8948E+05 1.1528E+00 1.2055E-03 1.300 7.8853E+05 1.9471E+00 1.6848E-03 1.600 7.8758E+05 2. 9467E+00 2. 1690E-03 1.900 7.8663E+05 4..1508E+00 2 .6534E-03 2.000 7.8631E+05 4.5974E+00 2.8146E-03 2.300 7.8536E+05 5.4814E+00 2. 0378E-03 2.600 7.8442E+05 6.4873E+00 1.9266E-03 2.900 7.8347E+05 7. 6148E+00 2.0379E-03 3.200 7.8253E+05 8.8 635E+00 2.2233E-03 3.500 7.8159E+05 1.0233E+01 2. 4330E-03 3.800 7.8064E+05 1.1722E+01 2 .6504E-03 4.100 7.7970E+05 1.3332E+01 2.8698E-03 4.400 7.7876E+05 1.5061E+01 3.0893E-03 4.700 7.7783E+05 1.6909E+01 3.3084E-03 5.000 7.7689E+05 1'.8875E+01 3.5268E-03 5.300 7.7595E+05 2 .0960E+01 3.7444E-03 5.600 7.7502E+05 2 .3162E+01 3.9613E-03 5.900 7.7408E+05 2.5482E+01 4.1774E-03 6.200 7.7315E+05 2. 7919E+01 4.3928E-03 6.500 7.7222E+05 3.0472E+01 4.6074E-03 6.800 7.7129E+05 3.3141E+01 4.8212E-03 7.100 7.7036E+05 3. 5926E+01 5.03.42E-03 7.400 7.6943E+05 3. 8826E+01 5.2465E-03 7.700 7.6850E+05 4. 1840E+01 5.4580E-03 8.000 7.6758E+05 4. 4970E+01 5.6688E-03 8.300 7. 6665E+05 4.7352E+01 3.1967E-03 8.600 7. 6573E+05 4. 9819E+01 2.4138E-03 8.900 7. 6481E+05 5.2369E+01 2.1970E-03 9.200 7. 6389E+05 5. 5003E+01 2.1697E-03 9.500 7. 6297E+05 5.7721E+01 2.2057E-03 9.800 7 .6205E+05 6.0522E+01 2.2629E-03 10.100 7. 6113E+05 6.3405E+01 2.3270E-03 10.400 7. 6021E+05 6.6371E+01 2.3933E-03 24.000 7. 1978E+05 2.8290E+02 5.2286E-03 45.500 6.6020E+05 7.9388E+02 4.9330E-03 96.000 5.5067E+05. 7.9388E+02 5.9596E-83 720.000 5.8534E+04 7.9388E+02 0.OOOOE+00 Intact SG Time (hr) 1-131 (Curies) 0.000 1.4491E-02 0.004 6.0846E-01 0.083 2.7534E+01 0.400 1.3422E+02 0.700 2.3483E+02 1.000 3.3500E+02 1.300, 4.3473E+02 1.600 5.3403E+02 1.900 6.3290E+02 2.000 6.6576E+02

P Xcel Energjy Calculation No. GEN-PI-083 Revision No. 0 Page No. 72 of 128 2.300 7.6465E+02 2.600 8.6318E+02 2.900 9.6137E+02 3.200 1.0592E+03 3.500 1.1567E+03 3.800 1.2538E+03 4.100 1.3506E+03 4.400 1.4471E+03 4.700 1.5432E+03 5.000 1.6390E+03 5.300 1.7344E+03 5.600 1.8295E+03 5.900 1.9243E+03 6.200 2.0187E+03 6.500 2.1128E+03 6.800 2.2065E+03 7.100 .2.2999E+03 7.400 2.3930E+03 7.70'0 2.4857E+03 8.000 2.5781E+03 8.300 2.6711E+03 8.600 2.7637E+03 8.900 2.8560E+03 9.200 2.9480E+03 9.500 3.0398E+03 9.800 3.1312E+03 10.100 3.2223E+03 10.400 3.3132E+03 24.000 7.1297E+03 45..500 1.2187E+04 96.000 1.0165E+04 720.000 1.0805E+03

1. 1. 1. 1. C###a##########teDo####S##m#m####################r Cumulative Dose Summary

1. 1. 1. 1. 4###########################4############################

Exclusion Area Bounda Low Population Zone Control Room Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 0.OOOOE+00 0.0000E+00 0. 000E+00 0.0000E+00 0.0000E+00 0.0000E+00 0.004 1.5446E-06 5.3614E-08 4.2125E-07 1.4622E-08 1.0987E-07 3.4487E-09 0.083 2.3747E-03 8.2421E-05 6. 4765E-04 2.2478E-05 4.9588E-03 1.5564E-04 0.400 5.6476E-02 1.9438E-03 1.5403E-02 5.3012E-04 7.0045E-02 2 .1960E-03 0.700 1.7305E-01 5. 9139E-03 4.7194E-02 1. 6129E-03 2.2769E-01 7.1305E-03 1.000 3. 5253E-01 1.19733E-02 9.614 5E-02 3.2653E-03 5. 1227E-01 1.6027E-02 1.300 5. 9434E-01 2.0074E-02 1.6209E-01 5.4746E-03 9. 3368E-01 2.9186E-02 1.600 8. 9787E-01 3.0176E-02 2 .4487E-01 8.2300E-03 1.4944E+00 4.6676E-02 1.900 1.2626E+00 4.2248E-02 3.4434E-01 1.1522E-02 2 1943E+00 6.8490E-02 2.000 1.3977E+00 4.6704E-02 3.8118E-01 1.2737E-02 2.4584E+00 7.6717E-02 2.300 1.6645E+00 5. 5482E-02 4.5396E-01 1. 5132E-02 3. 1374E+00 9.7860E-02 2.600 1.9675E+00 6. 5409E-02 5.3660E-01 1.7839E-02 3. 7019E+00 1. 1542E-01 2.900 2.3064E+00 7.6472E-02 6.2901E-01 2.0856E-02 4 .2701E+00 1 .3309E-01 3.200 2 6807E+00 8.8 658E-02 7.3111E-01 2.4179E-02 4.8814E+00 1.5209E-01 3.500 3. 0904E+00 1 .0196E-01 8.4284E-01 2.7806E-02 5.5486E+00 1.7282E-01 3.800 3.5351E+00 1. 1636E-01 9.6411E-01 3.1734E-02 6.2756E+00 1 .9539E-01 4 .100 4 .0145E+00 1 . 3185E-01 1.0949E+00 3.5959E-02 7.0634E+00 2.1984E-01 4 .400 4.5284E+00 1. 4843E-01 1.2350E+00 4.0480E-02 7. 9122E+00 2.4616E-01 4.700 5.0766E+00 1 . 6607E-01 1.3845E+00 4.5293E-02 8.8215E+00 2.7436E-01 5.000 5.6588E+00 1. 8479E-01 1.5433E+00 5.0396E-02 9.7911E+00 3.0441E-01

C4 XceIEnergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 73 of 128 5.300 6.2747E+00 2. 0455E-01 1.7113E+00 5.5787E-02 1 .0820E+01 3.3631E-01 5.600 6. 9242E+00 2.2537E-01 1.8884E+00 6.14 64E-02 1. 1909E+01 3.7003E-01 5.900 7. 6069E+00 2.4722E-01 2.0746E+00 6.7424E-02 1 .3057E+01 4. 0558E-01 6.200 8. 3227E+00 2. 7010E-01 2.2698E+00 7.3665E-02 1. 4263E+01 4.4292E-01 6.500 9. 0714E+00 2. 9401E-01 2.4740E+00 8.0184E-02 1. 5528E+01 4. 8205E-01 6.800 9. 8526E-÷00 3. 1893E-01 2. 6871E+00 8 .6981E-02 1. 6850E+01 5.2296E-01 7.100 1. 0666E+01 3. 4486E-01 2.9090E+00 9.4051E-02 1. 8230E+01 5.6564E-01 7.400 1. 1512E+01 3. 7178E-01 3.1396E+00 1 . 0139E-01 1. 9666E+01 6. 1006E-01 7.700 1.2390E+01 3. 9970E-01 3.3790E+00 1.0901E-01 2.1160E+01 6. 5623E-01 8.000 1. 3299E+01 4 .2860E-01 3.6270E+00 1.1689E-01 2. 2709E+01 7. 0412E-01 8.300 1. 3990E+01 4 5055E-01 3.6489E+00 1.1760E-01 2.3886E+01 7.4048E-01

8. 600 1. 4705E+01 4 .7322E-01 3. 6715E+00 1. 1834E-01 2.4646E+01 7 .6396E-01 8.900 1. 5442E+01 4. 9660E-01 3.6948E+00 1. 1910E-01 2. 5278E+01 7 .8351E-01 9.200 1. 6203E+01 5.2069E-01 3. 7189E+00 1. 1988E-01 2. 5880E+01 8. 0210E-01 9.500 1. 6986E+01 5 .4549E-01 3.7436E+00 1.2068E-01 2. 6484E+01 8 .2075E-01 9.800 1. 7792E+01 5. 7099E-01 3.7691E+00 1.2151E-01 2 .7100E+01 8. 3977E-01 10.100 1. 8621E+01 5. 9719E-01 3.7953E+00 1.2235E-01 2. 7731E+01 8 .5927E-01 10.400 1. 9472E+01 6. 2407E-01 3.8222E+00 1 .2322E-01 2. 8380E+01 8 .7930E-01 24.000 7. 9837E+01 2 . 5131E+00 5.7308E+00 1. 8397E-01 7.4895E+01 2. 3100E+00 45.500 2. 1532E+02 6. 7053E+00 6.7076E+00 2. 1437E-01 1. 1855E+02 3.6466E+00 96.000 2. 1532E+02 6. 7053E+00 6.7076E+00 2. 1437E-01 1. 1947E+02 3.6747E+00 720.000 2 1532E+02 6. 7053E+00 6.7076E+00 2. 1437E-01 1. 1947E+02 3.6747E+00

1. 1. 1. - 4#################################Wos#####T##T#-u####o####

Worst Two-Hour Doses

1. 1. 1. 1. 4###########################################

Exclusion Area Boundary Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 24.0 4.3110E-03 1.2603E+01 3.8997E-01

I IXceIEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 74 of 128 Attachment 13.2 RADTRAD Output File PLRAINGO1.oO

1. 1. 1. 1. 4############

RADTRAD Version 3.03 (Spring 2001) run on 5/25/2009 at 2:00:50

1. 1. 1. 1. F###############m###################i##########o################

1. 4####4###############44######4#####################44#################

File information

1. 44###4#################4##############4#########4###############4#####

Plant file = G:\Radtrad 3.03\Input\PI\GEN-PI-083\PLRAINGOl.psf Inventory file = g:\radtrad 3.03\defaults\pilra iodin def.txt Release file = g:\radtrad 3.03\defaults\pingp ng rft.txt Dose Conversion file = g:\radtrad 3.03\defaults\pingp fgll&12.txt

1. 1. 1. ##### # # # ##### it

# # jut # it it it

t it it it it ## it It It it #t

1. 1. 1. 1. iti it it it it it it itit it it it it it it it it It #11 It it it it It ititititIt it It It It Radtrad 3.03 4/15/2001 PINGP I & 2 Locked Rotor Accident AST Analysis - Noble Gas Release From Intact SGs Nuclide Inventory File:

g:\radtrad 3.03\defaults\pilra iodin def.txt Plant Power Level:

1.8520E+03 Compartments:

3 Compartment 1:

RCS 3

5.2900E+03 0

0 0

Compartment 2:

Environment 2

0.OOOOE+00 0

0 0

Compartment 3:

Control Room 1

6.1315E+04

XceI Energy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 75 of 128 0

0 1

0 0

Pathways:

3 Pathway 1:

Environment to Control Room 2

3 2

Pathway 2:

Control Room to Environment 3

2 2

Pathway 3:

RCS to Envir onment 1

2 2

End of Plant Model File Scenario Description Name:

Plant Model Filename:

Source Term:

1 I 1.0000E+00 g:\radtrad 3.03\defaults\pingpfgll&12.txt g:\radtrad 3.03\defaults\pingpngrft.txt o.OOOOE+00 1

0.0000E+00 9.7000E-01 3.0000E-02 1.0000E+00 Overlying Pool:

0 o.OOOOE+00 0

0 0

0 Compartments:

3 Compartment 1.:

0 1

0 0

0 Compartment 2:

0 1

0 0

0

XcelEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 76 of 128 0

0 0

0 Compartment 3:

1 1

0 0

1 3.6000E+03 3

o.OOOOE+00 o.OOOOE+00 o.OOOOE+00 0.OOOOE+00 8.3300E-02 9. 9000E+01 9. 5000E+01 9. 5000E+01 7.2000E+02 o.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0

0 Pathways:

3 Pathway 1:

0 0

0 1

3 o.OOOOE+00 2.OOOOE+03 o.OOOOE+00 0.OOOOE+00 0.OOOOE+00 8.3300E-02 3.OOOOE+02 o.OOOOE+00 0.OOOOE+00 o.OOOOE+00 7.2000E+02 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0

0 0

0 Pathway 2:

0 0

0 1

3 o.OOOOE+00 2.OOOOE+03 o.OOOOE+00 0.OOOOE+00 0.OOOOE+00 8.3300E-02 3.OOOOE+02 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 7.2000E+02 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0

0 0

0 Pathway 3:

0 0

XceIfnergy ICalculation No. GEN-PI-083 Revision No. 0 Page No. 77 of 128 0

1 2

0*.OOOOE+00 3.7600E-02 o . 000E+OO 0.0000E+00 o.0000E+00

4. 5500E+01 0.0000E+00 o . 000E+00 0.0000E+00 0.0000E+00 0

0 0

0 Dose Locations:

3 Location 1:

Exclusion Area Boundary 2

1 2

0.0000E+00 6.4900E-04 7.2000E+02 0.OOOOE+00 1

2 0.0000OE+00 3.5000E-04 7.2000E+02 0.000OE+00 0

Location 2:

Low Population Zone 2

1 5

0.OOOOE+00 1.7700E-04 8.OOOOE+00 3.9900E-05

2. 4000E+01 7.1200E-06

9. 6000E+01 1.0400E-06 7.2000E+02 o.OOOOE+00 1

4 o.OOOOE+00 3.5000E-04 8.OOOOE+00 1.8000E-04 2.4000E+01 2.3000E-04 7.2000E+02 o.OOOOE+00 0

Location 3:

Control Room 3

0 1

2 0.OOOOE+00 3.5000E-04 7.2000E+02 O.OOOOE+00 1

4 0.OOOOE+00 1.OOOOE+00 2.4000E+01 6.OOOOE-01 9.6000E+01 4.OOOOE-01 7.2000E+02 O.OOOOE+00 Effective Volume Location:

1 6

0.OOOOE+00 1.8300E-02

XceI Energy- Calculation No. GEN-PI-083 Revision No.0 Page No. 78 of 128 2.OOOOE+00 1.4200E-02 8.OOOOE+00 6.3000E-03 2.4000E+01 4.2900E-03 9.6000E+01 3.3800E-03 7.2000E+02 O.0OOOE+00 Simulation Parameters:

6 O.OOOOE+00 1.OOOOE-01 2.OOOOE+00 5.OOOOE-01 8.OOOOE+00 1.OOOOE+00 2.4000E+01 2.OOOOE+00 9.6000E+01 4.OOOOE+00 7.2000E+02 O.OOOOE+00 Output Filename:

G:\Radtrad 3.o62 1

1 1

0 0

End of Scenario File

XcefIEnergy ICalculation No. GEN-PI-083 Revision No. 0 Page No. 79 of 128 RADTRAD Version 3.03 (Spring 2001) run on 5/25/2009 at 2:00:50

1. 1. 1. 1. 4###############################################################

1. 1. 1. 1. 4####################################

Plant Description

1. 1. 1. t.####4########4###################4###################################

Number of Nuclides = 60 Inventory Power = 1.OOOOE+00 MWth Plant Power Level = 1.8520E+03 MWth Number of .compartments = 3 Compartment information Compartment number 1 (Source term fraction = 1.OOOOE+00 Name: RCS Compartment volume = 5.2900E+03 (Cubic feet)

Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 3: RCS to Environment Compartment number 2 Name: Environment Compartment type is Environment Pathways into and out of compartment, 2 Inlet Pathway Number 2: Control Room to Environment Inlet Pathway Number 3: RCS to Environment Exit Pathway Number 1: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume = 6.1315E+04 (Cubic feet)

Compartment type is Control Room Removal devices within compartment:

Filter(s)

Pathways into and out of compartment 3 Inlet Pathway Number 1: Environment to Control Room Exit Pathway Number 2: Control Room to Environment Total number of pathways = 3 N

XcelEnergy I Calculation No. GEN-PI-083 Revision No. 0 Page No.80 of 128 RADTRAD Version 3.03 (Spring 2001) run on 5/25/2009 at 2:00:50

1. 1. 1. 1. 4########################i#t#####################

Scenario Description Radioactive Decay is enabled Calculation of Daughters is enabled Release Fractions and Timings GAP EARLY IN-VESSEL LATE RELEASE RELEASE MASS 0.003600 hr 0.0000 hrs 0.0000 hrs (gm)

NOBLES 1.OOOOE+00 0 OOOOE+00 0 OOOOE+00 5.058E+01 IODINE 0.OOOOE+00 0 OOOOE+00 0 OOOOE+00 0.OOOE+00 CESIUM 0.OOOOE+00 0 OOOOE+00 0 OOOOE+00 0.OOOE+00 TELLURIUM 0.OOOOE+00 0 OOOOE+00 0 OOOOE+00 0.OOOE+00.

STRONTIUM 0.OOOOE+00 0 OOOOE+00 0 OOOOE+00 0.OOOE+00 BARIUM 0.OOOOE+00 0 OOOOE+00 0 OOOOE+00 0.OOOE+00 RUTHENIUM 0.OOOOE+00 0 OOOOE+00 0 OOOOE+00 0.OOOE+00 CERIUM 0.OOOOE+00 0 OOOOE+00 0. OOOOE+00 0.OOOE+00 LANTHANUM 0.000OE+00 0 OOOOE+00 0 OOOOE+00 0.OOOE+00 Inventory Power = 1852. MWt Nuclide Group Specific half Whole Body Inhaled Inhaled Name Inventory life DCF Thyroid Effective (Ci/MWt) (s) (Sv-m3/Bq-s) (Sv/Bq) (Sv/Bq)

Kr-83m 1 3.487E-02 6. 588E+03 1.500E-18 0. OOOE+00 0.OOOE+00 Kr-85 1 9.466E+00 3. 383E+08 1.190E-16 0. OOOE+00 0.OOOE+00 Kr-85m 1 6.431E+01 1. 613E+04 7.480E-15, 0. OOOE+00 0.OOOE+00 Kr-87 1 1.261E+02 4. 578E+03 4 .120E-14 0. OOOE+00 0.OOOE+00 Kr-88 1 1.678E+02 1 .022E+04 1.020E-13 0. OOOE+00 0.OOOE+00 Xe-131m 1 3.189E+00 1.028E+06 3.890E-16 0. OOOE+00 0.OOOE+00 Xe-133 1 5.668E+02 4 . 532E+05 1.560E-15 0. OOOE+00 O.OOOE+00 Xe-133m 1 1.732E+01 1.890E+05 1.370E-15 0. OOOE+00 O.OOOE+00 Xe-135 1i 1.237E+02 3. 272E+04 1.190E-14 0.OOOE+00 O.OOOE+00 Xe-135m 1 1.159E+02 9. 174E+02 2.040E-14 0. OOOE+00 0.OOOE+00 Xe-138 1 4.588E+02 8. 502E+02 5.770E-14 0. OOOE+00 0.OOOE+00 Nuclide Daughter Fraction Daughter Fraction Daughter Fraction Kr-85m Kr-85 0.21 none 0.00 none 0.00 Kr-87 Rb-87 1.00 none 0.00 none 0.00 Kr-88 Rb-88 1.00 none 0.00 none 0.00 1-131 Xe-131m 0.01 none 0.00 none 0.00 1-133 Xe-133m 0.03 Xe-133 0.97 none 0.00 1-135 Xe-135m 0.15 Xe-135 0.85 none 0.00 Xe-133m Xe-133 1.00 none 0.00 none 0.00 Xe-135 Cs-135 1.00 none 0.00 none 0.00 Xe-135m Xe-135 1.00 none 0.00 none 0.00 Xe-138 Cs-138 1.00 none 0.00 none 0.00 Iodine fractions Aerosol = 0.OOOOE+00 Elemental 9.7000E-01 Organic = 3.OOOOE-02 COMPARTMENT DATA

SXIcefnergy ICalculation No. GEN-PI-083 Revision No. 0 Page No. 81 of 128 Compartment number 1: RCS Compartment number 2: Environment Compartment number .3: Control Room Compartment Filter Data Time (hr) Flow Rate Filter Efficiencies (%

(cfm) Aerosol Elemental Organic 0.OOOOE+00 3.6000E+03 o.OOOOE+00 0.0000E+00 0.0000E+00 8.3300E-02 3.6000E+03 9.9000E+01 9.5000E+01 9. 5000E+01 7.2000E+02 3.6000E+03 0.OOO0E+00 o.OOOOE+00 o.0000E+00 PATHWAY DATA 4 Pathway number 1: Environment to Control Room Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(c fm) Aerosol Elemental Organic 0.0000E+00 2.0000E+03 0.OOOOE+00 0.0000E+00 0.0000E+00 8.3300E-02 3.0000E+02 0.OOOOE+00 0.0000E+00 O.0000E+00 7.2000E+02 O.O000E+00 0.0000E+00 0.0000E+00 0.0000E+00 Pathway number 2: Control Room to Environment Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 0.0000E+00 2.0000E+03 0.0000E+00 0.0000E+00 0.0000E+00 8.3300E-02 3.0000E+02 0.0000E+00 0.0000E+00 0.0000E+00 7.2000E+02 0.0000E+00 0.0000E+00 0.0000E+00 0.0000E+00 Pathway number 3: RCS to Environment Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 0.0000E+00 3.7600E-02 0.0000E+00 0.0000E+00 0.0000E+00

4. 5500E+01 0.0000E+00 0.0000E+00 0.OOOOE+00 0.0000E+00 LOCATION DATA Location Exclusion Area Boundary is in compartment 2 Location X/Q Data Time (hr) X/Q (s

m^-3) 0.0000E+00 6.4900E-04 7.2000E+02 0.OOOOE+00 Location Breathing Rate Data Time (hr) Breathing Rate (m^3

sec^-l) 0.OOOOE+00 3.5000E-04 7.2000E+02 0.OOOOE+00 Location Low Population Zone is in compartment 2

XCelEnergY' Calculation No. GEN-PI-083 Revision No. 0 Page No. 82 of 128 Location X/Q Data Time (hr) X/Q (s

m^-3) 0.OOOE+00 1.7700E-04 8.0000E+00 3.9900E-05 2.4000E+01 7.1200E-06 9.6000E+01 1.0400E-06 7.2000E+02 0.OOOOE+00 Location Breathing Rate Data Time (hr) Breathing Rate (m^3

sec^-l) 0.0000E+00 3.5000E-04 8.OOOOE+00 1.8000E-04 2.4000E+01 2.3000E-04 7.2000E+02 0.0000E+00 Location Control Room is in compartment 3 Location X/Q Data Time (hr) X/Q (s

m^-3) 0.0000E+00 1.8300E-02 2.0000E+00 1.4200E-02 8.0000E+00 6.3000E-03 2.4000E+01 4.2900E-03 9.6000E+01 3.3800E-03 7.2000E+02 O.O000E+00 Location Breathing Rate Data Time (hr) Breathing Rate (m^3

sec^-l) 0.OOOOE+00 3.5000E-04 7.2000E+02 0.OOOOE+00 Location Occupancy Factor Data Time (hr) Occupancy Factor 0.0000E+00 1.0000E+00 2.4000E+01 6.0000E-01 9.6000E+01 4.0000E-01 7.2000E+02 0.0000E+00 USER SPECIFIED TIME STEP DATA - SUPPLEMENTAL TIME STEPS Time Time step 0.OOOOE+00 1.OOOOE-01 2.OOOOE+00 5.0000E-01 8.0000E+00 1.0000E+00 2.4000E+01 2.OOOOE+00 9.6000E+01 4.0000E+00 7.2000E+02 0.0000E+00

6) XCeEnergy Calculation No. GEN-PI-83 Revision No. 0 Page No. 83 of 128

1. 1. 1. 1. A#####Ve##o##3##.##0(###Sn#####g#01#no###/##2###29###:#####0##0 RADTRAD Version 3.03 (Spring 2001) run on 5/25/2009 at 2:.00:50 4################################4##############4####################4##

t ##### #4t###

i# #if###l

1. 1. 1. 1. 4#################4############4#####

Dose, Detailed model and Detailed Inventory Output

1. 1. 1. 1. E########A#######a###r####ye###########

Exclusion Area Boundary Doses:

Time (h) = 0.0036 Whole Body Thyroid TEDE Delta dose (rem) 1.8407E-04 0.OOOOE+00 1.8407E-04 Accumulated dose (rem) 1.8407E-04 0.000OE+00 1.8407E-04 Low Population Zone Doses:

Time (h) = 0.0036 Whole Body Thyroid TEDE Delta dose (rem) 5.0201E-05 0.OOOOE+00 5. 0201E-05 Accumulated dose (rem) 5.0201E-05 0.OOOOE+00 5. 0201E-05 Control Room Doses:

Time (h) = 0.0036. Whole Body Thyroid TEDE Delta dose (rem) 5.0312E-07 0.OOOOE+00 5. 0312E-07 Accumulated dose (rem) 5.0312E-07 0.OOOOE+00 5. 0312E-07 Control Room Compartment Nuclide Inventory:

Time (h) 0.0036 Ci kg Atoms Decay Kr-83m 8. 5312E-07 4. 1349E-17 3. 0001E+08 2.9050E+05 Kr-85 2. 3191E-04 5. 9110E-10 4.1879E+15 7.8930E+07 Kr-85m 1.5747E-03 1.9134E-13 1. 3556E+12 5.3604E+08 Kr-87 3.0833E-03 1.0885E-13 7. 5347E+ll 1. 0501E+09 Kr-88 4.1074E-03 3. 2756E-13 2 .2416E+12 1.3984E+09 Xe-131m 7. 8127E-05 9. 3274E-13 4.2879E+12 2.6590E+07 Xe-133 1.3886E-02 7. 4184E-11 3. 3590E+14 4.7261E+09 Xe-133m 4.2431E-04 9.4563E-13 4.2817E+12 1.4441EB+08 Xe-135 3. 0310E-03 1.1869E-12 5.2946E+12 1. 0315E+09 Xe-135m 2.8152E-03 3. 0905E-14 1. 3786E+ll 9. 6148E+08 Xe-138 1.1122E-02 1. 1567E-13 5.0476E+ll 3.7997E+09 Control Room Transport Group Inventory:

Time (h) = 0.0036 Atmosphere Sump Noble gases (atoms) 4.5426E+15 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00

XceI nergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 84 of 128 Aerosols (kg) 0.OOOOE+00 0.0000E+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 0.0000E+00 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 0.OOOOE+00 Total I (Ci) 0.OOOOE+00 Deposition Recirculating Time (h) = 0.0036 Surfaces Filter Nobl'e gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.0OOOE+00 0.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 0.0036 Filtered Transported Noble gases (atoms) 0.OOOOE+00 4.5533E+15 Elemental I (atoms) 0.OOOOE+00 0.0000E+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.0000E+00 0.0oooE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 0.0036 Filtered Transported Noble gases (atoms) 1.0673E+13 0.0000E+00 Elemental I (atoms) 0.0000E+00 0.0000E+00 Organic I (atoms) 0.0000E+00 0.0000E+00 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Exclusion Area Boundary Doses:

Time (h) = 0.0833 Whole Body Thyroid TEDE Delta dose (rem) 8.1153E-03 0.OOOOE+00 8. 1153E-03 Accumulated dose (rem) 8.2994E-03 0.OOOOE+00 8.2994E-03 Low Population Zone Doses:

Time (h) =, 0.0833 Whole Body Thyroid TEDE Delta dose (rem) 2.2133E-03 0.OOOOE+00 2.2133E-03 Accumulated dose (rem) 2.2635E-03 0.0000E+00 2.2635E-03 Control Room Doses:

Time (h) = 0.0833 Whole Body Thyroid TEDE Delta dose (rem) 6.1120E-04 0.OOOOE+00 6. 1120E-04 Accumulated dose (rem) 6.1170E-04 0.0000E+00 6.1170E-04 Control Room Compartment Nuclide Inventory:

Time (h) 0.0833 Ci kg Atoms Decay Kr-83m 3.4723E-05 1 . 6830E-15 1.2211E+10 3.7453E+08 Kr-85 9.7283E-03 2.4796E-08 1.7567E+17 1.0335E+11 Kr-85m 6.524SE-02 7 .9282E-12 5.6170E+13 6. 9747E+ll Kr-87 1 .2384E-01 4. 3720E-12 3.0263E+13 1.3447E+12 Kr-88 1. 6898E-01 1.3476E-11 9.2221E+13 1.8128E+12 Xe-131m 3.2767E-03 3. 9120E-11 1.7983E+14 3. 4815E+10 Xe-133 5. 8225E-01 3. 1106E-09 1.4085E+16 6. 1872E+12 Xe-133m 1.7780E-02 3. 9626E-11 1. 7942E+14 1.8900E+ll Xe-135 1 . 2703E-01 4. 9743E-11 2.2189E+14 1.3468E+12

S XceIEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 85 of 128 Xe-135m 9..5110E-02 1.0441E-12 4.6576E+412 1. 1284E+12 Xe-138 3.6924E-01 3.8401E-12, 1.6758E+13 4.4201E+12 Control Room Transport Group Inventory:

Time (h) = 0.0833 Atmosphere Sump Noble gases (atoms) 1.9054E+17 0.0000E+00 Elemental I (atoms) O.OOOOE+00 0.OOOOE+00 Organic I (atoms) O.OOOOE+00 O.OOOOE+00 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 0.OOOOE+00 Total I (,Ci) 0.OOOOE+00 Deposition Recirculating Time (h) = 0.0833 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.0oooE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.0OOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 0.0833 Filtered Transported Noble gases (atoms) 0.OOOOE+00 2.0616E+17 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 0.0833 Filtered Transported Noble gases (atoms) 1.5614E+16 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) O.OOOOE+00 0.OOOOE+00 Exclusion Area Boundary Doses:

Time (h) = 8.0000 Whole Body Thyroid TEDE Delta dose (rem) 1.8147E-01 0.OOOOE+00 1. 8147E-01 Accumulated dose (rem) 1.8977E-01 0.OOOOE+00 1.8977E-01 Low Population Zone Doses:

Time (h) = 8.0000 Whole Body Thyroid TEDE Delta dose (rem) 4.9493E-02 0.OOOOE+00 4.9493E-02 Accumulated dose (rem) 5.1757E-02 0.OOOOE+00 5. 1757E-02 Control Room Doses:

Time (h) = 8.0000 Whole Body Thyroid TEDE Delta dose (rem) 8.6461E-02 0.OOOOE+00 8. 6461E-02 Accumulated dose (rem) 8.7073E-02 0.OOOOE+00 8.7073E-02 Control Room Compartment Nuclide Inventory:

Time (h) = 8.0000 Ci kg Atoms Decay Kr-83m 8.5646E-06 4.1511E-16 3.0119E+09 3. 6877E+10

XceInergy~ Calculation No. GEN-PI-083 Revision No. 0 Page No. 86 of 128 Kr-85 4.8128E-02 1.2267E-07 8.6910E+17 4.0606E+13 Kr-85m 9.4833E-02 1.1523E-11 8.1642E+13 1.4406E+14 Kr-87 8. 1881E-03 2.8907E-13 2 . 0009E+12 8 6615E+13 Kr-88 1. 2107E-01 9. 6557E-12 6. 6077E+13 2. 7154E+14 Xe-131m 1.5902E-02 1.8985E-10 8.7276E+14 1.3529E+13 Xe-133 2.7612E+00 1.4752E-08 6. 6794E+16 2. 3731E+15 Xe-133m 7.9236E-02 1 .7659E-10 7. 9958E+14 6. 9989E+13 Xe-135 3. 5108E-01 1. 3748E-10 6. 1327E+14 3. 9007E+14 Xe-135m 2 . 0929E-10 2 .2975E-21 1.0249E+04 8.7606E+12 Control Room Transport Group Inventory:

Time (h) = 8.0000 Atmosphere Sump Noble gases (atoms) 9.3833E+17 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.0000E+00 Jý Dose Effective (Ci/cc) 1-131 (Thyroid) 0.0000E+00 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 0.0000E+00 Total I (Ci) 0.0000E+00 Deposition Recirculating Time (h) = 8.0000 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.0000E+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.0000E+00 0.0000E+00 Aerosols (kg)' 0.OOOOE+00 0.0000E+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 8.0000 Filtered Transported Noble gases (atoms) 0.000OE+00 2.6899E+18 Elemental I (atoms) 0.0000E+00 0.0000E+00 Organic I (atoms) 0,OOOOE+00 0.0000E+00 Aerosols (kg) 0.OOOOE+00 0.0000E+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 8.0000 Filtered Transported Noble gases (atoms) 1.7482E+18 0.0000E+00 Elemental I (atoms) 0.0000E+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.0000E+00 Aerosols (kg) 0.OOOOE+00 0. 0000E00 Exclusion Area Boundary Doses:

Time (h) = 24.0000 Whole Body Thyroid TEDE Delta dose (rem) 6.0919E-02 0.0000E+00 6. 0919E-02 Accumulated dose (rem) 2.5069E-01 0.0000E+00 2. 5069E-01 Low Population Zone Doses:

Time (h) = 24.0000 Whole Body Thyroid TEDE Delta dose (rem) 3.7452E-03 0.OOOOE+00 3.7452E-03 Accumulated dose (rem) 5.5502E-02 0.OOOOE+00 5.5502E-02 Control Room Doses:

Time (h) = 24.0000 Whole Body Thyroid I TEDE

o Xce Eergy I Calculation No. GEN-PI-083 Revision No. 0 Page No.87 of 128 Delta dose (rem) 2.8363E-02 O.0000E+00 2.8363E-02 Accumulated dose (rem) 1.1544E-01 0.0000E+00 1.1544E-01 Control Room Compartment Nuclide Inventory:

Time (h) = 24.0000 Ci kg Atoms Decay Kr-83m 9.4479E-09 4. 5792E-19 3.3225E+06 3. 9171E+10 Kr-85 2.2748E-02 5.7980E-08 4.1078E+17 9. 9693E+13 Kr-85m 3.7708E-03 4.5820E-13 3.2463E+12 1. 9367E+14 Kr-87 6. 3129E-07 2. 2287E-17 1.5427E+08 8. 8233E+13 Kr-88 1.1526E-03 9. 1923E-14 6.2906E+11 3.1747E+14 Xe-131m 7.2306E-03 8. 6324E-11 3. 9684E+14 3.2722E+13 Xe-133 1.1980E+00 6.4002E-09 2.8979E+16 5. 6378E+15 Xe-133m 3.0324E-02 6.7581E-11 3.0600E+14 1.5876E+14 Xe-135 4.8992E-02 1 . 9185E-11 8. 5579E+13 6.5745E+14 Control Room Transport Group Inventory:

Time (h) = 24.0000 Atmosphere Sump Noble gases (atoms) 4.4055E+17 0.OOOOE+00 Elemental I (atoms) 0.0000E+00 0.OOOOE+00 Organic I (atoms) 0.0000E+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.0000E+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 0.0000E+00 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 0.0000E+00 Total I (Ci) 0.0000E+00 Deposition Recirculating Time (h) = 24.0000 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.0000E+00 Elemental I (atoms) 0.0000E+00 0.0000E+00 Organic I (atoms) 0.OOOOE+00 0.0000E+00 Aerosols (kg) O.O000E+00 O.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 24.0000 Filtered Transported Noble gases (atoms) 0.0000E+00 4.7491E+18 Elemental I (atoms) 0.0000E+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.0000E+00 Aerosols (kg.) 0.OOOOE+00 0.0000E+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 24.0000 Filtered Transported Noble gases (atoms) 4.3015E+18 0.OOOOE+00 Elemental I (atoms) 0.0000E+00 0.OOOOE+00 Organic I (atoms) 0.0000E+00 0.OOOOE+00 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Exclusion Area Boundary Doses:

Time (h) = 45.5000 Whole Body Thyroid TEDE Delta dose (rem) 3.5836E-02 0.OOOOE+00 3.5836E-02 Accumulated dose (rem) 2.8653E-01 0.0000E+00 2.8653E-01 Low Population Zone Doses:

Time (h) = 45.5000 Whole Body Thyroid TEDE

S Xce Energy Calculation No. GEN-PI-083 Revision No. 0 Page No.88 of 128 Delta dose (rem) 3. 9314E-04 0.OOOOE+00 3. 9314E-04 Accumulated dose (rem) 5.5895E-02 0.OOOOE+00 5.5895E-02 Control Room Doses:

Time (h) 45.5000 Whole Body Thyroid TEDE Delta dose (rem) 5.4843E-03 0.OOOOE+00 5.4843E-03 Accumulated dose (rem) 1.2092E-01 0.OOOOE+00 1.2092E-01 Control Room Compartment Nuclide Inventory:

Time (h) 45.5000 Ci kg Atoms Decay Kr-85 1.5203E-02 3.8750E-08 2.7454E+17 1. 4628E+14 Kr-85m 9.0536E-05 1 . 1001E-14 7 .7943E+10 1. 9608E+14 Kr-88 4.0535E-06 3.2327E-16 2 .2122E+09 3. 1797E+14 Xe-131m 4.5875E-03 5.4769E-11 2.5178E+14 4.7167E+13 Xe-133 7. 1335E-01 3.8110E-09 1 .7256E+16 7. 9607E+15 Xe-133m 1.5262E-02 3.4012E-11 1.5401E+14 2. 1317E+14 Xe-135 6.3560E-03 2.4889E-12 1. 1103E+13 7.0870E+14 Control Room Transport Group Inventory:

Time (h) = 45.5000 Atmosphere Sump Noble gases (atoms) 2.9221E+17 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 0.0000E+00 Total I (Ci) O.OOOOE+00 Deposition Recirculating Time (h) = 45.5000 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) O. OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.00OOE+00 Aerosols (kg) 0.OOOOE+00 0.0000E+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 45.5000 Filtered Transported Noble gases (atoms) 0.0000E+00 6.6050E+18 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 o.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 45.5000 Filtered Transported Noble gases (atoms) 6.3032E+18 o.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 O.O000E+00 Exclusion Area Boundary Doses:

Time (h) = 96.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 O.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 2.8653E-01 O.OOOOE+00 2. 8653E-01

C9 Aceltnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 89 of 128 Low Population Zone Doses:

Time (h) = 96.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 5.5895E-02 0.OOOOE+00 5.5895E-02 Control Room Doses:

Time (h) = 96.0000 Whole Body Thyroid TEDE Delta dose (rem) 6.6003E-04 0.OOOOE+00 6.6003E-04 Accumulated dose (rem) 1.2158E-01 0.OOOOE+00 1. 2158E-01 Control Room Compartment Nuclide Inventory:

Time (h) = 96.0000 Ci kg Atoms Decay Kr-85 5.5375E-09 1.4114E-14 9. 9998E+10 1. 5228E+14 Xe-131m 1.4788E-09 1.7654E-17 8.1159E+07 4. 8963E+13 Xe-133 1.9780E-07 1.0567E-15 4.7848E+09 8.2371E+15 Xe-133m 2.8553E-09 6.3634E-18 2.8813E+07 2.1893E+14 Xe-135 4.9243E-11 1.9283E-20 8. 6017E+04 7.1070E+14 Control Room Transport Group Inventory:

Time (h) = 96.0000 Atmosphere Sump Noble gases (atoms) 1.0489E+ll 0.0600E+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.0000E+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 0.OOOOE+00 Total I (Ci) 0.OOOOE+00 Deposition Recirculating Time (h) = 96.0000 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg.) 0.OOOOE+00 0.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 96.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.6050E+18 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) O.OOOOE+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 96.0000 Filtered Transported Noble gases (atoms) 6.5951E+18 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.0000E+00 Aerosols (kg) O.OOOOE+00 0.OOOOE+00 Exclusion Area Boundary Doses:

Time (h) = 720.0000 Whole Body Thyroid TEDE

Xce Energy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 90 of 128 Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 2.8653E-01 0.OOOOE+00 2.8653E-01 Low Population Zone Doses:

Time (h) = 720.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 5.5895E-02 0.OOOOE+00 5.5895E-02 Control Room Doses:

Time (h) = 720.0000 Whole Body Thyroid TEDE Delta dose (rem) 1.1522E-10 0.000OE+00 1. 1522E-10 Accumulated dose (rem) 1.2158E-01 0.OOOOE+00 1.2158E-01 Control Room Compartment Nuclide Inventory:

Time (h) = 720.0000 Ci kg Atoms Decay Control Room Transport Group Inventory:

Time (h) = 720.0000 Atmosphere Sump Noble gases (atoms) 2.7697E-69 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.0000E+00 Organic I (atoms) 0.OOOOE+00 O.OOOOE+00 Aerosols (kg) O.OOOOE+00 0.00,OOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 0.OOOOE+00 Total I (Ci) 0.OOOOE+00 Deposition Recirculating Time (h) = 720.0000 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) 0.0ooOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 720.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.6050E+18 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic i (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 720.0000 Filtered Transported Noble gases (atoms) 6.5951E+18 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 840 1-131 Summary

XceIEnergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 91 of 128 RCS Environment Control Room Time (hr) 1-131 (Curies) 1-131 (Curies) 1-131 (Curies) 0.000 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.004 0.OOOOE+00 0.0000E+00 0.OOOOE+00 0.083 0.000OE+00 0.OOOOE+00 0.0000E+00 0.400 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.700 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 1.000 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 1.300 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 1.600 0.OOOOE+00 0.OOOOE+00 0.0000E+00 1 .900 0.OOOOE+00 0.0000E+00 0.OOOOE+00 2.200 0.000OE+00 0.0000E+00 0.0000E+00 2.500 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 2 .800 0.OOOOE+00 0.OOOOE+00 0.0000E+00 3.100 0.OOOOE+00 0.0000E+00 0.0000E+00 3.400 II 0.OOOOE+00 0.OOOOE+00 0.0000E+00 3.700 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 4.000 0.0000E+00 0.0000E+00 0.OOOOE+00 4 .300 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 4 .600 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 4 .900 0.OOOOE+00 0.000OE+00 0.OOOOE+00 5.200 0.0000E+00 0.0000E+00 0.0000E+00 5.500 0.OOOOE+00 0.000OE+00 0.0000E+00 5.800 0.OOOOE+00 0.0000E+00 0.OOOOE+00 6.100 0.0000E+00 0'.0000E+00 0.OOOOE+00 6.400 0.000OE+00 0.000OE+00 0.OOOOE+00 6.700 0.0000E+00 0.OOOOE+00 0.OOOOE+00 7.000 0.OOOOE+00 0.OOOOE+00 0.0000E+00 7.300 0.OOOOE+00 0.0000E+00 0.0000E+00

7. 600 0.OOOOE+00 0.000OE+00 0.0000E+00 7.900 0.OOOOE+00 0.0000E+00 0.OOOOE+00 8.000 0.OOOOE+00 0.0000E+00 0.0000E+00 8.300 0.0000E+00 0.OOOOE+00 0.OOOOE+00

8. 600 0.OOOOE+00 0.0000E+00 0.0000E+00 8.900 0.OOOOE+00 0.0000E+00 0.0000E+00 9.200 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 9.500 0.0000E+00 0.OOOOE+00 0.OOOOE+00 9.800 0.0000E+00 0.OOOOE+00 0.0000E+00 10.100 0.OOOOE+00 0.OOOOE+00 0.0000E+00 10.400 0.OOOOE+00 0.0000E+00 0.0000E+00 24 .000 0.OOOOE+00 0.0000E+00 0.0000E+00

45. 500 0.OOOOE+00 0.0000E+00 0.OOOOE+00 96.000 0.0000E+00 0.0000E+00 0.OOOOE+00 720.000 0.OOOOE+00 0.0000E+00 0.OOOOE+00

1. 1. 1. 1. C########S#############m##############r######################

Cumulative Dose Summary

1. 1. 1. 1. 4#####################################

Exclusion Area Bounda Low Population Zone Control Room Time Thyroid TEDE Thyroid TEDE Thyroid TEDE (hr) (rem) (rem) (rem) (rem) (rem) (rem) 0.000 0.0000E+00 0.0000E+00 0.0000E+0.0 0.0000E+00 0.OOOOE+00 0.0000E+00 0.004 0.0000E+00 1.8407E-04 O.O000E+00 5. 0201E-05 0.0000E+00 5.0312E-07 0.083 0.OOOOE+00 8.2994E-03 0.0000E+00 2.2635E-03 0.OOOOE+00 6.1170E-04 0.400 0.0000E+00 3.2757E-02 0.0000E+00 8.9336E-03 0.OOOOE+00 5.0900E-03 0.700 0.OOOOE+00 4.9146E-02 0.0000E+00 1.3403E-02 0.OOOOE+00 9.2610E-03 1.000 0.0000E+00 6.2269E-02 0.OOOOE+00 1.6983E-02 0.OOOOE+00 1.3429E-02 1.300 0.0000E+00 7.3554E-02 0.OOOOE+00 2.0060E-02 0.OOOOE+00 1.7663E-02 1.600 0.OOOOE+00 8.3641E-02 0.0000E+00 2. 2811E-02 0.OOOOE+00 2.1979E-02

Xce! Energy Calculation No. GEN-PI-083 Revision No. 0 Page No. 92 of 128 1.900 0.OOOOE+00 9.2836E-02 0.OOOOE+00 2.5319E-02 0.0000E+00 2.6356E-02 2.200 0.OOOOE+00 1. 0130E-01 0.OOOOE+00 2.7628E-02 0.OOOOE+00 3.0724E-02 2.500 0.OOOOE+00 1. 0914E-01 0.OOOOE+00 2.9766E-02 0.OOOOE+00 3.4948.E-02 2.800 0.OOOOE+00 1. 1642E-01 0.OOOOE+00 3 .1752E-02 0'.OOOOE+00 3.9016E-02 3.100 0.OOOOE+00 1.2320E-01 0.OOOOE+00 3.3600E-02 0.OOOOE+00 4.2926E-02 3.400 0.OOOOE+00 1 .2952E-01 0.OOOOE+00 3.5324E-02 0.OOOOE+00 4.6678E-02 3.700 0.OOOOE+00 1.3542E-01 0. OOOOE+00 3.6934E-02 0.OOOOE+00 5.0273E-02 4.000 0.OOOOE+00 1. 4094E-01 0.OOOOE+00 3.8439E-02 0.OOOOE+00 5. 3712E-02 4.300 0.OOOOE+00 1.4611E-01 0.OOOOE+00 3.9849E-02 0.OOOOE+00 5.6999E-02 4.600 0.OOOOE+00 1. 5096E-01 0.OOOOE+00 4.1171E-02 0.0000E+00 6. 0138E-02 4.900 0.OOOOE+00 1.5551E-01 0.OOOOE+00 4.2412E-02 0.0000E+00 6.3134E-02 5.200 0.OOOOE+00 1.5979E-01 0.OOOOE+00 4.3579E-02 0.OOOOE+00 6.5992E-02 5.500 0.OOOOE+00 1. 6381E-01 0.OOOOE+00 4.4676E-02 0.OOOOE+00 6. 8718E-02 5.800 0.OOOOE+00 1. 6761E-01 0.OOOOE+00 4. 5711E-02 0.OOOOE+00 7. 1318E-02 6.100 0.OOOOE+00 1.7118E-01 0.OOOOE+00 4.6686E-02 0.000OE+00 7.3797E-02 6.400 0.OOOOE+00 1 .7456E-01 0.OOOOE+00 4.7608E-02 0.OOOOE+00 7.6162E-02 6.700 0.OOOOE+00 1.7776E-01 0.OOOOE+00 4.8479E-02 0.OOOOE+00 7.8418E-02 7.000 0.OOOOE+00 1.8078E-01 0.OOOOE+00 4.9303E-02 0.OOOOE+00 8.0571E-02 7.300 0.OOOOE+00 1.8364E-01 0.OOO0E+00 5.0085E-02 0.OOOOE+00 8.12627E-02

7. 600 0.OOOOE+00 1.8636E-01 0.OOOOE+00 5.0826E-02 0.OOOOE+00 8.4590E-02 7.900 0.OOOOE+00 1.8894E-01 0.OOOOE+00 5. 1530E-02 0.OOOOE+00 8.6466E-02 8.000 0.OOOOE+00 1.8977E-01 0.OOOOE+00 5 .1757E-02 0.0000E+00 8.7073E-02 8 .3o00 0.OOOOE+00 1.9219E-01 0.OOOOE+00 5. 1905E-02 0.OOOOE+00 8.8796E-02

8. 600 0.OOOOE+00 1 .9449E-01 0.OOOOE+00 5.2046E-02 0.OOOOE+00 9.0366E-02 8.900 0.OOOOE+00 1.9668E-01 0.OOOOE+00 5 .2181E-02 0.OOOOE+00 9. 1799E-02 9.200 0.OOOOE+00 1 . 9877E-01 0.OOOOE+00 5. 2310E-02 0.OOOOE+00 9. 3113E-02 9.500 0.OOOOE+00 2. 0077E-01 0.OOOOE+00 5. 2432E-02 0.OOOOE+00 9. 4319E-02 9.800 0.OOOOE+00 2. 0268E-01 0.0000E+00 5. 2550E-02 0 OOOOE+00 9.5432E-02 10.100 0.OOOOE+00 2. 0450E-01 0 OOOOE+00 5.2662E-02 0.000M+00 9.6460E-02 10.400 0.OOOOE+00 2 .0626E-Q1 0 OOOOE+00 5.2770E-02 0 OOOOE+00 9.7414E-02 24.000 0.OOOOE+00 2. 5069E-01 0 OOOOE+00 5. 5502E-02 0 OOOOE+00 1.1544E-01 45.500 0.OOOOE+00 2. 8653E-0i 0 OOOOE+00 5. 5895E-02 0 OOOOE+00 1 .2092E-01 96.000 0.OOOOE+00 2 8653E-01 0 OOOOE+00 5. 5895E-02 0 OOOOE+00 1. 2158E-01 720.000 0.OOOOE+00 2 8653E-01 0 OOOOE+00 5. 5895E-02 0 OOOOE+00 1 .2158E-01 Worst Two-Hour Doses Exclusion Area Boundary Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 9.5659E-02 0.OOOOE+00 9.5659E-02

Xce Energy Calculation No. GEN-PI-083 Revision No. 0 Page No. 93 of 128 Attachment 13.3 RADTRAD Output File PILRAINLQ01.oO

1. 1. 1. 1. 4#################################################################

RADTRAD Version 3.03 (Spring 2001) run on 5/25/2009 at 1:55:05

1. 1. 1. 1. 4##########

File information

1. 1. 1. 1. 444#############4###########4########4######4#########

Plant file = G:\Radtrad 3.03\Input\PI\GEN-PI-083\PLRAINLQ01.psf Inventory file = g:\radtrad 3.03\defaults\pilra liq def.txt Release file = G:\Radtrad 3.03\Defaults\PINGPIodineRFT.txt Dose Conversion file = g:\radtrad 3.03\defaults\pingp-fgll&12.txt

1. 1. 1. 1. 4444 ##### 4 # # ##### 4 4 #####

4 # # 4 # #4 # 4 4 4 4 #

4 4 4 4 4 #4 4 4,. 4 4 # 4 444## #### 4#### 4 # 4 4 #4###4 # # 4 4 #4 44# 444# 4 4 4 4 #. 44# ## 4 4 # #

#### 4 4 4 # 4 #444 4 Radtrad 3.03 4/15/2001 PINGP 1 & 2 Locked Rotor Accident AST Analysis - SG Liquid Iodine Released From Intact SGs Nuclide Inventory File:

g:\radtrad 3.03\defaults\pilra-liqdef.txt Plant Power Level:

1.8520E+03 Compartments:

3 Compartment 1:

Intact SG 3

3.4380E+03 0

0 0

Compartment 2:

Environment 2

0.OOOOE+00 0

0 0

Compartment 3:

Control Room 1

9~XbeIfnergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 94 of 128

6. 1315E+04 0

0 1

0 0

Pathways:

3 t, Pathway 1:

Intact SG to Environment 2

2 Pathway 2:

Environment to Control Room "4 2

3 2

Pathway 3:

Control Room to Environment 3

2 2

End of Plant Model File Scenario Description Name:

Plant Model Filename:

Source Term:

1 1 1.OOOOE+00 g:\radtrad 3.03\defaults\pingpfgll&12.txt G:\Radtrad 3.03\Defaults\PINGP Iodine RFT.txt o.0000E+00 1

0.0000E+00 9.7000E-01 3.OOOOE-02 l.OOOOE+00 Overlying Pool:

0 0.OOOOE+00 0

0 0

0 Compartments:

3 Compartment 1:

0 1

0 0

0 Compartment 2:

0 1

0 0

X eIEnergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 95 of 128 0

0 0

0 0

Compartment 3:

1 1

0 0

1

3. 6000E+03 3

0. OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOOE+00 8.3300E-02 9. 9000E+01 9. 5000E+01 9. 5000E+01

7. 2000E+02 0.0000E+00 0.0000E+00 0.OOOOE+00 0

0 Pathways:

3 Pathway 1:

0 0

0 1

5 0.000OE+00 3. 9420E-01 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00

2. OOOOE+0O 2.3610E-01 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00

8. OOOOE+0O 1.7340E-01 0.oooOE+00 0.OOOOE+00 0.OOOOE+00

2. 4000E+01 1. 3980E-01 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 4 .5500E+01 O.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 0

0 0

0 Pathway 2:

0 0

0 0.

0*

1 3

o .OOOOE+OO 2.OOOOE+03 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00

8. 3300E-02 3.OOOOE+02 0.0000E+00 0.0000E+00 0.OOOOE+00

7. 2000E+02 0.0000E+00 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0

0 0

Pathway 3:

0

XceI Energy Calculation No. GEN-PI-083 Revision No. 0 Page No. 96 of 128 0

0 0

0 1

3 0.0000E+00 2.0000E+03. 0.OOOOE+00 0-0000E+00 0.0000E+00 8 *.3300E-02 3.0000E+02 0. 00OE+00 0-0000E+00 0.0000E+00 7.2000E+02 0.0000E+00 0.0000E+00 0.0000E+00 0.0000E+00 0

0 0

0 Dose Locations:

3 Location 1:

Exclusion Area Boundary 2

2 o.OOOOE+00 6.4900E-04 7.2000E+02 0.OOOOE+00 1

2 0.OOOOE+00 3.5000E-04 7.2000E+02 0.OOOOE+00 0

Location 2:

Low Population Zone 2

1 5

0.000OE+00 1.7700E-04 8.OOOOE+00 3.9900E-05 2.4000E+01 7. 1200E-06

9. 6000E+01 1.0400E-06 7.2000E+02 0.OOOOE+00 1

4 0.OOOOE+00 3.5000E-04 8.OOOOE+00 1.8000E-04 4

2. 4000E+01 2.3000E-04 7.2000E+02 o.OOOOE+00 0

Location 3:

Control Room 3

0 1

2 0.OOOOE+00 3.5000E-04 7.2000E+02 0.OOOOE+00 1

4 0.OOOOE+00 1.0000E+00 2.4000E+01 6.0000E-01 9.6000E+01 4 . OOOOE-01 7.2000E+02 0.OOOOE+00

9~Xcelfnergy- Calculation No. GEN-PL-083 Revision No. 0 Page No. 97 of 128 Effective Volume Location:

1 6

O.OOOOE+00 1.8300E-02 2.OOOOE+00 1.4200E-02 8.OOOOE+00 6.3000E-03 2.4000E+01 4.2900E-03 9.6000E+01 3.3800E-03 7.2000E+02 0.OOOOE+00 Simulation Parameters:

0.0000E+00 1.0000E-01 2.0000E+00 5.OOOOE-01 8.0000E+00 1.0000E+00 2.4000E+01 2.0000E+00 9.6000E+01 4.0000E+00 7.2000E+02 0.0000E+00 Output Filename:

G:\Radtrad 3.o61 1

1 1

0 0

End of Scenario File

X*el Energy- ICalculation No. GEN-PI-083 Revision No. 0 Page No. 98 of 128

4################*#####4#######4##*####**####4ý########################

RADTRAD Version 3.03 (Spring 2001) run on 5/25/2009 at 1:55:05

1. 1. 1. 1. 4#########################################4##########

1. 1. 1. 1. 4###########################4########f#4##4####################

Plant Description

1. 1. 1. 1. 4######################4##########################################

Number of Nuclides = 60 Inventory Power = 1.OOOOE+00 MWth Plant Power Level = 1.8520E+03 MWth Number of compartments = 3 Compartment information Compartment number 1 (Source term fraction = 1.OOOOE+00 Name: Intact SG Compartment volume = 3.4380E+03 (Cubic feet)

Compartment type is Normal Pathways into and out of compartment 1 Exit Pathway Number 1: Intact SG to Environment Compartment number 2 Name: Environment Compartment type is Environment Pathways into and out of compartment 2 Inlet Pathway Number 1: Intact SG to Environment Inlet Pathway Number 3: Control Room to Environment Exit Pathway Number 2: Environment to Control Room Compartment number 3 Name: Control Room Compartment volume = 6.1315E+04 (Cubic feet)

Compartment type is Control Room Removal devices within compartment:

Filter(s)

Pathways into and out of compartment 3 Inlet Pathway Number 2: Environment to Control Room Exit Pathway Number 3: Control Room to Environment Total number of pathways = 3

XcelEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 99 of 128

1. 1. 1. 4###############################################################O###

RADTRAD Version 3.03 (Spring 2001) run on 5/25/2009 at 1:55:05

1. 1. 1. 1. 0############################################

Scenario Description

1. 1. 1. 1. 4############ #####i##############################################

Radioactive Decay is enabled Calculation of Daughters is enabled Release Fractions and Timings GAP EARLY IN-VESSEL LATE*RELEASE RELEASE MASS 0.003600 hr 0.0000 hrs 0.0000 hrs (gm)

NOBLES 0. 000E+00 0 OOOOE+00 0 OOOOE+00 0.OOOE+00 IODINE 1.OOOOE+00 0 OOOOE+00 0 OOOOE+00 8.142E-05 CESIUM 0.0000E+00 0 OOOOE+00 0. 0000E+00 0.OOOE+00 TELLURIUM 0.OOOOE+00 0 OOOOE+00 0. 000OE+00 0.OOOE+00 STRONTIUM 0.OOOOE+00 0 OOOOE+00 0 OOOOE+00 0.OOOE+00 BARIUM 0.OOOOE+00 0 OOOOE+00 0 OOOOE+00 0.OOOE+00 RUTHENIUM 0.OOOOE+00 0 OOOOE+00 0 OOOOE+00 0.OOOE+00 CERIUM 0.OOOOE+00 0 OOOOE+00 0. 0000E+00 0.OOOE+00 LANTHANUM 0.000OE+00 0 OOOOE+00 0 OOOOE+00 0.OOOE+00 Inventory Power = 1852. MWt Nuclide Group Specific half Whole Body Inhaled Inhaled Name Inventory life DCF Thyroid Effective (Ci/MWt) (s) (Sv-m3/Bq-s) (Sv/Bq) (Sv/Bq) 1-131 2 4.500E-03 6. 947E+05 1.820E-14 2.920E-07 8.890E-09 1-132 2 4.940E-03 8 .280E+03 1.120E-13 1. 740E-09 1.030E-10 1-133 2 6.846E-03 7.488E+04 2.940E-14 4.860E-08 1.580E-09 1-134 2 1.027E-03 3. 156E+03 1.300E-13 2.880E-10 3.550E-11 1-135 2 3.882E-03 2. 380E+04 8.294E-14 8.460E-09 3.320E-10 Nuclide Daughter Fraction Daughter Fraction Daughter Fraction 1-131 Xe-131m 0.01 none 0.00 none 0.00 1-133 Xe7133m 0.03 Xe-13.3 0.97 none 0.00 1-135 Xe-135m 0.15 Xe-135 0.85 none 0.00 Iodine fractions Aerosol = 0.OOOOE+00 Elemental = 9.7000E-01 Organic = 3.OOOOE-02 COMPARTMENT DATA Compartment number 1: Intact SG Compartment number 2: Environment Compartment number 3: Control Room Compartment Filter Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 0.000OE+00 3.600GE+03 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00

8. 3300E-02 3.6000E+03 9. 9000E+01 9.5000E+01 9. 5000E+01

9~XceIfnergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 100 of 128 7.2000E+02 3.6000E+03 O.OOOOE+00 O.OOOOE+00 O.OOOOE+00 PATHWAY DATA Pathway number 1: Intact SG to Environment

,,Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 0.000OE+00 3. 9420E-01 O.OOOOE+00 0.0000E+00 0.OOOOE+00 2.OOOE+00 2.3610E-01 0.0000E+00 O.OOOOE+00 0.0000E+00 8.OOOOE+00 1.7340E-01 0.0000E+00 0.OOOE+00 0.OOOOE+00 2.4000E+01 1.3980E-01 0.OOOOE+00 O.OOOOE+00 0.OOOOE+00 4.5500E+01 0.0000E+00 0.OOOOE+00 0.0OOOE+00 0.0000E+00 Pathway number 2: Environment to Control Room Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic 0.0000E+00 2.0000E+03 0.0000E+00 O.OOOOE+00 0.OOOE+00 8.3300E-02 3.OOOE+02 0.0000E+00 0.OOOOE+00 0.0000E+00 7.2000E+02 0.0000E+00 0.000OE+00 0.OOOE+00 0.0000E+00 Pathway number 3: Control Room to Environment Pathway Filter: Removal Data Time (hr) Flow Rate Filter Efficiencies (%)

(cfm) Aerosol Elemental Organic.

0.OOOOE+00 2.0000E+03 0.OOOOE+00 .OOOOE+00 O.OOOOE+00 8.3300E-02 3.0000E+02 0.OOOOE+00 O.0OOOE+00 0.OOOOE+00 7.2000E+02 0.0000E+00 O.OOOOE+00 O.OOOOE+00 0.OOOOE+00 LOCATION DATA Location Exclusion Area Boundary is in compartment 2 Location X/Q Data Time (hr) X/Q (s

m^-3) 0.000OE+00 6.4900E-04 7.2000E+02 0.OOOOE+00 Location Breathing Rate Data Time (hr) Breathing Rate (m^3

sec^-l) 0.OOOOE+00 3.5000E-04 7.2000E+02 0.0000E+00 Location Low Population Zone is in compartment 2 Location X/Q Data Time (hr) X/Q (s

m^-3) 0.OOOOE+00 1.7700E-04 8.0000E+00 3.9900E-05 2.4000E+01 7.1200E-06 9.6000E+01 1.0400E-06 7.2000E+02 0.0000E+00 Location Breathing Rate Data Time (hr) Breathing Rate (m^3

sec^-1)

er ayClatioNoENP083 Revision No. 0 Page No. 101 of 128 0.0000E+00 3.5000E-04 8.0000E+00 1.8000E-04 2.4000E+01 2.3000E-04 7.2000E+02 0.OOOOE+00 Location Control Room is in compartment 3 Location X/Q Data Time (hr) X/ (s

m^-3) o .OOOOE+00 1.8300E-02

2. OOOOE+00 1.4200E-02

8. OOOOE+00 6.3000E-03

2. 4000E+01 4.2900E-03

9. 6000E+01 3.3800E-03 7.2000E+02 0.OOOOE+00 Location Breathing Rate Data Time (hr) Breathing Rate (m^3

sec^-I) 0.0000E+00 3.5000E-04 7.2000E+02 0.0000E+00 Location Occupancy Factor Data Time (hr) Occupancy Factor 0.0000E+00 1.0000E+00 2.4000E+01 6.0000E-01 9.6000E+01 4.OOOOE-01 7.2000E+02 0.OOOOE+00 USER SPECIFIED TIME STEP DATA - SUPPLEMENTAL TIME STEPS Time Time step o .OOOOE+O0 1 . 0000E-01

2. OOOOE+00 5. OOOE-01

8. OOOOE+00 1 .OOOOE+00 2 4000E+01 2. OOOOE+00

9. 6000E+01 4 .0000E+00 7 .2000E+02 0 OOOOE+00

XceI Energy' Calculation No. GEN-PI-083 Revision No. 10 Page No. 102 of 128 V######on##3#######

n 20#######runon#5######/20##09 at###1:0#####

RADTRAD Version 3.03 (Spring 2001) run on 5/25/2009 at 1:55:05

1. 1. 1. 1. itt#######titi###i#####i### t##i##i###########i#i########it###t#####i##########*#

1. 1. 1. # #t #i#### ###t## # it #####iti

.# # # #t # it # # it it it # it # it # it it it# # #t #t

t i##### # it t *1 it it i # it it

# it #t #t # # it

1. 1. 1. #### # it #t

1. 1. 1. 1. 4###########################

Dose, Detailed model and Detailed Inventory Output

1. 1. 1. 1. E######B########n#########

Exclusion Area Boundary Doses:

Time (h) = 0.0036 Whole Body Thyroid TEDE Delta dose (rem) 7.1130E-08 3.2544E-05 1.0860E-06 Accumulated dose (rem) 7.1130E-08 3.2544E-05 1.0860E-06 Low Population Zone Doses:

Time (h) = 0.0036 Whole Body Thyroid TEDE Delta dose (rem) 1.9399E-08 8.8756E-06 2. 9619E-07 Accumulated dose (rem) 1.9399E-08 8.8756E-06 2. 9619E-07 Control Room Doses:

Time (h) = 0.0036 Whole Body Thyroid TEDE Delta dose (rem) 1.9443E-10 2. 5137E-06 7.8586E-08 Accumulated dose (rem) 1.9443E-10 2. 5137E-06 7.8586E-08 Control Room Compartment Nudlide Inventory:

Time (h) = 0.0036 Ci kg Atoms Decay 1-131 1.7784E-06 1. 4345E-14 6. 5945E+10 6.0528E+05 1-132 1.9502E-06 1.8894E-16 8. 6197E+08 6.6401E+05 1-133 2.7053E-06 2. 3881E-15 1.0813E+10 9 .2077E+05 1-134 4.0473E-07 1. 5172E-17 6.8183E+07 1.3789E+05 1-135 1.5336E-06 4 .3670E-16 1.9480E+09 5.2203E+05 Xe-133 4.2437E-11 2 .2672E-19 1.0266E+06 2. 1883E+00 Xe-133m 3. 0414E-12 6.7781E-21 3. 0691E+04 1.5683E-01 Xe-135 2. 9202E-10 1. 1435E-19 5. 1010E+05 1.5057E+01 Xe-135m 1.8359E-09 2. 0154E-20 8.9903E+04 9.4420E+01 Control Room Transport Group Inventory:

Time (h) = 0.0036 Atmosphere Sump Noble gases (atoms) 1.6649E+06 0.OOOOE+00 Elemental I (atoms) 7.7247E+10 0.OOOOE+00 Organic I (atoms) 2.3891E+09 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 1.3161E-15

XCe, Energy I Calculation No. GEN-PI-083 Revision No. 0 Page No. 103 of 128 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 1.5587E-15 Total I (Ci) 8.3723E-06 Deposition Recirculating Time (h) = 0.0036 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.0000E+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 0.0036 Filtered Transported Noble gases (atoms) 0.OOOOE+00 2.1714E+05 Elemental I (atoms) 0.OOOOE+00 7.7431E+10 Organic I (atoms) 0.OOOOE+00 2.3948E+09 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 0.0036 Filtered Transported Noble gases (atoms) 7.6333E+02 0.OOOOE+00 Elemental I (atoms) 1.8151E+08 0.OOOOE+00 Organic I (atoms) 5.6136E+06 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Exclusion Area Boundary Doses:

Time (h) = 0.0833 Whole Body Thyroid TEDE Delta dose (rem) 3.1469E-06 1.4405E-03 4.8070E-05 Accumulated dose (rem) 3.2180E-06 1. 4731E-03 4. 9156E-05 Low Population Zone Doses:

Time (h) = 0.0833 Whole Body Thyroid TEDE Delta dose (rem) 8.5824E-07 3.9287E-04 1.3110E-05 Accumulated dose (rem) 8.7763E-07 4.0174E-04 1.3406E-05 Control Room Doses:

Time (h) = 0.0833 Whole Body Thyroid TEDE Delta dose (rem) 2.3701E-07 3.0656E-03 9. 5841E-05 Accumulated dose (rem) 2.3720E-07 3.0681E-03 9. 5919E-05 Control Room Compartment Nuclide Inventory:

Time (h) 0.0833 Ci kg Atoms Decay 1-131 7.4561E-05 6. 0142E-13 2.7648E+12 7.9226E+08 1-132 7.9846E-05 7 . 7354E-15 3.5291E+10 8.5858E+08 1-133 1. 1315E-04 9. 9886E-14 4.5228E+lI 1.2037E+09 1-134 1.5937E-05 5. 9740E-16 2.6848E+09 1.7477E+08 1-135 6.3781E-05 1.8162E-14 8. 1016E+10 6.8046E+08 Xe-131m 1.6414E-10 1. 9597E-18 9.0087E+06 5.8130E+01 Xe-133 4.9898E-08 2. 6657E-16 1.2070E+09 1.7690E+04 Xe-133m 3.5760E-09 7. 9696E-18 3.6086E+07 1.2674E+03 Xe-135 3.4265E-07 1.3418E-16 5.9855E+08 1.2138E+05 Xe-135m 2.1408E-06 2. 3501E-17 1.0483E+08 6.8845E+05

XceI nerg Calculation No. GEN-PI-083 Revision No. 0 Page No. 104 of 128 Control Room Transport Group Inventory:

Time (h) = 0.0833 Atmosphere Sump Noble gases (atoms) 1.9555E+09 0.OOOOE+00 Elemental I (atoms) 3.2360E+12 0.OOOOE+00 Organic I (atoms) 1.0008E+ll 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 5.5138E-14 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 6. 5234E-14 Total I (Ci) 3.4728E-04 Deposition Recirculating Time (h) = 0.0833 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.0000E+00 0.0000E+00 Aerosols (kg) 0.0000E+00 0.0000E+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 0.0833 Filtered Transported Noble gases (atoms) 0.OOOOE+00 6.9291E+07 Elemental I (atoms) O. OOOOE+00 3.5048E+12 Organic I (atoms) 0.OOOOE+00 1.0840E+ll Aerosols (kg) 0.OOOOE+00 0.O0OOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 0.0833 Filtered Transported Noble gases (atoms) 5.3627E+06 0.OOOOE+00 Elemental I (atoms) 2.6546E+ll 0.OOOOE+00 Organic I (atoms) 8.2102E+09 0.OOOOE+00 Aerosols (kg) O.OOOOE+00 0.OOOOE+00 Exclusion Area Boundary Doses:

Time (h) = 2.0000 Whole Body Thyroid TEDE Delta dose (rem) 6.1929E-05 3.3982E-02 1. 1195E-03 Accumulated dose (rem) 6.5147E-05 3.5456E-02 1. 1686E-03 Low Population Zone Doses:

Time (h) = 2.0000 Whole Body Thyroid TEDE Delta dose (rem) 1.6890E-05 9.2679E-03 3. 0531E-04 Accumulated dose (rem) 1.7767E-05 9.6697E-03 3. 1872E-04 Control Room Doses:

Time (h) = 2.0000 Whole Body Thyroid TEDE Delta dose (rem) 5.7538E-06 8.6804E-02 2.7075E-03 Accumulated dose (rem) 5.9910E-06 8.9873E-02 2.8034E-03 Control Room Compartment Nuclide Inventory:

Time (h) = 2.0000 Ci kg Atoms Decay 1-131 4.0070E-05 3. 2321E-13 1.4858E+12 1.2145E+10 1-132 2.4249E-05 2.3492E-15 1.0718E+10 1. 0310E+10 1-133 5.7441E-05 5.0707E-14 2 .2960E+ll 1.7983E+10 1-134 1.8947E-06 7. 1025E-17 3. 1919E+08 1.4978E+09

& ~XceIfnergy, Calculation No. GEN-PI-083 Revision No. 0 Page No. 105 of 128 1-135 2.8230E-05 8. 0384E-15 3. 5858E+10 9.5667E+09 Xe-131m 8.0079E-09 9. 5604E-17 4. 3950E+08 8.7731E+05 Xe-133 2.3758E-06 1 .2692E-14 5 .7470E+10 2.6220E+08 Xe-133m 1.6862E-07 3. 7579E-16 1. 7016E+09 1.8666E+07 Xe-135 1.6529E-05 6.4727E-15 2. 8874E+10 1.8620E+09 Xe-135m 9.9555E-06 1.0929E-16 4. 8753E+08 2.2406E+09 Control Room Transport Group Inventory:

Time (h) = 2.0000 Atmosphere Sump Noble gases (atoms) 8.8972E+10 0.0000E+00 Elemental I (atoms) 1.7095E+12 0.0000E+00 Organic I (atoms) 5.2870E+10 0.OOOOE+00 Aerosols (kg) 0.0000E+00 0.0000E+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 2.9140E-14 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 3.3797E-14 Total I (Ci) 1. 5188E-04 Deposition Recirculating Time (h) = 2.0000 Surfaces Filter Noble gases (atoms) 0.0000E+00 0.OOOOE+00 Elemental I (atoms) 0.0000E+00 1.2505E+13 Organic I (atoms) 0.0000E+00 3.8675E+Il Aerosols (kg) 0.0000E+00 0.0000E+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 2.0000 Filtered Transported Noble gases (atoms) 0.0000E+00 8.4487E+10 Elemental I (atoms) 0.0000E+00 1.5627E+13 Organic I (atoms) 0.0000E+00 4.8332E+11 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 2.0000 Filtered Transported Noble gases (atoms) 2.1056E+10 0.OOOOE+00 Elemental I (atoms) 1.3624E+12 0.0000E+00 Organic I (atoms) 4.2136E+10 0.OOOOE+00 Aerosols (kg) 0.0000E+00 0. 00E+00 Exclusion Area Boundary Doses:

Time (h) = 8.0000 Whole Body Thyroid TEDE Delta dose (rem) 6.5830E-05 5.9825E-02 1. 9181E-03 Accumulated dose (rem) 1.3098E-04 9. 5281E-02 3.0867E-03 Low Population Zone Doses:

Time (h) = 8.0000 Whole Body Thyroid TEDE Delta dose (rem) 1.7954E-05 1. 6316E-02 5. 2312E-04 Accumulated dose (rem) 3.5721E-05 2.5986E-02 8.4184E-04 Control Room Doses:

Time (h)-= 8.0000 Whole Body Thyroid TEDE Delta dose (rem) 4.9844E-06 1. 1157E-01 3.4599E-03 Accumulated dose (rem) 1.0975E-05 2.0144E-01 6.2634E-03

Xce IEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 106 of 128 Control Room Compartment Nuclide Inventory:

Time (h) 8.0000 Ci kg Atoms Decay 1-131 1.7753E-05 1 .4320E-13 6.5830E+11 2.7315E+10 1-132 1.7997E-06 1.7436E-16 7. 9546E+08 1. 4794E+10 1-133 2.1291E-05 1.8795E-14 8. 5102E+10 3. 7984E+10 1-134 7.4657E-09 2 .7986E-19 1 .2577E+06 1. 6691E+09 1-135 6. 8119E-06 1.9397E-15 8.6526E+09 1. 7696E+10 Xe-131m 3.1254E-08 3.7313E-16 1 .7153E+09 1.5460E+07 Xe-133 8.5699E-06 4 .5784E-14 2. 0730E+l1 4.3942E+09 Xe-133m 5.9024E-07 1.3154E-15 5.9562E+09 3.0653E+08 Xe-135 3.9486E-05 1 .5462E-14 6.8974E+10 2.4519E+10 Xe-135m 2.4373E-06 2. 6756E-17 1 .1936E+08 5. 3110E+09 Control Room Transport Group Inventory:

Time (h) = 8.0000 Atmosphere Sump Noble gases (atoms) 2.8407E+11 0.OOOOE+00 Elemental I (atoms) 7.3026E+11 0.OOOOE+00 Organic I (atoms) 2.2585E+10 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 1.2386E-14 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 1. 3867E-14 Total I (Ci) 4.7663E-05 Deposition Recirculating Time (h) = 8.0000 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.OOOOE+00 Elemental I (atoms). 0.0000E+00 2.8617E+13 Organic I (atoms) 0.0000E+00 8.8505E+I1 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 8.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 5.9174E+11 Elemental I (atoms) 0.0000E+00 3.2220E+13 Organic I (atoms) 0.0000E+00 9.9651E+51 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 8.0000 Filtered Transported Noble gases (atoms) 3.3469E+11 0.0000E+00 Elemental I (atoms) 2.7757E+12 0.OOOOE+00 Organic I (atoms) 8.5846E+10 0.0000E+00 Aerosols (kg) 0.0000E+00 0.0000E+00 Exclusion Area Boundary Doses:

Time (h) = 24.0000 Whole Body Thyroid TEDE Delta dose (rem) 6.0338E-05 1.0266E-01 3.2199E-03 Accumulated dose (rem) 1.9132E-04 1.9794E-01 6.3066E-03 Low Population Zone Doses:

Time (h) = 24.0000 Whole Body Thyroid TEDE Delta dose (rem) 3.7095E-06 3.2459E-03 1.0361E-04 Accumulated dose (rem) 3.9431E-05 2.9232E-02 9.4544E-04

X e,Energy' CalculationNo. GEN-PI-083 Revision No. 0 Page No. 107 of 128 Control Room Doses:

Time (h) = 24.0000 Whole Body Thyroid TEDE Delta dose (rem) 2.7632E-06 8.3584E-02 2.5755E-03 Accumulated dose (rem) 1.3739E-05 2. 8503E-01 8.8389E-03 Control Room Compartment Nuclide Inventory:

Time (h) = 24.0000 Ci kg Atoms Decay 1-131 5.2019E-06 4.1959E-14 1. 9289E+11 3. 9359E+I0 1-132 4 .4971E-09 4.3568E-19 1.9877E+06 1.5083E+10 1-133 3.8769E-06 3.4224E-15 1. 5496E+10 4.9611E+10 1-135 3.9486E-07 1. 1244E-16 5. 0156E+08 2.0081E+10 Xe-131m 3. 6185E-08 4 .3200E-16 1.9859E+09 7. 5126E+07 Xe-133 7.9096E-06 4 .2256E-14 1. 9133E+l1 1.8964E+10 Xe-133m 5. 0513E-07 1. 1257E-15 5.0973E+09 1.2716E+09 Xe-135 1.1811E-05 4.6251E-15 2. 0632E+10 6. 4352E+10 Xe-135m 2.2445E-07 2.4640E-18 1.0992E+07 6. 5122E+09 Control Room Transport Group Inventory:

Time (h) = 24.0000 Atmosphere Sump Noble gases (atoms) 2.1906E+ll 0.OOOOE+00 Elemental I (atoms) 2.0262E+11 0.OOOOE+00 Organic I (atoms) 6.2667E+09 0.0000E+00 Aerosols (kg) 0.0000E+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 3.3743E-15 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 3.6119E-15 Total I (Ci) 9. 4781E-06 Deposition Recirculating Time (h) = 24.0000 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.0000E+00 Elemental I (atoms) 0.OOOOE+00 4.0829E+13 Organic I (atoms) 0.OOOOE+00 1.2627E+12 Aerosols (kg) 0.0000E+00 0.0000E+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 24.0000 Filtered Transported Noble gases (atoms) 0.0000E+00 1.5247E+12 Elemental I (atoms) 0.OOOOE+00 4.5002E+13 Organic I (atoms) 0.OOOOE+00 1.3918E+12 Aerosols (kg) 0.OOOOE+00 0.0000E+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 24.0000 Filtered Transported Noble gases (atoms) 1.2923E+12 0.0000E+00 Elemental I (atoms) 3.8469E+12 0.0000E+00 Organic I (atoms) 1.1898E+11 0.0000E+00 Aerosols (kg) 0.0000E+00 0.0000E+00 Exclusion Area Boundary Doses:

Time (h) = 45.5000 Whole Body Thyroid TEDE Delta dose (rem) 3.2882E-05 9.2798E-02 2.8753E-03 Accumulated dose (rem) 2.2420E-04 2.9074E-01 9. 1819E-03

XceI fnergy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 108 of 128 Low Population Zone Doses:

Time (h) = 45.5000 Whole Body Thyroid, TEDE Delta dose (rem) 3.6074E-07 6. 6901E-04 2.0852E-05 Accumulated dose (rem) 3.9791E-05 2. 9901E-02 9.6630E-04 Control Room Doses:

Time (h) = 45.5000 Whole Body Thyroid TEDE Delta dose (rem) 6.0053E-07 3.0356E-02 9.3044E-04 Accumulated dose (rem) 1.4339E-05 3. 1538E-01 9.7693E-03 Control Room Compartment Nuclide Inventory:

Time (h) = 45.5000 Ci kg Atoms Decay 1-131 2. 5081E-06 2.0231E-14 9. 3001E+10 4 .7028E+10 1-133 9.8639E-07 8.7074E-16 3.9427E+09 5. 3864E+10 1-135 2. 1579E-08 6.1445E-18 2. 7410E+07 2.0324E+10 Xe-131m 3. 6123E-08 4. 3127E-16 1.9826E+09 1.6334E+08 Xe-133 5.8335E-06 3. 1165E-14 1.4111E+ll 3. 5453E+10 Xe-133m 3. 3471E-07 7 .4594E-16 3.3776E+09 2.2726E+09 Xe-135 1.9033E-06 7.4531E-16 3.3247E+09 7. 7214E+10 Xe-135m 1. 1973E-08 1.3144E-19 5.8632E+05 6. 6813E+09 Control Room Transport Group Inventory:

Time (h) = 45.5000 Atmosphere Sump Noble gases (atoms) 1.4980E+ll 0.0000E+00 Elemental I (atoms) 9.4062E+10 0.0000E+00 Organic I (atoms) 2.9091E+09 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 1. 5395E-15 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 1. 5974E-15 Total I (Ci) 3.5161E-06 Deposition Recirculating Time (h) = 45.5000 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.0000E+00 Elemental I (atoms) o.OOOOE+00 4.8222E+13 Organic I (atoms) 0.OOOOE+00 1.4914E+12 Aerosols (kg) 0.0000E+00 O.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 45.5000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 2.4527E+12 Elemental I (atoms) 0.OOOOE+00 5.3015E+13 Organic I (atoms) 0.OOOOE+00 1.6396E+12 Aerosols (kg) O.O000E+00 0.0000E+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 45.5000 Filtered Transported Noble gases (atoms) 2.2647E+12 0.OOOOE+00 Elemental I (atoms) 4.4955E+12 0.OOOOE+00 Organic I (atoms) 1.3904E+11 0.OOOOE+00 Aerosols (kg) 0.0000E+00 0.0000E+00

XceIfnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 109 of 128 Exclusion Area Boundary Doses:

Time (h) = 96.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 2.2420E-04 2. 9074E-01 9. 1819E-03 Low Population Zone Doses:

Time (h) = 96.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 3.9791E-05 2. 9901E-02 9.6630E-04 Control Room Doses:

Time (h) = 96.0000 Whole Body Thyroid TEDE Delta dose (rem) 2.0339E-08 4.7231E-04 1.4461E-05 Accumulated dose (rem) 1.4359E-05 3. 1586E-01 9.7838E-03 Control Room Compartment Nuclide Inventory:

Time (h) = 96.0000 Ci kg Atoms Decay Xe-133 1.6311E-12 8.7137E-21 3.9455E+04 3. 7715E+10 Control Room Transport Group Inventory:

Time (h) = 96.0000 Atmosphere Sump Noble gases (atoms) 4.0752E+04 0.OOOOE+00 Elemental I (atoms) 1.1001E-69 0.OOOOE+00 Organic I (atoms) 3.4025E-71 0.0000E+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 1.7706E-95 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 1.7860E-95 Total I (Ci) 3.2957E-86 Deposition Recirculating Time (h) = 96.0000 Surfaces Filter Noble gases (atoms) 0.OOOOE+00 0.0000E+00 Elemental I (atoms) 0.OOOOE+00 4.8292E+13 Organic I (atoms) 0.OOOOE+00 1.4936E+12 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 96.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 2.4527E+12 Elemental I (atoms) 0.000OE+00 5.3015E+13 Organic I (atoms) 0.OOOOE+00 1.6396E+12 Aerosols (kg) O.OOOOE+00 O.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 96.0000 Filtered Transported Noble gases (atoms) 2.4116E+12 0.OOOOE+00 Elemental I (atoms) 4.5016E+12 0.OOOOE+00 Organic I (atoms) 1.3922E+ll 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Exclusion Area Boundary Doses:

SXceIEnergy- ICalculation No. GEN-PI-083 Revision No. 0 Page No. 110 of 128 Time (h) = 720.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.0000E+00 0.OOOOE+00 Accumulated dose (rem) 2.2420E-04 2.9074E-01 9. 1819E-03 Low Population Zone Doses:

Time (h) = 720.0000 Whole Body Thyroid TEDE Delta dose (rem) 0.OOOOE+00 0.OOOOE+00 0.OOOOE+00 Accumulated dose (rem) 3.9791E-05 2. 9901E-02 9.6630E-04 Control Room Doses:

Time (h) = 720.0000 Whole Body Thyroid TEDE Delta dose (rem) 1.0198E-15 5.0800E-84 1. 0198E-15 Accumulated dose (rem) 1.43,59E-05 3. 1586E-01 9.'7838E-03 Control Room Compartment Nuclide Inventory:

Time (h) = 720.0000 Ci kg Atoms Decay Control Room Transport Group Inventory:

Time (h) = 720.0000 Atmosphere Sump Noble gases (atoms) 4.0155E-77 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 0.OOOOE+00 Organic I (atoms) 0.OOOOE+00 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (Thyroid) 0.OOOOE+00 Dose Effective (Ci/cc) 1-131 (ICRP2 Thyroid) 0.OOOOE+00 Total I (Ci) 0.OOOOE+00 Deposition Recirculating Time (h) = 720.0000 Surfaces Filter Noble gases (atoms) 0.0000E+00 0.OOOOE+00 Elemental I (atoms) 0.OOOOE+00 4.8292E+13 Organic I (atoms) 0.OOOOE+00 1.4936E+12 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Environment to Control Room Transport Group Inventory:

Pathway Time (h) = 720.0000 Filtered Transported Noble gases (atoms) 0.OOOOE+00 2.4527E+12 Elemental I (atoms) 0.OOOOE+00 5.3015E+13 Organic I (atoms) 0.0ooOE+00 1.6396E+12 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 Control Room to Environment Transport Group Inventory:

Pathway Time (h) = 720.0000 Filtered Transported Noble gases (atoms) 2.4116E+12 0.OOOOE+00 Elemental I (atoms) 4.5016E+12 0.OOOOE+00 Organic I (atoms) 1.3922E+ll 0.OOOOE+00 Aerosols (kg) 0.OOOOE+00 0.OOOOE+00 840 1-131 Summary

[ XceIEnergy- Calculation No. GEN-PI-083 Revision No. 0 Page o. 111 of 128 Intact SG Environment Control Room Time (hr) 1-131 (Curies) 1-131 (Curies) 1-131 (Curies) 0.000 1.2861E+00 2.4577E-0,6 4.2438E-08 0.004 8.3338E+00 1.0320E-04 1.7784E-06 0.083 8.3268E+00 4.6701E-03 7.4561E-05 0.400 8.2993E+00 2.2779E-02 5.1347E-05 0.700 8.2732E+00 3.9878E-02 4.4151E-05 1.000 8.2473E+00 5.6923E-02 4.1655E-05 1.300 8.2214E+00 7.3914E-02 4.0734E-05 1.600 8.1956E+00 9.0853E-02 4.0341E-05 1.900 8.1699E+00 1.0774E-01 4.0126E-05 2.000 8.1614E+00 1.1335E-01 4.0070E-05 2.300 8.1425E+00 1.2343E-01 2.5749E-05

2. 600 8.1237E+00 1.3348E-01 2.0921E-05 2.900 8.1049E+00 1.4351E-01 1.9274E-05 3.200 8.0862E+00 1.5352E-01 1.8694E-05 3.500 8.0675E+00 1.6350E-01 1.8471E-05 3.800 8.0489E+00 1.7346E-01 1.8368E-05 4.100 8.0303E+00 1.8339E-01 1.8305E-05 4.400 8.0117E+00 1.9331E-01 1.8256E-05 4.700 7. 9932E+00 2.0320E-01 1.8212E-05 5.000 7. 9747E+00 2.1306E-01 1.8169E-05 5.300 7. 9563E+00 2.2291E-01 1.8127E-05 5.600 7. 9379E+00 2.3273E-01 1.8085E-05 5.900 7. 9195E+00 2.4253E-01 1.8043E-05 6.200 7. 9012E+00 2.5231E-01 1.8001E-05 6.500 7. 8830E+00 2.6206E-01 1.7960E-05 6.800 7. 8648E+00 2.7179E-01 1.7918E-05 7.100 7.8466E+00 2.8150E-01 1.7877E-05 7.400 7. 8284E+00 2.9119E-01 1.7835E-05 7.700 7.8104E+00 3.0085E-01 1.7794E-05 8..000 7.7923E+00 3.1049E-01 1.7753E-05 8.300 7.7768E+00 3.1756E-01 9.7834E-06 8.600 7.7614E+00 3.2461E-01 7.1047E-06 8.900 7.7460E+00 3.3165E-01 6.1993E-06 9.200 7.7307E+00 3.3867E-01 5.8883E-06 9.500 7.7153E+00 3.4568E-01 5.7765E-06 9.800 7.7000E+00 3.5268E-01 5.7314E-06 10.100 7.6848E+00 3.5966E-01 5.7088E-06 10.400 7.6695E+00 3.6663E-01 5.6937E-06 24.000 7.0093E+00 6.6804E-01 5.2019E-06 45.500 6.1568E+00 1.0123E+00 2.5081E-06 96.000 5.1354E+00 1.0123E+00 3.0300E-86 720.000 5.4587E-01 1.0123E+00 0.0000E+00 Cumulative Dose Summary

1. 1. 1. 1. 4###############

Exclusion Area Bounda Low Population Zone Control Room Time Thyroid TEDE Thyroid . TEDE Thyroid TEDE (hr) . (rem) (rem) (rem) (rem) (rem) (rem) 0.000 0.0000E+00 0 OOOOE+00 0.0000E+00 0.OOOOE+00 0.OOOOE+00 0.0000E+00 0.004 3.2544E-05 1. 0860E-06 8.8756E-06 2.9619E-07 2.5137E-06 7 .8586E-08 0.083 1.4731E-03 4. 9156E-05 4.0174E-04 1.3406E-05 3.0681E-03 9. 5919E-05 0.400 7.1753E-03 2 .3890E-04 1.9569E-03 6. 5153E-05 2.2496E-02 7.0296E-04 0.700 1.2544E-02 4 1677E-04 3.4212E-03 1. 1366E-04 3.6695E-02 1. 1463E-03 1.000 1.7882E-02 5. 9291E-04 4.8769E-03 1 . 6170E-04 4.9514E-02 1 .5462E-03 1.300 2. 3189E-02 7 .6741E-04 6.3243E-03 2.0929E-04 6.1825E-02 1. 9300E-03

Xce~negy~ Calculation No. GEN-PI-083 Revision No. 0 Page No. 112 of 128 1.600 2.8466E-02 9.4034E-04 7.7635E-03 2.5646E-04 7.3920E-02 2.3068E-03 1.900 3. 3713E-02 1. 1118E-03 9. 1945E-03 3.0322E-04 8.5899E-02 2.6798E-03 2.000 3.5456E-02 1. 1686E-03 9.6697E-03 3. 1872E-04 8.9873E-02 2.8034E-03 2.300 3.8576E-02 1.2702E-03 1.0521E-02 3.4643E-04 9.9305E-02 3.0969E-03 2.600 4.1682E-02 1. 3711E-03 1. 1368E-02 3.7394E-04 1. 0610E-01 3.3083E-03 2.900 4.4773E-02 1. 4713E-03 1 .2211E-02 4. 0126E-04 1. 1200E-01 3 .4917E-03 3.200 4. 7851E-02 1.5708E-03 1. 3050E-02 4 .2840E-04 1.1758E-01 3. 6651E-03 3.500 5. 0914E-02 1.6697E-03 1. 3886E-02 4 .5537E-04 1.2304E-01 3.8347E-03 3.800 5.3963E-02 1.7679E-03 1. 4717E-02 4 .8216E-04 1.2845E-01 4.0024E-03 4 .100 5.6998E-02 1.8656E-03 1.5545E-02 5 .0880E-04 1. 3381E-01 4 .1690E-03 4.400 6.0020E-02 1.9626E-03 1. 6369E-02 5 .3527E-04 1.3915E-01 4.3347E-03 4.700 6.3029E-02 2.0591E-03 1.7190E-02 5.6158E-04 1. 4447E-01 4.4995E-03 5.000 6.6024E-02 2..1551E-03 1. 8007E-02 5.8775E-04 1.4976E-01 4.6635E-03 5.300 6.9006E-02 2.2505E-03 1. 8820E-02 6.1377E-04 1. 5503E-01 4.8268E-03 5.600 7. 1975E-02 2.3454E-03 1. 9630E-02 6.3965E-04 1 . 6027E-01 4.9893E-03 5.900 7.4932E-02 2.4397E-03 2 .0436E-02 6. 6538E-04 1. 6550E-01 5. 1511E-03 6.200 7.7876E-02 2.5336E-03 2. 1239E-02 6.9098E-04 1.7070E-01 5.3121E-03 6.500 8.0807E-02 2.6270E-03 2. 2038E-02 7 .1644E-04 1 .7588E-01 5.4724E-03 6.800 8.3726E-02 2.7198E-03 2. 2834E-02 7.4177E-04 1.8103E-01 5.6320E-03 7.100 8.6633E-02 2 .8123E-03 2 .3627E-02 7. 6698E-04 1. 8617E-01 5.7909E-03 7.400 8.9528E-02 2.9042E-03 2.4417E-02 7. 9205E-04 1. 9128E-01 5.9491E-03 7.700 9.2410E-02 2.9957E-03 2.5203E-02 8 1701E-04 1. 9637E-01 6. 1066E-03 8.000 9. 5281E-02 3.0867E-03 2.5986E-02 8. 4184E-04 2 .0144E-01 6.2634E-03 8.300 9. 7381E-02 3.1533E-03 2.6052E-02 8.4399E-04 2. 0519E-01 6.3791E-03

8. 600 9.9473E-02 3.2195E-03 2. 6118E-02 8.4614E-04 2 .0753E-01 6. 4514E-03 8.900 1 . 0156E-01 3.2855E-03 2. 6184E-02 8.4827E-04 2. 0939E-01 6.5092E-03 9.200 1.0363E-01 3. 3512E-03 2.6250E-02 8.5040E-04 2 .11OE-01 6. 5619E-03 9.500 1. 0570E-01 3.4166E-03 2.6315E-02 8. 5251E-04 2. 1275E-01 6. 6128E-03 9.800 1.0776E-01 3.4817E-03 2.6380E-02 8 . 54 61E-04 2 1437E-01 6.6629E-03 10.100 1.0982E-01 3.5465E-03 2.6445E-02 8. 5671E-04 2. 1598E-01 6. 7127E-03 10.400 1.1186E-01 3. 6111E-03 2. 6510E-02 8.5879E-04 2 1759E-01 6.7623E-03 24.000 1.9794E-01 6.3066E-03 2.9232E-02 9.4544E-04 2 .8503E-01 8.8389E-03 45.500 2. 9074E-01 9. 1819E-03 2.9901E-02 9.6630E-04 3. 1538E-01 9.7693E-03 96.000 2.9074E-01 9. 1819E-03 2. 9901E-02 9.6630E-04 3. 1586E-01 9.7838E-03 720.000 2.9074E-01 9. 1819E-03 2. 9901E-02 9.6630E-04 3. 1586E-01 9.7838E-03

1. - 1. 1. W#To#o##########################

Worst Two-Hour Doses Exclusion Area Boundarý Time Whole Body Thyroid TEDE (hr) (rem) (rem) (rem) 0.0 6.5147E-05 3.5456E-02 1. 1686E-03

XceI Energy ICalculation No. GEN-PI-083 Revision No. P age No. 113 of 128 Attachment 13.4 Modified RADTRAD Dose Conversion File PINGP fgl l&12.txt PINGPFGR11&12 added 7 nuclides; deleted sr-89,Ba-139,Cm244,AM-242,Pu2.38-240 2/2001 Implicit daughter halflives (m) less than 90 and less than 0.100 of parent 9 ORGANS DEFINED IN THIS FILE:

GONADS BREAST LUNGS RED MARR BONE SUR THYROID REMAINDER EFFECTIVE SKIN(FGR) 60 NUCLIDES DEFINED IN THIS FILE:

Co-58 Y Co-60 Y Kr-83m data entered by Gopal J. Patel NUCORE/10/08/2001 Kr-85 Kr-85m Kr-87 Kr-88 Rb-86 D Rb-88 data entered by Gopal J. Patel NUCORE/12/05/2001 Sr-90 Y

.Sr-91 Y Including:Y-91m Sr-92 Y Y-90 Y Y-91 Y Y-92 Y Y-93 Y zr-95 D zr-97 Y Including:Nb-97m , Including:Nb-97 Nb-95 Y Mo-99 Y TC-99m D Ru-103 Y Incl udi ng: Rh-103m RU-105 Y RU- 106 Y Including: Rh-106 Rh-105 Y Sb-127 w Sb-129 w

XceEEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 114 of 128 Te-127 w Te-127m w Te-129 w Te-129m w Including:Te-129 Te-131m w Including:Te-131 Te-132 w 1-131 D 1-132 D 1-133 D 1-134 D 1-135 D Including:xe-135m Xe-131m data entered by Gopal J. Patel NUCORE/10/08/2001 xe-133 Xe-133m data entered by Gopal J. Patel NUCORE/10/08/2001 xe-135 xe-135m data entered by Gopal J. Patel NUCORE/10/08/2001 xe-138 data entered by Gopal 3. Patel NUCORE/10/08/2001 Cs-134 D Cs-136 D Cs-137 D Including:Ba-137m Cs-138 data entered by Gopal J. Patel NUCORE/12/05/2001 Ba- 140 D La- 140 w La-141 D La-142 D Ce- 141 Y Ce-143 Y Ce-144 Y Including:Pr-144m, Including:Pr-144 Pr-143 Y Nd-147 Y Np-239 w Pu-241 Y Cm-242 w CLOUDSHINE GROUND GROUND GROUND INHALED INHALED INGESTION SHINE 8HR SHINE 7DAY SHINE RATE ACUTE CHRONIC Co-58 GONADS 4. 660E-14 2. 867E-11 5. 828E-10 9.970E-16-1.000E+O0 6. 170E-10 1.040E-09 BREAST 5. 300E-14 2.737E-11 5.565E-10 9.520E-16-1.OOOE+O0 9. 370E-10 1. 790E-10 LUNGS 4. 640E-14 2.617E-11 5.319E-10 9.100E-16-1.OOOE+0O 1.600E-08 8.530E-11 RED MARR 4. 530E-14 2.671E-11 5.430E-10 9.290E-16-1.OOOE+O0 9.230E-10 2.600E-10 BONE SUR 7.410E-14 3.795E-11 7.716E-10 1.320E-15-1.OOOE+00 6.930E-10 1. 250E-10 THYROID 4. 770E-14 2. 720E-11 5. 530E-10 9.460E-16-1.000E+00 8. 720E-10 6.310E-11 REMAINDER 4. 440E-14 2.585E-11 5. 255E-10 8.990E-16-1.OOOE+O0 1. 890E-09 1. 580E-09

XceI Energy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 115 of 128 EFFECTIVE 4.760E-14 2.732E-11 5.553E-10 9.500E-16-1.OOOE+00 2.940E-09 8.090E-10 SKIN(FGR) 5.580E-14 3.278E-11 6.664E-10 1.140E-15-1.000E+00 0. OOOE+00 0.000 E+00 co-60 GONADS 1.230E-13 7.056E-11 1.480E-09 2.450E-15-1.OOOE+00 4.760E-09 3.190E-09 BREAST 1.390E-13 6.739E-11 1.413E-09 2.340E-15-1.000E+00 1.840E-08 1.100E-09 LUNGS 1.240E-13 6.537E-11 1. 371E-09 2.270E-15-1.OOOE+00 3.450E-07 8. 770E-10 RED MARR 1.230E-13 6.710E-11 1.407E-09 2.330E-15-1.OOOE+00 1.720E-08 1. 320E-09 BONE SUR 1.780E-13 8.956E-11 1. 879E-09 3.110E-15-1.OOOE+00 1. 350E-08 9. 390E-10 THYROID 1.270E-13 6.480E-11 1. 359E-09 2.250E-15-1.000E+00 1.620E-08 7.880E-10 REMAINDER 1.200E-13 6. 508E-11 1. 365E-09 2.260E-15-1.OOOE+00 3.600E-08 4.970E-09 EFFECTIVE 1.260E-13 6.768E-11 1. 419E-09 2.350E-15-1.OOOE+00 5.910E-08 2.770E-09 SKIN(FGR) 1.450E-13 7.948E-11 1.667E-09 2.760E-15-1.OOOE+00 0.OOOE+00 0.O000E+00 Kr-83m GONADS 1. 710E-18 0.O00E+00 0.OOOE+00 0.O00E+00-1. OOOE+00 0.OOOE+00 0.OOOE+00 BREAST 5.050E-18 O.O00E+00 O.O00E+00 0.OOOE+00-1 .OOOE+00 0.OOOE+00 0-OOOE+00 LUNGS 1. 640E-19 0.O00E+00 O.000E+00 0.OOOE+00-1. OOOE+00 O.000E+00 0.OOOE+00 RED MARR 3.830E-19 0.O00E+00 0.OOOE+O0 0.O00E+00-1. 000E+00 0.OOOE+00 0.OOOE+00 BONE SUR 2.250E-18 0.O00E+O0 0.OOOE+O0 0O000E+00-1.000E+00 0.OOOE+00 0.OOOE+00 THYROID 6.430E-19 0.O00E+O0 O.000E+00 0.OOOE+O0-1.OOOE+0O O. OOOE+O0 0.OOOE+00 REMAINDER 5. 300E-19 O.O00E+00 O.O00E+00 0.OOOE+00-1. OOOE+00 0.O00E+O0 O.000E+00 EFFECTIVE 1.500E-18 0.O00E+00 0.O000E+00 0.O00E+00-1. O00E+00 0.000 E+00 0.000 E+00 SKIN(FGR) 3.560E-17 O.OOOE+00 0.OOOE+00 0.OOOE+00-1.OOOE+00 O.000E+00 0.000E+00 Kr-85 GONADS 1. 170E-16 8. 121E-14 1. 704E-12 2.820E-18-1.OOOE+00 0.000 E+00 O.000E+00 BREAST 1.340E-16 7. 891E-14 1. 656E-12 2.740E-18-1.OOOE+00 0.000EE+00 0.OOOE+00 LUNGS 1. 140E-16 7.056E-14 1.481E-12 2 .450E-18-1.000E+00 O.OOOE+00 0.000 E+00 RED MARR 1. 090E-16 6. 998E-14 1.469E-12 2.430E-18-1.OOOE+00 0.000 E+00 0. OOOE+00 BONE SUR 2.200E-16 1. 287E-13 2. 702E-12 4.470E-18-1.OOOE+O0 0.O000E+00 0,1. OOOE+0O THYROID 1.180E-16 7.459E-14 1. 565E-12 2.590E-18-1.OOOE+00 0.OOOE+00 O.O00E+00 REMAINDER 1.090E-16 6. 941E-14 1.457E-12 2.410E-18-1.OOOE+00 0. OOOE+00 0.000 E+00 EFFECTIVE 1. 190E-16 7. 603E-14 1. 596E-12 2.640E-18-1.000E+00 0.000 E+00 0.OOOE+00 SKIN(FGR) 1.320E-14 2. 304E-11 4. 835E-10 8.OOOE-16-1.OOOE+00 0.000 E+00 0.OOOE+00 Kr-85m GONADS 7. 310E-15 2. 594E-12 3.653E-12 1.570E-16-1.OOOE+O0 0.O000E+O0 O. OOOE+00 BREAST 8.410E-15 2. 527E-12 3. 560E-12 1.530E-16-1.OOOE+00 0.000 E+00 0.OOOE+00 LUNGS 7.040E-15 2. 379E-12 3. 351E-12 1.440E-16-1.000E+00 0.000 E+00 0.000 E+00 RED MARR 6.430E-15 2.346E-12 3. 304E-12 1.420E-16-1.000E+00 0.O000E+00 0.OOOE+O0 BONE SUR 1. 880E-14 5.286E-12 7.446E-12 3.200E-16-1.OOOE+00 0.OOOE+00 0 .00 E+00 THYROID 7. 330E-15 2.395E-12 3. 374E-12 1.450E-16-1.OOOE+00 0.000 E+00 0.OOOE+00 REMAINDER 6.640E-15 '2.313E-12 3. 257E-12 1.400E-16-1.OOOE+00 0.000 E+00 0.OOOE+00 EFFECTIVE 7.480E-15 2.511E-12 3.537E-12 1.520E-16-1.000E+00 0.000 E+00 0.OOOE+00 SKIN(FGR) 2.240E-14 .2.247E-11 3. 164E-11 1.360E-15-1.OOOE+00 0.000 E+00 0.000 E+00 Kr-87

XcelEnergy ICalculation No. GEN-PI-083 Revision No. 0 Page No. 116 of 128 GONADS 4.OOOE-14 4. 962E-12 5.026E-12 7.610E-16-1.OOOE+00 0.OOOE+00 0.000 E+00 BREAST 4. 500E-14 4. 740E-12 4. 802E-12 7.270E-16-1.OOOE+00 0.OOOE+00 0.000 E+00 LUNGS 4.040E-14 4.603E-12 4. 663E-12 7.060E-16-1.OOOE+00 0.O000E+00 0.000 E+00 RED MARR 4.OOOE-14 4. 708E-12 4. 769E-12 7.220E-16-1.OOOE+00 0.OOOE+00 0.000 E+00 BONE SUR 6.020E-14 6. 514E-12 6. 598E-12 9.990E-16-1.OOOE+00 0.OOOE+O0 0.000 E+00 THYROID 4.130E-14 4.473E-12 4. 531E-12 6.860E-16-1.OOOE+O0 O.O00E+00 0. OOOE+O0 REMAINDER 3.910E-14 4. 590E-12 4.650E-12 7.040E-16-1.OOOE+00 0.000 E+00 O.000E+00 EFFECTIVE 4.120E-14 4.773E-12 4.835E-12 7.320E-16-1.OOOE+00 0.O000E+00 O.000E+00 SKIN(FGR) 1. 370E-13 8.802E-11 8.9i6E-11 1.350E-14-1.OOOE+00 0.O000E+00 0.000E+00 Kr-88 GONADS 9. 900E-14 2. 278E-11 2.65SE-11 1.800E-15-1.000E+00 0.OOOE+00 0.OOOE+00 BREAST 1. 11OE-13 2. 177E-11 2.537E-11 1.720E-15-1.OOOE+00 0.000E+00 0.0000E+00 LUNGS 1.010E-13 2. 139E-11 2.493E-11 1.690E-15-1.OOOE+00 0.O000E+00 0. OOOE+00 RED MARR 1.000E-13 2. 190E-11 2. 552E-11 1.730E-15-1.OOOE+00 0.O000E+00 0 .000 E+00 BONE SUR 1. 390E-13 2.886E-11 3. 363E-11 2.280E-15-1.OOOE+00 0.O000E+00 0-. OOOE+00 THYROID 1.030E-13 2.012E-11 2.345E-11 1.590E-15-1.OOOE+00 0.O000E+O0 0.000 E+00 REMAINDER 9.790E-14 2. 139E-11 2.493E-11 1.690E-15-1.OOOE+00 0.O000E+00 0.000 E+00 EFFECTIVE 1.020E-13 2.202E-11 2. 567E-11 1.740E-15-1.OOOE+00 0.O000E+00 O.000E+00 SKIN(FGR) 1. 3SOE-13 5. 607E-11 6. 534E-11 4.430E-15-1.OOOE+00 0.O000E+00 0.000E+00 Rb-86 GONADS 4. 710E-15 2. 788E-12 5.187E-11 9.740E-17-1.OOOE+00 1. 340E-09 2. 150E-09 BREAST 5. 340E-15 2. 662E-12 4.953E-11 9.300E-17-1.OOOE+O0 1. 330E-09 2.140E-09 LUNGS 4. 710E-15 2. 553E-12 4.750E-11 8.920E-17-1.OOOE+00 3. 300E-09 2.140E-09 RED MARR 4.640E-15 2. 619E-12 4.873E-11 9.150E-17-1.OOOE+00 2. 320E-09 3.720E-09 BONE SUR 7.050E-15 3. 635E-12 6. 764E-11 1.270E-16-1.OOOE+00 4. 270E-09 6.860E-09 THYROID 4.840E-15 2. 599E-12 4. 836E-11 9.080E-17-1.OOOE+00 1. 330E-09 2. 140E-09 REMAINDER 4. 520E-15 2 542E-12 4. 729E-11 8.880E-17-1.OOOE+00 1. 380E-09 2. 330E-09 EFFECTIVE 4.810E-15 2. 665E-12 4.958E-11 9.310E-17-1.OOOE+00 1. 790E-09 2. 530E-09 SKIN(FGR) 4.850E-14 2.210E-10 4. 111E-09 7.720E-15-1.000E+00 0.OOOE+00 O000 E+00 Rb-88 GONADS 3.260E-14 O.OOOE+00 0.OOOE+00 0.OOOE+00-1.OOOE+00 1. 310E-12 2. 780E-12 BREAST 3. 670E-14 0.000 E+00 O.OOOE+00 0.OOOE+00-1.OOOE+00 1. 430E-12 2.820E-12 LUNGS 3. 310E-14 0.O000E+O0 0.OOOE+00 0.OOOE+00-1.OOOE+00 1. 470E-10 2. 910E-12 RED MARR 3. 300E-14 0.000E+00 0. 000E+00 O.OOOE+00-I.OOOE+00 1. 450E-12 2. 760E-12 BONE SUR 4.620E-14 0.000 E+00 0. OOOE+00 O.OOOE+00-1.OOOE+00 1. 470E-12 2. 750E-12 THYROID 3. 370E-14 0.000 E+O0 O. OOOE+00 O.OOOE+00-1.OOOE+00 1. 370E-12 2.430E-12 REMAINDER 3. 210E-14 0.000E+00 0.O000E+00 O.OOOE+00-1.OOOE+00 1. 380E-11 1. 500E-10 EFFECTIVE 3. 360E-14 0.O000E+00 O.OOOE+00 O.OOOE+00-1.OOOE+00 2. 260E-11 4.710E-11 SKIN(FGR) 1. 830E-13 0.O000E+00 O.OOOE+00 O.OOOE+00-1.OOOE+00 0.O00E+00 0.000 E+00 Sr.-90 GONADS 7. 780E-18 9. 590E-15 2.014E-13 3.330E719-1.OOOE+00 2.690E-10 5.040E-11 BREAST 9.490E-18 1.008E-14 2. 116E-13 3.500E-19-1.OOOE+00 2. 690E-10 5.040E-11 LUNGS 6.440E-18 6. 307E-15 1. 324E-13 2.190E-19-1.OOOE+00 2.860E-06 5.040E-11

Xce Energy Calculation No. GEN-PI-083 Revision No. 0 Page No. 117 of 128 RED MARR 5.440E-18 5. 558E-15 1. 167E-13 1.930E-19-1.OOOE+00 3. 280E-08 6.450E-09 BONE SUR 2. 280E-17 2.393E-14 5 .025E-13 8.310E-19-1.OOOE+00 7.090E-08 1. 390E-08 THYROID 7. 330E-18 7.171E-15 1. 506E-13 2.490E-19-1.OOOE+00 2.690E-10 5.040E-11 REMAINDER 6. 110E-18 6.422E-15 1. 348E-13 2.230E-19-1.O0OE+00 5. 730E-09 6.700E-09 EFFECTIVE 7.530E-18 8. 179E-15 1. 717E-13 2.840E-19-1.OOOE+00 3. 510E-07 3.230E-09 SKIN(FGR) 9. 200E-15 4.032E-12 8.465E-11 1.400E-16-1.OOOE+00 0.000E+O0 0.000 E+00 Sr-91 GONADS 4.819E-14 2. 155E-11 5.062E-11 1.026E-15-1.OOOE+O0 5.669E-11 2.520E-10 BREAST 5.477E-14 2.059E-11 4.838E-11 9.806E-16-1.OOOE+00 1.77 5E-11 3.676E-11 LUNGS 4.803E-14 1.970E-11 4.626E-11 9.376E-16-1.OOOE+00 2.170E-09 1.055E-11 RED MARR 4.691E-14 2.011E-11 4.722E-11 9.570E-16-1.OOOE+00 2.275E-11 5.659E-11 BONE SUR 7.674E-14 2.852E-11 6.709E-11 1.360E-15-1.OOOE+00 1. 306E-11 2.070E-11 THYROID 4.938E-14 2.035E-11 4.782E-11 9.693E-16-1.O0OE+00 9. 930E-12 1. 968E-12 REMAINDER 4.610E-14 1.948E-11 4.573E-11 9.268E-16-1.OO0E+00 5.802E-10 2.557E-09 EFFECTIVE 4.924E-14 2.057E-11 4.832E-11 9.793E-16-1.000E+00 4. 547E-10 8-455E-10 SKIN(FGR) 9.938E-14 1. 748E-10 3.987E-10 8.O80E-15-1.OOOE+00 0.OOOE+00 0.OOOE+00 Sr-92 GONADS 6. 610E-14 1. 593E-I1 1. 830E-11 1.300E-15-1.000E+O0 1.020E-II 8. 180E-11 BREAST 7. 480E-14 1. 520E-11 1. 745E-11 1.240E-15-1.OOOE+00 6.490E-12 1. 700E-11 LUNGS 6. 670E-14 1.483E-11 1. 703E-11 1.210E-15-1.000E+O0 1.050E-09 7. 220E-12 RED MARR 6. 620E-14 1. 520E-11 1.745E-11 1.240E-15-1.OOOE+00 6. 980E-12 2.290E-11 BONE SUR 9.490E-14 2.010E-11 2.308E-11 1.640E-15-1.OOOE+00 4. 360E-12 8 .490E-12 THYROID 6.820E-14 1.446E-11 1.661E-11 1.180E-15-1.000E+0O 3.920E-12 1.300E-12 REMAINDER 6.450E-14 1.471E-11 1.689E-11 1.200E-15-1.OOOE+00 2.900E-10 1.720E-09 EFFECTIVE 6.790E-14 1. 532E-11 1.759E-11 1.250E-15-1.000E+00 2.180E-I0 5.430E-10 SKIN(FGR) 8. 560E-14 2.280E-11 2.618E-11 1.860E-15-1.OOOE+00 0.000 E+00 0.OOOE+00 Y-90 GONADS 1. 890E-16 1. 586E-13 1.601E-12 5.750E-18-1.OOOE+00 5. 170E-13 1.430E-14 BREAST 2.200E-16 1. 578E-13 1. 593E-12 5.720E-18-1.OOOE+00 5. 170E-13 1. 270E-14 LUNGS 1. 770E-16 1. 313E-13 1.326E-12 4.760E-18-1.OOOE+00 9.310E-09 1. 260E-14 RED MARR 1.620E-16 1. 261E-13 1.273E-12 4.570E-18-1.OOOE+00 1. 520E-11 3.700E-13 BONE SUR 4.440E-16 3. 228E-13 3. 259E-12 1.170E-17-1.OOOE+00 1. 510E-11 3.670E-13 THYROID 1.870E-16 1. 385E-13 1. 398E-12 5.020E-18-1.OOOE+00 5. 170E-13 1. 260E-14 REMAINDER 1. 680E-16 1. 291E-13 1. 303E-12 4.680E-18-1.OOOE+00 3. 870E-09 9.680E-09 EFFECTIVE 1.900E-16 1.468E-13 1.482E-12 5.320E-18-1.OOOE+00 2.280E-09 2.910E-09 SKIN(FGR) 6.240E-14 2.897E-10 2.924E-09 1.050E-14-1.000E+00 0. 000E+00 0.000 E+00 Y-91 GONADS 2. 560E-16 1. 756E-13 3.546E-12 6. 110E-18-1.000E+O0 8.200E-12 3. 540E-12 BREAST 2. 930E-16 1. 713E-13 3.459E-12 5.960E-18-1.OOOE+00 8.920E-12 5. 540E-13 LUNGS 2. 500E-16 1. 526E-13 3.082E-12 5.310E-18-1.OOOE+00 9.870E-08 2.020E-13 RED MARR 2.410E-16 1. 521E-13 3.070E-12 5.290E-18-1.OOOE+00 3. 190E-10 6. 590E-12 BONE SUR 4. 560E-16 2.903E-13 5. 862E-12 1.010E-17-1.000E+00 3. 180E-10 6. 130E-12 THYROID 2.600E-16 1. 564E-13 3.157E-12 5.440E-18-1.OOOE+00 8. 500E-12 1. 290E-13

Xce IEnergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 118 of 128 REMAINDER 2. 390E-16 1. 509E-13 3.047E-12 5.250E-18-1.OOOE+O0 4.200E-09 8. 570E-09 EFFECTIVE 2.600E-16 1. 650E-13 3.332E-12 5.740E-18-1.OOOE+O0 1. 320E-08 2. 570E-09 SKIN(FGR) 3.850E-14 1. 989E-10 4.016E-09 6.920E-15-1.OOOE+00 0.000 E+00 0. OOOE+00 Y-92 GONADS 1. 270E-14 3. 855E-12 4.872E-12 2.650E-16-1.OOOE+O0 2.610E-12 1.960E-11 BREAST 1.440E-14 3.680E-12 4.652E-12 2.530E-16-1.OOOE+O0 1. 500E-12 3.5SOE-12 LUNGS 1. 270E-14 3. 535E-12 4.468E-12 2.430E-16-1.OOOE+00 1. 240E-09 1. 390E-12 RED MARR 1. 250E-14 3. 608E-12 4. 560E-12 2.480E-16-1.OOOE+O0 2.070E-12 4. 910E-12 BONE SUR 1. 950E-14 5.091E-12 6.435E-12 3.500E-16-1.OOOE+00 1. 510E-12 1.750E-12 THYROID 1. 300E-14 3. 579E-12 4. 523E-12 2.460E-16-1.OOOE+0O 1.050E-12 1. 770E-13 REMAINDER 1. 220E-14 3. 506E-12 4.431E-12 2.410E-16-1.OOOE+00 2.030E-10 1.700E-09 I

EFFECTIVE 1. 300E-14 3. 680E-12 4. 652E-12 2.530E-16-1.OOOE+00 2. Il0E-10 5. 150E-10 SKIN(FGR) 1. 140E-13 2.022E-10 2. 556E-10 1.390E-14-1.OOOE+O0 0. OOOE+O0 0.OOOE+00 Y-93 GONADS 4.670E-15 2. 108E-12 4.989E-12 9.510E-17-1.OOOE+00 5. 310E-12 2.200E-11 BREAST 5. 300E-15 2.026E-12 4. 794E-12 9.140E-17-1.OOOE+00 1. 740E-12 3. 130E-12 LUNGS 4.680E-15 1. 937E-12 4.585E-12 8.740E-17-1.OOOE+00 2.520E-09 8. 670E-13 RED MARR 4. 580E-15 1. 972E-12 4.669E-12 8.900E-17-1.OOOE+00 4.040E-12 4. 930E-12 BONE SUR 7.580E-15 2. 948E-12 6.977E-12 1.330E-16-1.OOE+00 3.140E-12 1. 730E-12 THYROID 4. 790E-15 1. 908E-12 4.516E-12 8.610E-17-1.OOOE+00 9.260E-13 1.260E-13 REMAINDER 4. 510E-15 1.919E-12 4.543E-12 8.660E-17-1.O0OE+00 9.250E-10 4.090E-09 EFFECTIVE 4. 800E-15 2.021E-12 4. 784E=12 9.120E-17-1.OOE+00 5.820E-10 1.230E-09 SKIN(FGR) 8. 500E-14 2. 726E-10 6.452E-10 1.230E-14-1.OOOE+00 0 000E+00 0.OOOE+00 Zr-95 GONADS 3. 530E-14 2.182E-11 4.421E-10 7.590E-16-1.OOOE+00 1.880E-09 8. 160E-10 BREAST 4. O1OE-14 2.084E-11 4. 223E-10 7.250E-16-1.OOOE+0O 1.910E-09 1.050E- 10 LUNGS 3. 510E-14 1.989E-11 4.030E-10 6.920E-16-1.OOOE+00 2. 170E-09 2. 340E-11 RED MARR 3.430E-14 2.030E-11 4.112E-10 7.060E-16-1.OOOE+00 1.300E-08 2.140E-10 BONE SUR 5. 620E-14 2.875E-11 5. 824E-10 1.OOOE-15-1.OOOE+00 1.030E-07 4.860E-10 THYROID 3.610E-14 2.076E-11 4.205E-10 7.220E-16-1.OOOE+00 1. 440E-09 8. 270E-12 REMAINDER 3.360E-14 1.963E-11 3.978E-10 6.830E-16-1.OOOE+00 2.280E-09 2. 530E-09 EFFECTIVE 3. 600E-14 2.078E-11 4.211E-10 7.230E-16-1.000E+00 6.390E-09 1.020E-09 SKIN(FGR) 4. 500E-14 2.561E-11 5.190E-10 8.910E-16-1.OOOE+00 O.O00E+00 0.000 E+00 zr-97 GONADS 4. 331E-14 2.179E-11 7. 799E-11 9.253E-16-1.OOOE+00 1. 840E-10 6. 228E-10 BREAST 4.928E-14 2.083E-11 7.455E-11 8.846E-16-1.OOOE+00 4. 706E-11 8.137E-11 LUNGS 4.322E-14 1. 992E-11 7. 127E-11 8.456E-16-1.OOOE+0O 4.108E-09 1. 770E-11 RED MARR 4.224E-14 2.034E-11 7. 279E-11 8.634E-16-1. OOOE+O0 6.376E-11 1. 302E-I0 BONE SUR 6.897E-14 2.881E-11 1.031E-10 1.224E-15-1.OO0E+00 3. 504E-11 4. 558E-11 THYROID 4.443E-14 2.061E-11 7.377E-11 8.755E-16-1.OOOE+00 2.315E-11 2.671E-12 REMAINDER 4.139E-14 1.966E-11 7.035E-11 8.345E-16-1.O00E+00 2.041E-09 6.990E-09 EFFECTIVE 4.432E-14 2.078E-11 7.438E-11 8.824E-16-1 OOOE+00 1. 171E-09 2.283E-09 SKIN(FGR) 9.835E-14 2. 281E-10 8. 148E-10 9.587E-15-1.OOOE+00 0. OOOE+00 0.000 E+00

XceI Energy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 119 of 128 Nb-95 GONADS 3. 660E-14 2. 253E-11 4.435E-10 7.850E-16-1.OOOE+00 4.320E-10 8. 050E-10 BREAST 4. 160E-14 2. 150E-11 4. 231E-10 7.490E-16-1.OOOE+O0 4.070E-10 1.070E-10 LUNGS 3. 650E-14 2.055E-11 4.045E-10 7.160E-16-1.OOOE+00 8.320E-09 2. 740E-11 RED MARR 3. 560E-14 2. 101E-11 4. 135E-10 7.320E-16-1.OOOE+00 4.420E-10 1.990E-10 BONE SUR 5. 790E-14 2.957E-11 5. 819E-10 1.030E-15-1.OOOE+00 5.130E-10 2.940E-10 THYROID 3. 750E-14 2. 144E-11 4. 220E-10 7.470E-16-1.OOOE+00 3.580E-10 1.180E-11 REMAINDER 3. 490E-14 2.032E-11 4. 0OOE-10 7.080E-16-1.OOOE+0O 1.070E-09 1.470E-09 EFFECTIVE 3. 740E-14 2.147E-11 4.226E-10 7.480E-16-1.OOOE+00 1.570E-09 6.950E-10 SKIN(FGR) 4. 300E-14 2. 598E-11 5.112E-10 9.050E-16-1.OOOE+00 O.OOOE+00 0.000 E+00 MO-99 GONADS 7. 130E-15 4.282E-12 4.403E-11 1.550E-16-1.OOOE+00 9.510E-11 2.180E-10 BREAST 8. 130E-15 4. 116E-12 4. 233E-11 1.490E-16-1.OOOE+O0 2.750E-11 3.430E-11 LUNGS 7.060E-15 3. 867E-12 3. 977E-11 1.400E-16-1.OOOE+00 4.290E-09 1. 510E-11 RED MARR 6. 820E-15 3.923E-12 4.034E-11 1.420E-16-1.OOOE+00 5.240E-11 8. 320E-11 BONE SUR 1. 240E-14 6. 105E-12 6. 278E-11 2.210E-16-1.OOOE+00 4.130E-11 6. 320E-11 THYROID 7. 270E-15 4.033E-12 4. 147E-11 1.460E-16-1.OOOE+00 1.520E-11 1.030E-11 REMAINDER 6. 740E-15 3.812E-12 3. 920E-11 1.380E-16-1.OOOE+00 1. 740E-09 4.280E-09 EFFECTIVE 7. 280E-15 4.061E-12 4. 176E-11 1.470E-16-1.000E+0O 1.070E-09 1. 360E-09 SKIN(FGR) 3. 140E-14 1. 039E-10 1.068E-09 3.760E-15-1.OOOE+00 O.OOOE+00 0.000 E+00 Tc-99m GONADS 5.750E-15 2. 334E-12 3. 877E-12 1.240E-16-1.OOOE+00 2.770E-12 9. 750E-12 BREAST 6.650E-15 2.258E-12 3.752E-12 1.200E-16-1.OOOE+00 2.150E-12 3. 570E-12 LUNGS 5. 490E-15 2. 127E-12 3. 533E-12 1.130E-16-1.OOOE+00 2.280E-11 3. 140E-12 RED MARR 4.910E-15 2.070E-12 3.439E-12 1.100E-16-1.OOOE+00 3.360E-12 6. 290E-12 BONE SUR 1. 630E-14 5. 383E-12 8. 942E-12 2.860E-16-1.OOOE+00 2.620E-12 4.060E-12 THYROID 5.750E-15 2.145E-12 3. 564E-12 1.140E-16-1.OOOE+00 5.010E-11 8.460E-11 REMAINDER 5. 150E-15 2.070E-12 3.439E-12 1.100E-16-1.OOOE+00 1.020E-11 3. 340E-11 EFFECTIVE 5. 890E- 15 2.277E-12 3.783E-12 1.210E-16-1.OOOE+00 8.800E-12 1.680E-11 SKIN(FGR) 7. 140E-15 2. 710E-12 4. 502E-12 1.440E-16-1.OOOE+O0 0.OOOE+O0 0 . OOOE+00 Ru-103 GONADS 2. 191E-14 1.404E-11 2.783E-10 4.892E-16-1.OOOE+00 3.070E-10 5. 720E-10 BREAST 2. 512E-14 1.350E-11 2. 677E-10 4.705E-16-1.OOOE+O0 3.110E-10 1. 200E-10 LUNGS 2. 180E-14 1.273E-11 2.522E-10 4.432E-16-1.OOOE+00 1.561E-08 7. 310E-11 RED MARR 2. 100E-14 1. 287E-11 2. 551E-10 4.483E-16-1.OOOE+00 3.190E-10 1.660E-10 BONE SUR 3.892E-14 1. 958E-11 3.882E-10 6.823E-16-1.OOOE+00 2.370E-10 9.631E-11 THYROID 2. 241E-14 1. 331E-11 2. 639E-10 4.638E-16-1.OOOE+00 2.570E-10 6. 250E-11 REMAINDER 2.080E-14 1. 248E-11 2. 472E-10 4.346E-16-1.OOOE+00 1.250E-09 2. 110E-09 EFFECTIVE 2. 251E-14 1. 332E-11 2.641E-10 4.642E-16-1.OOOE+O0 2.421E-09 8.271E-10 SKIN(FGR) 2. 774E-14 1. 785E-11 3. 543E-10 6.229E-16-1.OOE+00 O.OOOE+00 0.000 E+00 RU-105 GONADS 3. 720E-14 1. 327E-11 1. 861E-11 8.070E-16-1.O0OE+00 1.590E-11 9. 670E-11 BREAST 4. 240E-14 1. 271E-11 1. 783E-11 7.730E-16-1.OOOE+00 6.610E-12 1. 590E-11

XcelEergy i on No. GEN-PI-083 Revision No. 0 Page No. 120 of 128 LUNGS 3.700E-14 1 210E-11 1.697E-11 7.360E-16-1.OOOE+00 5.730E-10 6. 210E-12 RED MARR 3.590E-14 1. 230E-11 1. 725E-11 7.480E-16-1.000E+00 7.700E-12 2.350E-11 BONE SUR 6.280E-14 1.809E-11 2.537E-11 1.100E-15-1.OOOE+00 4.620E-12 8.890E-12 THYROID 3.800E-14 1.260E-11 1. 766E-11 7.660E-16-1.OOOE+00 4.150E-12 1.820E-12 REMAINDER 3.540E-14 1.189E-11 1.667E-11 7.230E-16-1.OOOE+00 1.610E-10 8. 540E-10 EFFECTIVE 3.810E-14 1. 265E-11 1. 773E-11 7.690E-16-1.OOOE+00 1.230E-10 2. 870E-10 SKIN(FGR) 6.730E-14 7. 368E-11 1.033E-10 4.480E-15-1.000E+00 0 O000 E+00 0.000E+00 RU-106 GONADS 1.010E-14 6.411E-12 1.340E-10 2.230E-16-1.OOOE+00 1. 300E-09 1.640E-09 BREAST 1. 160E-14 6.152E-12 1.286E-10 2.140E-16-1.OOOE+00 1.780E-09 1.440E-09 LUNGS 1. O1OE-14 5. 836E-12 1.220E-10 2.030E-16-1.OOOE+00 1.040E-06 1.420E-09 RED MARR 9. 750E-15 5.893E-12 1.232E-10 2.050E-16-1.OOOE+00 1. 760E-09 1.460E-09 BONE SUR 1. 720E-14 8.883E-12 1.856E-10 3.090E-16-1.OOOE+00 1.610E-09 1.430E-09 THYROID 1.030E-14 6.066E-12 1.268E-10 2.110E-16-1.OOOE+00 1.720E-09 1.410E-09 REMAINDER 9. 630E-15 5. 721E-12 1.196E-10 1.990E-16-1.OOOE+00 1. 200E-08 2-. llOE-08 EFFECTIVE 1.040E-14 6.095E-12 1.274E-10 2.120E-16-1.OOOE+00 1. 290E-07 7.400E-09 SKIN(FGR) 1.090E-13 4.082E-10 8.531EL09 1.420E-14-1.000E+00 0 . 000E+00 0.000 E+00 Rh-105 GONADS 3..640E-15 2. 127E-12 1.411E-11 7.980E-17-1.000E+00 2. 0OE-11 5.800E-11 BREAST 4. 160E-15 2.063E-12 1. 369E-11 7.740E-17-1.000E+O0 5.610E-12 8. 970E-12 LUNGS 3.570E-15 1.935E-12 1.284E-11 7.260E-17-1.OOOE+O0 9. 580E-10. 3.860E-12 RED MARR 3.380E-15 1. 946E-12 1. 291E-11 7.300E-17-1.000E+00 7. 770E-12 1.470E-11 BONE SUR 7.530E-15 3.332E-12 2.210E-11 1.250E-16-1.OOOE+00 4.460E-12 6.750E-12 THYROID 3.680E-15 1. 983E-12 1. 316E-11 7.440E-17-1.OOOE+00 2.880E-12 2. 910E-12 REMAINDER 3.390E-15 1. 885E-12 1. 250E-11 7.070E-17-1.OOOE+00 4.530E-10 1. 270E-09 EFFECTIVE 3. 720E-15 2.031E-12 1. 347E-11 7.620E-17-1.OOOE+00 2.580E-10 3.990E-10 SKIN(FGR) 1.070E-14 4.691E-12 3.112E-11 1.760E-16-1.OOOE+00 0.000 E+00 0.OOOE+00 Sb-127 GONADS 3. 260E-14 1. 985E-11 2.441E-10 7.100E-16-1.000E+00 2. 520E-10 6. 140E-10 BREAST 3. 720E-14 1. 904E-11 2. 341E-10 6.810E-16-1.OOOE+O0 9. 120E-11 7.600E-11 LUNGS 3.240E-14 1. 809E-11 2. 224E-10 6.470E-16-1.OOOE+00 6.940E-09 1. 570E-11 RED MARR 3.140E-14 1. 834E-11 2. 255E-10 6.560E-16-1.OOOE+00 1. 610E-10 1. 330E-10 BONE SUR 5. 520E-14 2. 720E-11 3.345E-10 9.730E-16-1.OO0E+00 1. 340E-10 5.240E-11 THYROID 3. 330E-14 1. 884E-11 2. 317E-10 6.740E-16-1.OOOE+00 6. 150E-11 4.640E-12 REMAINDER 3.090E-14 1. 775E-11 2.183E-10 6.350E-16-1.OOOE+00 2. 330E-09 5.870E-09 EFFECTIVE 3. 330E-14 1.890E-11 2. 324E-10 6.760E-16-1.OOOE+00 1.630E709 1.950E-09 SKIN(FGR) 5. 580E-14 7.967E-i1 9.799E-10 2.850E-15-1.OOOE+0O 0.000E+00 0.000 E+00 sb-129 GONADS 6.970E-14 2. 336E-11 3. 231E-11 1.440E-15-1.OO0E+00 2.150E-11 1. 510E-1 BREAST 7.910E-14 2.222E-11 3.074E-11 1.370E-15-1OOOE+00 1.280E-11 2. 560E-11 LUNGS 6. 980E-14 2.141E-11 2.962E-11 1.320E-15-1.OOOE+00 8.980E-10 9.390E-12 RED MARR 6.860E-14 2. 190E-11 3.029E-11 1.350E-15-1.OOOE+00 1.700E-11 3.670E-11.

BONE SUR 1.070E-13 3.033E-11 4. 196E-11 1.870E-15-1.OOOE+O0 1.460E-11 1. 340E-11

XceI Energy, Calculation No. GEN-PI-083 Revision No. 0 Page No. 121 of 128 THYROID 7.160E-14 2. 174E-11 3.007E-11 1.340E-15-1.OOOE+0O 9. 720E-12 1.470E-12 REMAINDER 6. 710E-14 2. 125E-11 2. 939E-11 1.310E-15-1.OOOE+00 1. 870E-10 1.450E-09 EFFECTIVE 7. 140E-14 2. 238E-11 3.096E-11 1.380E-15-1.OOOE+O0 1. 740E-10 4.840E-10 SKIN(FGR) 1.050E-13 8.273E-11 1. 144E-10 5.100E-15-1.OOOE+O0 O.O000E+O0 0.OOOE+00 Te-127 GONADS 2. 370E-16 1.191E-13 2. 661E-13 5.480E-18-1.OOOE+0O 2.020E-12 4.020E-12 BREAST 2. 730E-16 1.158E-13 2. 588E-13 5.330E-18-1.000E+0O 1.880E-12 3.OOOE-12 LUNGS 2. 320E-16 1.060E-13 2.370E-13 4.880E-18-1.OOOE+O0 4. 270E-10 2. 890E-12 RED MARR 2.210E-16 1.058E-13 2. 365E-13 4.870E-18-1.OOOE+00 4.090E-12 6. 570E-12 BONE SUR 4.650E-16 1.862E-13 4.162E-13 8.570E-18-1.000E+0O 4.090E-12 6.460E-12 THYROID 2.400E-16 1.106E-13 2.472E-13 5.090E-18-1.000E+O0 1.840E-12 2. 860E-12 REMAINDER 2. 210E-16 1.036E-13 2.316E-13 4.770E-18-1.OOOE+O0 1. l10E-10 6. 130E-10 EFFECTIVE 2.420E-16 1.125E-13 2.515E-13 5.180E-18-1.000E+00 8.600E-11 1. 870E-10 SKIN(FGR) 1. 140E-14 1.173E-11 2.622E-11 5.400E-16-1.OOOE+00 0 .00E+00 0.OOOE+00.

Te-127m GONADS 1. 900E-16 4.689E-13 9.642E-12 1.630E-17-1.000E+00 1. 100E-10 1.250E-10 BREAST 2.690E-16 5. 150E-13 1.059E-11 1.790E-17-1.000E+00 1. IOOE-10 9. 740E-11 LUNGS 7. 620E-17 1. 602E-13 3.295E-12 5.570E-18-1.000E+00 3.340E-08 9.620E-11 RED MARR 6.430E-17 1. 249E-13 2. 567E-12 4.340E-18-1.000E+O0 5. 360E-09 5.430E-09 BONE SUR 3.940E-16 9.005E-13 1.852E-11 3.130E-17-1.000E+O0 2.040E-08 2.070E-08 THYROID 1. 500E-16 2.779E-13 5. 714E-12 9.660E-18-1.000E+00 9.660E-11 9.430E-11 REMAINDER 8.640E-17 1. 999E-13 4. 111E-12 6.950E-18-1.OOOE+O0 1.660E-09 2.980E-09 EFFECTIVE 1.470E-16 3.251E-13 6.684E-12 1.130E-17-1.OOOE+0O 5.810E-09 2. 230E-09 SKIN(FGR) 8.490E-16 1.496E-12 3.076E-11 5.200E-17-1.000E+00 0.000E+O0 0. 000E+00 Te-129 GONADS 2.710E-15 3. 889E-13 3.922E-13 6.510E-17-1.000E+00 5.050E-13 1. 590E-12 BREAST 3. 120E-15 3. 800E-13 3.832E-13 6.360E-17-1.000E+00 5. 390E-13 6.050E-13 LUNGS 2.640E-15 3. 298E-13 3.326E-13 5.520E-17-1.OOOE+00 1. 530E-10 4. 910E-13 RED MARR 2. 540E-15 3. 298E-13 3.326E-13 5.520E-17-1.000E+O0 6.190E-13 7. 640E-13 BONE SUR 4. 880E-15 5.753E-13 5. 802E-13 9.630E-17-1.OOOE+00 6.220E-13 5.400E-13 THYROID 2.740E-15 3.525E-13 3. 555E-13 5.900E-17-1.OOOE+0O 5.090E-13 3.360E-13 REMAINDER 2. 520E-15 3. 262E-13 3.289E-13 5.460E-17-1.000E+0O 7. 280E-12 1. 790E-10 EFFECTIVE 2. 750E-15 3. 590E-13 3.621E-13 6.010E-17-1.000E+00 2.090E-11 5.450E-11 SKIN(FGR) 3. 570E-14 3.429E-11 3.458E-11 5.740E-15-1.OOOE+0O 0.000 E+00 O. OOOE+O0 Te-129m GONADS 3.321E-15 2. 206E-12 4. 799E-11 8.561E-17-i.OOOE+00 1.783E-10 2.420E-10 BREAST 3. 838E-15 2. 181E-12 4.739E-11 8.454E-17-1.OOOE+00 1. 694E-10 1. 664E-10 LUNGS 3. 176E-15 1. 741E-12 3.815E-11 6.808E-17-1.000E+00 4.040E-08 1. 593E-10 RED MARR 3.071E-15 1. 729E-12 3.793E-11 6.768E-17-1.OOOE+00 3.100E-09 3.500E-09 BONE SUR 5. 772E-15 3.287E-12 7. 147E-11 1.275E-16-1.000E+O0 7.050E-09 7.990E-09 THYROID 3.341E-15 1. 923E-12 4. 201E-11 7.495E-17-1.000E+00 1. 563E-10 1. 572E-10 REMAINDER 3.048E-15 1. 746E-12 3. 822E-11 6.819E-17-1.OOOE+00 3.275E-09 7.196E-09 EFFECTIVE 3. 337E-15 1. 974E-12 4. 308E-11 7.686E-17-1.000E+00 6.484E-09 2.925E-09

XceI Energy Calculation No. GEN-PI-083 Revision No. 0 Page No. 122 of 128 SKIN(FGR) 3.811E-14 1.501E-10 3.360E-09 6.001E-15-1.OOOE+00 0.O00E+00 0.OOOE+00 Te-131m GONADS 7.292E-14. 4. 020E-11 2.343E-10 1.535E-15-1O000E+O0 2.345E-10 7.415E-10 BREAST 8. 286E-14 3.853E-11 2.246E-10 1.472E-15-1.OOOE+00 9. 309E-11 1. 361E-10 LUNGS 7. 265E-14 3.657E-11 2.131E-10 1.397E-15-1.000E+0O 2. 296E-09 6. 335E-11 RED MARR 7.097E-14 3.736E-11 2.178E-10 1.427E-15-1.OOE+00 1.417E-10 2.435E-10 BONE SUR 1. 174E-13 5.467E-11 3.189E-10 2.090E-15-1.OOOE+O0 2. 276E-10 3. 248E-10 THYROID 7.471E-14 3.741E-11 2.181E-10 1.429E-15-1.OOOE+0O 3.669E-08 4. 383E-08 REMAINDER 6.965E-14 3.626E-11 2.113E-10 1.385E-15-1.OOOE+00 9. 509E-10 3.153E-09 EFFECTIVE 7.463E-14 3.825E-11 2.229E-10 1.461E-15-1.000E+00 1. 758E-09 2. 514E-09 SKIN(FGR) 1.038E-13 1. 033E-10 6.188E-10 4.056E-15-1.OOOE+O0 0.O000E+O0 0.000 E+00 Te-132 GONADS 1.020E-14 6.812E-12 7.706E-11 2.450E-16-1.OOOE+00 4. 150E-10 5. 410E-10 BREAST 1. 180E-14 6. 756E-12 7.643E-11 2.430E-16-1.OOOE+00 3. 630E-10 3. 500E-10 LUNGS 9. 650E-15 5. 727E-12 6.479E-11 2.060E-16-1.000E+00 1.670E-09 3-.300E-10 RED MARR 8. 950E-15 5. 588E-12 6.322E-11 2.010E-16-1.OOOE+00 4.270E-10 4. 440E-10 BONE SUR 2.420E-14 1. 273E-11 1.441E-10 4.580E-16-1.OOOE+00 7. 120E-10 8. 300E-10 THYROID 1. 020E-14 5. 978E-12 6.762E-11 2.150E-16-1.OOOE+O0 6. 280E-08 5. 950E-08 REMAINDER 9.160E-15 5.644E-12 6.385E-11 2.030E-16-1.OOOE+00 7.890E-10 1.490E-09 EFFECTIVE 1.030E-14 6. 339E-12 7.171E-11 2.280E-16-1.OOOE+00 2. 550E-09 2. 540E-09 SKIN(FGR) 1. 390E-14 8.313E-12 9.405E-11 2.990E-16-1.000E+00 O.000E+O0 0. O00E+00 1-131 GONADS 1. 780E-14 1. 119E-11 1.789E-10 3.940E-16-1.OOOE+00 2.530E-11 4.070E-11 BREAST 2.040E-14 1.082E-11 1.730E-10 3.810E-16-1.OOOE+00 7.880E-11 1. 210E-10 LUNGS 1. 760E-14 1.016E-11 1.626E-10 3.580E-16-1.OOOE+00 6. 570E-10 1. 020E-10 RED MARR 1. 680E-14 1.022E-11 1.635E-10 3.600E-16-1.OOOE+00 6.260E-11 9.440E-11 BONE SUR 3. 450E-14 1.675E-11 2.'679E-10 5.900E-16-1.OOOE+00 5. 730E-11 8. 720E-11 THYROID I. 810E-14 1. 053E-11 1.685E-10 3.710E-16-1.OOOE+00 2.920E-07 4.760E-07 REMAINDER 1. 670E-14 9. 908E-12 1.585E-10 3.490E-16-1.OOOE+00 8.030E-11 1. 570E-10 EFFECTIVE 1. 820E-14 1.067E-11 1.707E-10 3.760E-16-1.OOOE+00 8.890E-09 1.440E-08 SKIN(FGR) 2.980E-14 1.825E-11 2.920E-10 6.430E-16-1.OOOE+00 0.000 E+00 0.OOOE+00 1-132 GONADS 1.090E-13 2.523E-11 2.771E-11 2.320E-15-1.OOOE+00 9.950E-12 2.330E-11 BREAST 1. 240E-13 2.414E-11 2.652E-11 2.220E-15-1.OOOE+O0 1. 410E-11 2. 520E-11 LUNGS 1.090E-13 2.305E-11 2.532E-11 2.120E-15-1.OOOE+00 2. 710E-10 2.640E-11 RED MARR 1.070E-13 2. 360E-11 2.592E-11 2.170E-15-1.OOOE+00 1.400E-11 2.460E-11 BONE SUR 1. 730E-13 3.327E-11 3.655E-11 3.060E-15-1.OOOE+00 1. 240E-11 2. 190E-11 THYROID 1. 120E-13 2.381E-11 2.616E-11 2.190E-15-1.OOOE+00 1. 740E-09 3.870E-09 REMAINDER 1.050E-13 2.283E-11 2.509E-11 2.100E-15-1.OOOE+00 3. 780E-11 1.650E-10 EFFECTIVE 1. 120E-13 2.403E-11 2.640E-11 2.210E-15-1.OOOE+O0 1.030E-10 1. 820E-10 SKINN(FGR) 1. 580E-13 8. 199E-11 9.007E-11 7.540E-15-1.OOOE+00 0.O000E+00 0.000E+00 1-133 GONADS 2.870E-14 1.585E-11 6.748E-11 6.270E-16-1.000E+O0 1.950E-11 3.630E-11

Xce Energy- Calculation No. GEN-PI-083 Revision No. 0 Page No. 123 of 128 BREAST 3.280E-14 1. 519E-11 6.468E-11 6.010E-16-1.000E+00 2.940E-11 4.680E-11 LUNGS 2.860E-14 1.446E-11 6.156E-11 5.720E-16-1.OOOE+00 8.200E-10 4.530E-11 RED MARR 2. 770E-14 1.466E-11 6. 242E-11 5.800E-16-1.OOOE+00 2. 720E-11 4. 300E-11 BONE SUR 4. 870E-14 2.161E-11 9. 202E-11 8.550E-16-1.OOOE+00 2. 520E-11 4.070E-11 THYROID 2. 930E-14 1.502E-11 6. 393E-11 5 .940E-16-1.OOOE+00 4.860E-08 9.100E-08 REMAINDER 2.730E-14 1.418E-11 6.038E-11 5.610E-16-1.000E+00 5.OOOE-11 1. 550E-10 EFFECTIVE 2.940E-14 1.509E-11 6.425E-11 5.970E-16-1.OOOE+00 1. 580E-09 2.800E-09 SKIN(FGR) 5.830E-14 1.150E-10 4.897E-10 4.550E-15-1.OOOE+00 0.000 E+00 0.000 E+00 1-134 GONADS 1.270E-13 1.200E-11 1.202E-11 2.640E-15-1.OOOE+00 4.250E-12 1. lOE-11 BREAST 1.440E-13 1. 145E-11 1.147E-11 2.520E-15-1.OOOE+00 6.170E-12 1. 170E-11 LUNGS 1 270E-13 1. 100E-11 1.102E-11 2.420E-15-1.OOOE+00 1.430E-10 1.260E-11 RED MARR 1.250E-13 1. 127E-11 1.129E-11 2.480E-15-1.OOOE+00 6.080E-12 1. 090E-11 BONE SUR 1.960E-13 1. 568E-11 1.571E-11 3.450E-15-1.OOOE+00 5.310E-12 9. 320E-12 THYROID 1.300E-13 1. 127E-11 1.129E-11 2.480E-15-1.OOOE+00 2.880E-10 6-.210E-10 REMAINDER 1. 220E-13 1.091E-11 1.093E-11 2.400E-15-1.OOOE+00 2.270E-11 1.340E-10 EFFECTIVE 1. 300E-13 1. 150E-11 1. 152E-11 2.530E-15-1.OOOE+00 3.550E-11 6.660E-11 SKIN(FGR) 1.870E-13 4.477E-11 4.485E-11 9.850E-15-1.OOOE+00 O.O00E+00 O.000E+00 1-135 GONADS 8.078E-14 3.113E-11 5.489E-11 1.599E-15-1.OOOE+00 1. 700E-11 3.610E-11 BREAST 9. 143E-14 2. 971E-11 5. 240E-11 1.526E-15-1.OOOE+0O 2. 340E-11 3.850E-11 LUNGS 8. 145E-14 2. 886E-11 5.089E-11 1.482E-15-1.OOOE+00 4.410E-10 3. 750E-11 RED MARR 8.054E-14 2.965E-11 5.228E-11 1.523E-15-1.OOOE+00 2.240E-11 3.650E-11 BONE SUR 1. 184E-13 3.983E-11 7.024E-11 2.046E-15-1.OOOE+00 2.010E-11 3.360E-11 THYROID 8.324E-14 2. 852E-11 5.030E-11 1.465E-15-1.OOOE+00 8.460E-09 1. 790E-08 REMAINDER 7.861E-14 2.883E-11 5.084E-11 1.481E-15-1.OOOE+00 4.700E-11 1. 540E-10 EFFECTIVE 8.294E-14 2.989E-11 5.271E-11 1.535E-15-1.OOOE+00 3. 320E-10 6.080E-10 SKIN(FGR) 1. 156E-13 9.826E-11 1. 733E-10 5.047E-15-1.OOOE+00 0.OOOE+00 0. OOOE+00 Xe-131m GONADS 4.570E-16 0. OOOE+00 0.OOOE+00 0.000E+00-1.000E+00 0.OOOE+00 0. OOOE+00 BREAST 6.020E-16 0.OOOE+00 0.OOOE+00 0.OOOE+00-1.OOOE+00 O.000E+00 0.OOOE+00 LUNGS 2. 670E-16 0.000 E+00 0.O00E+00 0.O00E+00-1.0OOE+00 0.O000E+00 0.000 E+00 RED MARR 2. 270E-16 0.OOOE+00 0.000 E+00 0.OOOE+00-1.OOOE+00 0.000 E+00 O.000E+00 BONE SUR 1. 060E-15 O.OOOE+00 0.OOOE+00 O.OOOE+O0-1.OOOE+00 0.000 E+O0 0. OOOE+00 THYROID 3.910E-16 0.OOOE+00 O.000E+00 0.O00E+00-1.OOOE+00 0.OOOE+00 0.OOOE+00 REMAINDER 2.710E-16 O.OOOE+00 0.000E+00 0.OOOE+00-1.OOOE+00 0.000E+00 0.000E+00 EFFECTIVE 3. 890E-16 0.OOOE+00 0.000 E+00 0.OOOE+00-1.OOOE+00 0.000E+00 0.000 E+00 SKIN(FGR) 4.820E-15 0.OOOE+00 0.O000E+00 0.OOOE+00-1.OOOE+00 0.OOOE+00 0.O000E+00 Xe-133 GONADS 1. 610E-15 1.465E-12 2.052E-11 5.200E-17-1.OOOE+00 O.OOOE+00 0.OOOE+00 BREAST 1.960E-15 1. 505E-12 2.107E-11 5.340E-17-1.OOOE+00 0.O00E+00 O.000E+00 LUNGS 1. 320E-15 1.045E-12 1.464E-11 3.710E-17-1.OOOE+00 0.000 E+00 0.OOOE+00 RED MARR 1.070E-15 8. 791E-13 1. 231E-11 3.120E-17-1.OOOE+00 0.000 E+00 0.O000E+00

XceI nergy Calculation No. GEN-PI-083 Revision No. 0 Page No. 124 of 128 BONE SUR 5.130E-15 4. 254E-12 5.958E-11 1.510E-16-1.000E+00 O.OOOE+00 0.000E+00 THYROID 1. 510E-15 1. 181E-12 1.653E-11 4.190E-17-1.OOOE+00 O.OOOE+00 0. OOOE+00 REMAINDER 1.240E-15 1.o42E-12 1.460E-11 3.700E-17-1.OOOE+00 0.OOOE+00 0.O000E+O0 EFFECTIVE 1. 560E-15 1. 299E-12 1. 819E-11 4.610E-17-1.OOOE+O0O0.OOOE+O0 0. OOOE+00 SKIN(FGR) 4.970E-15 1. 953E-12 2. 734E-11 6.930E-17-1.OOOE+00 0.OOOE+00 0. OOOE+00 xe-133m GONADS 1.420E-15 0.O00E+00 0.O000E+00 0.OOOE+00-1.OOOE+00 0.OOOE+00 0 . OOOE+00 BREAST 1. 700E-15 O.O00E+00 0.O000E+00 O.OOOE+00-1. OOOE+00 0.OOOE+00 0.000 E+00 LUNGS 1. 190E-15 0.O000E+00 0.OOOE+00 0.OOOE+00-1.OOOE+00 0.OOOE+00 0.000 E+00 RED MARR 1. lOE-15 0.000 E+00 0.000 E+00 0.000E+00-1.OOOE+00 O.OOOE+00 0. OOOE+00 BONE SUR 3.230E-15 0.000 E+00 0.000 E+00 O.OOOE+00-1.OOOE+00 0.OOOE+00 0.000E+00 THYROID 1.360E-15 0.O00E+00 0.000 E+00 0.OOOE+00-1.OOOE+00 0.OOOE+00 0.OOOE+00 0.O000E+O0 REMAINDER 1.'150E-15 O.OOOE+00 0. OOOE+00 0.OOOE+00-1.OOOE+00 0.OOOE+00 EFFECTIVE 1. 370E-15 0.OOOE+00 O.OOOE+00 0.OOOE+00-1. OOOE+00 O.OOOE+00 0.OOOE+00 SKIN(FGR) 1.040E-14 O.O00E+0O 0.000E+00 0.OOOE+00-1.OOOE+00 0.OOOE+00 0;.OOOE+00 Xe-135 GONADS 1.170E-14 5.455E-12 1. 194E-11 2.530E-16-1.OOOE+00 0.OOOE+00 0.00OE+00 BREAST 1. 330E-14 5.325E-12 1.166E-11 2 .470E-16-1.OOOE+00 0.OOOE+00 0.006E+00 LUNGS 1. 130E-14 4.959E-12 1.086E-11 2 .300E-16-1.OOOE+00 0.OOOE+O0 0 . OOOE÷00 RED MARR 1.070E-14 4.959E-12 1.086E-11 2.300E-16-1.OOOE+00 0.OOOE+00 0.000 E+00 BONE SUR 2. 570E-14 9.120E-12 1.997E-11 4.230E-16-1.OOOE+00 0.OOOE+00 0. 0. OOOE+00 O00E+O0 THYROID 1. 180E-14 5 .023E-12 1. lOE-11 2.330E-16-1.OOOE+00 0.OOOE+00 O.O00E+00 REMAINDER 1. 080E-14 4.829E-12 1.058E-11 2.240E-16-1.OOOE+00 0.OOOE+00 0. OOOE+00 EFFECTIVE 1. 190E-14 5.217E-12 1. 142E-11 2.420E-16-1.OOOE+00 0 OOOE+00 0.OOOE+00 SKIN(FGR) 3. 120E-14 4.506E-11 9.867E-11 2.090E-15-1.OOOE+00 0.OOOE+00 0.000 E+00 Xe-135m GONADS 2.000E-14 O.OOOE+00 O.OOOE+00 0.OOOE+00-1.OOOE+00 0.OOOE+00 0.000 E+00 BREAST 2.290E-14 0.O00E+00 O.O00E+00 0.OOOE+00-1.OOOE+00 O.OOOE+00 0.OOOE+00 LUNGS 1. 980E-14 O.O00E+00 0.O000E+00 0.OOOE+00-1.OOOE+00 0.OOOE+00 0.000 E+00 RED MARR 1. 910E-14 0.OOOE+O0 0.OOOE+00 O.000E+0O-1.OOOE+00 0.OOOE+00 0. OOOE+00 BONE SUR 3. 500E-14 O.000E+00 0.O00E+00 0.OOOE+00-1.0OOE+00 0.OOOE+00 0.OOOE+00 THYROID 2.040E-14 0.OOOE+00 0. OOOE+O0 0.O00E+00-1.OOOE+00 0.OOOE+00 0. OOOE+00 REMAINDER 1. 890E-14 0.O000E+00 0.000 E+00 0.OOOE+00-1.OOOE+00 0.OOOE+00 0.000 E+00 EFFECTIVE 2..040E-14 0.000 E+00 0.O000E+00 O.OOOE+00-1.OOOE+00 O.OOOE+00 0.000 E+00 SKIN(FGR) 2.970E-14 0.OOOE+00 0.O000E+00 0.OOOE+00-1.OOOE+00 0.OOOE+00 0.OOOE+00 Xe-138 GONADS 5. 590E-14 0. 000E+00 0.OOOE+00 0.OOOE+00-1.OOOE+00 O.OOOE+00 00.OOOE+00 .000 E+00 BREAST 6. 320E-14 0.OOOE+00 0.O00E+00 O.OOOE+00-1.OOOE+00 0.OOOE+00 0.000 E+00 LUNGS 5. 660E-14 0.O000E+00 0.000 E+00 0.OOOE+00-1.OOOE+00 0.OOOE+00 0.000E+00 RED MARR 5.600E-14 O.O00E+00 O.OOOE+00 0.OOOE+00-1.OOOE+00 O.OOOE+00 BONE SUR 8.460E-14 0.OOOE+00 0.000E+00 0.OOOE+00-1.OOOE+00 0.OOOE+00 0.OOOE+00 THYROID 5. 770E-14 0.000E+00 O.O00E+00 O.OOOE+00-1.OOOE+00 0.OOOE+00 0.OOOEE+00 REMAINDER 5.490E-14 0.O000E+00 0.O000E+00 O.O00E+O0-1.OOOE+00 O.OOOE+00 0. OOOE+00

Xcel Energy. ICalculation No. GEN-PI-083 Revision No. 0 aeN.15o Page 2 No. 125 of 128 EFFECTIVE 5.770E-14 0.000 E+0O 0.000E+00 0.OOOE+00-1.OOOE+00 0.000 E+00 0.O000E+00 SKIN(FGR) 1.070E-13 0.000 E+00 0. OOOE+00 0.OOOE+00-1.OOOE+00 0. OOOE+O0 0.000 E+00 Cs-134 GONADS 7.400E-14 4.607E-11 9.646E-10 1.600E-15-1.000E+00 1. 300E-08 2.060E-08 BREAST 8.430E-14 4.406E-11 9. 224E-10 1.530E-15-1.OOOE+O0 1.080E-08 1. 720E-08 LUNGS 7.370E-14 4.204E-11 8. 802E-10 1.460E-15-1.OOOE+00 1.180E-08 1.760E-08 RED MARR 7. 190E-14 4.262E-11 8. 922E-10 1.480E-15-1.000E+00 1. 180E-08 1. 870E-08 BONE SUR 1. 200E-13 6. 105E-11 1. 278E-09 2.120E-15-1.00OE+0O 1.100E-08 1. 740E-08 THYROID 7. 570E-14 4. 377E-11 9. 163E-10 1.520E-15-1.OOOE+00 1. 11OE-08 1. 760E-08 REMAINDER 7 .060E-14 4. 147E-11 8. 681E-10 1.440E-15-1.OOOE+00 1. 390E-08 2. 210E-08 EFFECTIVE 7. 570E-14 4. 377E-11 9.163E-10 1.520E-15-1.OOOE+00 1. 250E-08 1. 980E-08 SKIN(FGR) 9 .450E-14 .6. 249E-11 1. 308E-09 2.170E-15-1.OOOE+00 0.000 E+0O 0. OOOE+00 Cs-136 GONADS 1. 040E-13 6.223E-11 1. 102E-09 2.180E-15-1.OOOE+00 1.880E-09 3.040E-09 BREAST 1. 180E-13 5.966E-11 1.056E-09 2.090E-15-1.OOOE+00 1.670E-09 2-. 650E-09 LUNGS 1.040E-13 5.710E-11 1. 011E-09 2.OOOE-15-1. OOOE+00 2. 320E-09 2.620E-09 RED MARR 1.010E-13 5.824E-11 1.031E-09 2.040E-15-1.OOOE+00 1.860E-09 2.950E-09 BONE SUR 1. 660E-13 8.422E-11 1.491E-09 2.950E-15-1.OOOE+00 1.700E-09 2. 710E-09 THYROID 1.070E-13 5.852E-11 1.036E-09 2.050E-15-1000E+00 1. 730E-09 2.740E-09 REMAINDER 9.950E-14 5.652E-11 1.001E-09 1.980E-15-1.OOOE+00 2. 190E-09 3.520E-09 EFFECTIVE 1.060E-13 5.966E-11 1.056E-09 2.090E-15-1. OOOE+00 1.980E-09 3.040E-09 SKIN(FGR) 1. 250E-13 7. 251E-11 1. 284E-09 2.540E-15-1.OOOE+00 0.O000E+0O 0.000 E+00 Cs-137 GONADS 2.669E-14 1.669E-11 3. 530E-10 5.840E-16-1.OOOE+00 8.760E-09 1.390E-08 BREAST 3.047E-14 1. 596E-11 3. 376E-10 5.585E-16-1.OOOE+00 7.840E-09 1.240E-08 LUNGS 2.649E-14 1. 517E-11 3. 209E-10 5.309E-16-1.OOOE+00 8.820E-09 1. 270E-08

-RED MARR 2. 583E-14 1. 542E-11 3.. 260E-10 5.394E-16-1.OOOE+00 8.300E-09 1. 320E-08 BONE SUR 4.382E-14 2.238E-11 4. 734E-10 7.832E-16-1.OOOE+00 7. 940E-09 1. 260E-08 THYROID 2.725E-14 1. 588E-11 3. 358E-10 5.556E-16-1.OOOE+00 7.930E-09 1.260E-08 REMAINDER 2. 536E-14 1.490E-11 3. 152E-10 5.215E-16-1.OOOE+00 9.120E-09 1.450E-08 EFFECTIVE 2. 725E-14 1.585E-11 3.353E-10 5.546E-16-1.00OE+00 8.630E-09 1. 350E-08 SKIN(FGR) 4. 392E-14 5.253E-11 1.11OE-09 1.836E-15-1.OOOE+00 0.OOOE+00 O.O000E+00 Cs-138 GONADS 1. 170E-13 0.OOOE+00 0.000 E+00 O.OOOE+00-1.OOOE+00 3. 280E-12 8. OOOE-12 BREAST 1. 330E-13 0.OOOE+00 0.000 E+00 0.OOOE+00-1.OOOE+00 4.020E-12 8.OOOE-12 LUNGS 1. 190E-13 0.O000E+00 O.OOOE+00 O.OOOE+00-1.OOOE+00 1. 590E-10 8. 530E-12 RED MARR 1. 180E-13 0.O00E+00 O.000E+O0 0.O00E+0O-1. OOOE+00 3.950E-12 7. 370E-12 BONE SUR 1. 700E-13 0.000E+00 O.000E+00 0.OOOE+00-1.OOOE+00 3.550E-12 6. 470E-12 THYROID 1. 210E-13 0.OOOE+00 0.O000E+O0 0.OOOE+00-1.OOOE+00 3.570E-12 5. 730E-12 REMAINDER 1.150E-13 O.000E+00 0.OOOE+00 0.OOOE+00-1.OOOE+00 2.060E-11 1. 570E-10 EFFECTIVE 1. 210E-13 0.O000E+00 O.000E+00 0.OOOE+00-1.OOOE+00 2. 740E-11 5. 250E-11 SKIN(FGR) 2.170E-13 0.OOOE+00 0.O00E+00 0.OOOE+00-1.OOOE+00 0.000 E+00 0.OOOE+00 Ba-140

XceI Energy, Calculation No. GEN-PI-083 Re vision No. 0 Page No. 126 of 128 GONADS 8.410E-15 5.451E-12 9.607E-11 1.910E-16-1.000E+00 4. 300E-10 9.960E-10 BREAST 9.640E-15 5.280E-12 9. 305E-11 1.850E-16-1.OOOE+O0 2.870E-10 1. 590E-10 LUNGS 8. 270E-15 4.852E-12 8. 550E-11 1.700E-16-1.OOOE+00 1. 660E-09 6.630E-11 RED MARR 7. 930E-15 4.880E-12 8.601E-11 1.710E-16-1.OOOE+00 1. 290E-09 4. 390E-10 BONE SUR 1. 550E-14 8.020E-12 1.413E-10 2.810E-16-1.000E+00 2.410E-09 5. 530E-10 THYROID 8. 530E-15 5. 109E-12 9.003E-11 1.790E-16-1.OOOE+00 2. 560E-10 5. 250E-11 REMAINDER 7.890E-15 4. 766E-12 8. 399E-11 1.670E-16-1.00OE+0O 1.410E-09 7. 370E-09 EFFECTIVE 8.580E-15 5. 137E-12 9.053E-11 1.800E-16-1.000E+0O 1.01OE-09 2. 560E-09 SKIN(FGR) 2. 520E-14 5. 565E-11 9.808E-10 1.950E-15-1.OOOE+00 O.000E+00 O.OOOE+00 La-140 GONADS 1.14OE-13 6.027E-11 4.425E-10 2.240E-15-1.OOOE+O0 4. 540E-10 1. 340E-09 BREAST 1.290E-13 5. 758E-11 4.228E-10 2.140E-15-1.OOOE+00 1.450E-10 1.800E-10 LUNGS 1. 150E-13 5. 596E-11 4. 109E-10 2.080E-15-1.OOOE+00 4. 210E-09 4.010E-11 RED MARR 1. 140E-13 5.731E-11 4.208E-10 2.130E-15-1.OOOE+00 2. 140E-1O 2.810E-10 BONE SUR 1.690E-13 7. 776E-11 5. 709E-10 2.890E-15-1.OOOE+00 1.410E- 10 9-.770E-11 THYROID 1. 180E-13 5.462E-11 4. O1OE-10 2.030E-15-1.OOOE+00 6.870E-11 6.400E-12 REMAINDER 1. 110E-13 5. 569E-11 4.089E-10 2.070E-15-1.OOOE+0O 2.120E-09 6.260E-09 EFFECTIVE 1. 170E-13 5.812E-11 4. 267E-10 2.160E-15-1.0OOE+00 1. 310E-09 2.280E-09 SKIN(FGR) 1.660E-13 2.217E-10 1. 628E-09 8.240E-15-1.OOOE+00 0.000 E+00 0.O000E+00 La-141 GONADS 2.3 30E-15 7. 315E-13 9.675E-13 4.740E-17-1.OOOE+0O 1. O1OE-11 3..770E-12 BREAST 2.640E-15 7.007E-13 9. 267E-13 4.540E-17-1.OOOE+00 9.840E-12 7. 070E-13 LUNGS 2. 340E-15 6. 713E-13 8. 879E-13 4.350E-17-1.OOOE+00 6.460E-10 2.720E-13 RED MARR 2. 310E-15 6.852E-13 9.063E-13 4.440E-17-1.000E+00 2. 930E-11 1.070E-12 BONE SUR 3.490E-15 9.923E-13 1. 312E-12 6.430E-17-1.OOOE+0O 1.200E-10 6.060E-13 THYROID 2. 390E-15 6. 590E-13 8. 716E-13 4.,270E-17-1.OO0E+00 9. 400E-12 5. 290E-14 REMAINDER 2.260E-15 6.682E-13 8.838E-13 4.330E-17-1.OOOE+00 2.280E-10 1. 240E-09 EFFECTIVE 2. 390E-15 7.007E-13 9.267E-13 4.540E-17-1.OOOE+O0 1.570E-10 3.740E-10 SKIN(FGR) 6. 580E-14 1. 667E-10 2. 204E-10 1.080E-14-1.OOOE+00 0.000 E+0O 0.OOOE+00 La-142 GONADS 1.400E-13 1.978E-11 2.034E-11 2.540E-15-1.OOOE+O0 1.660E-11 6 990E-11 BREAST 1. 570E-13 1. 885E-11 1.938E-11 2.420E-15-1.OOOE+00 1. 130E-11 1.540E-11 LUNGS 1.420E-13 1.846E-11 1. 898E-11 2.370E-15-1.OOOE+00 3.010E-10 8.400E-12 RED MARR 1.420E-13 1.900E-11 1.954E-11 2.440E-15-1.000E+00 1. 360E-11 1.930E-11 BONE SUR 1. 950E-13 2.484E-11 2. 554E-11 3.190E-15-1.OOOE+00 1. lOE-11 7.400E-12 THYROID 1.450E-13 1. 768E-11 1. 818E-11 2.270E-15-1.OOOE+00 8. 740E-12 1. 160E-12 REMAINDER 1. 380E-13 i.853E-11 1. 906E-11 2.380E-15-1.OOOE+00 8.070E-11 5.200E-10 EFFECTIVE 1.440E-13 1.916E-11 1. 970E-11 2.460E-15-1.OOOE+00 6.840E-11 1. 790E-10 SKIN(FGR) 2. 160E-13 9. 111E-I1 9. 368E-11 1.170E-14-1.OOOE+00 0.000 E+O0 0.OOOE+00 Ce-141 GONADS 3.380E-15 2.213E-12 4. 332E-11 7.710E-17-1.OOOE+0Q 5. 540E-11 1.080E-10 BREAST 3.930E-15 2. 170E-12 4.247E-11 7.560E-17-1.OOOE+00 4.460E-11 1. lOE-Il LUNGS 3. 170E-15 1.951E-12 3.820E-11 6.800E-17-1.OOOE+00 1.670E-08 1.430E-12

" Xce Energy Calculation No. GEN-PI-083 Revision No. 0 Page No. 127 of 128 RED MARR 2. 830E-15 1. 860E-12 3.641E-11 6.480E-17-1.OOOE+00 8.960E-11 3. 390E-11 BONE SUR 9.410E-15 5. 166E-12 1.011E-10 1.800E-16-1.000E+00 2. 540E-10 2.300E-11 THYROID 3.350E-15 2.003E-12 3.922E-11 6.980E-17-1.OOOE+00 2. 550E-11 1.800E-13 REMAINDER 2. 980E-15 1. 894E-12 3.708E-11 6.600E-17-1.O00E+O0 1.260E-09 2.500E-09 EFFECTIVE 3.430E-15 2. 118E-12 4.146E-11 7.380E-17-1.000E+00 2.420E-09 7. 830E-10 SKIN(FGR) 1. 020E-14 3. 788E-12 7.416E-11 1.320E-16-1.OOOE+O0 0.OOOE+00 0.OOOE+00 Ce-143 GONADS 1. 280E-14 7.900E-12 4.958E-11 2.980E-16-1.OOOE+00 7.530E-11 2.120E-10 BREAST 1.470E-14 7. 688E-12 4.825E-11 2.900E-16-1.000E+00 1.660E-11 2.320E-11 LUNGS 1. 230E-14 6.893E-12 4.325E-11 2.600E-16-1.000E+00 3.880E-09 3. 820E-12 RED MARR 1. 170E-14 6. 787E-12 4.259E-11 2.560E-16-1.OOOE+0O 2.960E-11 5.070E-11 BONE SUR 2. 520E-14 1. 323E-11 8.302E-11 4.990E-16-1.O0OE+00 1.640E-11 1.610E-11 THYROID 1. 280E-14 7. 211E-12 4.525E-11 2.720E-16-1.OOOE+0O 6.230E-12 4.350E-13 REMAINDER 1. 170E-14 6. 734E-12 4.226E-11 2.540E-16-1.OOOE+00 1.420E-09 3.890E-09 EFFECTIVE 1. 290E-14 7. 396E-12 4.642E-11 2.790E-16-1.OOOE+00 9. 160E-10 1. 230E-09 SKIN(FGR) 3. 960E-14 1.058E-10 6.638E-10 3.990E-15-1.OOOE+00 0.000 E+O0 O. OOOE+00 Ce-144 GONADS 2.725E-15 6. 328E-13 1.319E-11 6.088E-17-1.OOOE+00 2. 390E-10 6.987E-11 BREAST 3.129E-15 6. 274E-13 1.307E-11 5.922E-17-1.OOOE+00 3.480E-10 1. 223E-11 LUNGS 2.639E-15 5.228E-13 1.089E-11 5.362E-17-1.OOOE+00 7. 911E-07 6. 551E-12 RED MARR 2.507E-15 4. 755E-13 9.907E-12 5.247E-17-1.OOOE+00 2.880E-09 8.923E-11 BONE SUR 5 441E-15 1.646E-12 3 .429E-11 1.127E-16-1.OOOE+00 4.720E-09 1. 280E-10 THYROID 2.753E-15 5. 529E-13 1.152E-11 5.418E-17-1.OOOE+O0 2.920E-10 5. 154E-12 REMAINDER 2.534E-15 5.086E-13 1.060E-11 5.283E-17-1.OOOE+00 1.910E-08 1.890E-08 EFFECTIVE 2.773E-15 5.909E-13 1.231E-11 5.766E-17-1.000E+00 1.01OE-07 5.711E-09 SKIN(FGR) 8.574E-14 7. 648E-13 1.594E-11 1.250E-14-1.OOOE+00 0.000 E+00 0.000 E+00 Pr-143 GONADS 2. 130E-17 2. 264E-14 4.032E-13 7.930E-19-1.OOOE+00 4. 370E-18 8.990E-18 BREAST 2. 550E-17 2. 330E-14 4.149E-13 8.160E-19-1.O0OE+O0 2. 220E-18 1.090E-18 LUNGS 1. 860E-17 1. 642E-14 2.923E-13 5.750E-19-1.OOOE+00 1.330E-08 1. 910E-19 RED MARR 1.620E-17 1.493E-14 2.659E-13 5.230E-19-1.OOOE+00 1.480E-11 1.030E-12 BONE SUR 5.930E-17 5.454E-14 9.711E-13 1.910E-18-1.000E+00 1.490E-11 1.030E-12 THYROID 2.050E-17 1. 802E-14 3.208E-13 6.310E-19-1.OOOE+00 1. 680E-18 2. 660E-20 REMAINDER 1. 760E-17 1. 642E-14 2.923E-13 5.750E-19-1.OOOE+0O 1.970E-09 4.220E-09 EFFECTIVE 2. 100E-17 2.002E-14 3.564E-13 7.010E-19-1.000E+0O 2.190E-09 1. 270E-09 SKIN(FGR) 1. 760E-14 5. 711E-11 1.017E-09 2.000E-15-1.000E+00 0.OOOE+00 0.OOOE+00 Nd-147 GONADS 6. 130E-15 4.218E-12 7.235E-11 1.480E-16-1.OOOE+O0 8.410E-11 1. 790E-10 BREAST 7.120E-15 4.132E-12 7.088E-11 1.450E-16-1.OOOE+00 3.450E-11 1.870E-11 LUNGS 5.820E-15 3. 648E-12 6.257E-11 1.280E-16-1.OOOE+00 1. 060E-08 2.440E-12 RED MARR 5.400E-15 3. 505E-12 6.013E-11 1.230E-16-1.OOOE+00 9. 190E-11 5 .050E-11 BONE SUR 1. 320E-14 8.265E-12 1.418E-10 2.900E-16-1.OOOE+00 3.260E-10 2. 220E-11 THYROID 6. 120E-15 3.876E-12 6.648E-11 1.360E-16-1.000E+00 1. 820E-11 2.640E-13

1 9 XceIEnergy- ICalculation No. GEN-PI-083 Revision Noý 0 Page No. 128 of 128 REMAINDER 5.530E-15 3. 562E-12 6. 111E-11 1.250E-16-1.OOOE+00 1. 760E-09 3. 760E-09 EFFECTIVE 6.190E-15 3.961E-12 6.795E-11 1.390E-16-1.OOOE+00 1.850E-09 1. 180E-09 SKIN(FGR) 1.950E-14 3.135E-11 5. 377E-10 1.100E-15-1.OOOE+00 0.OOOE+00 0.000E+00 Np-239 GONADS 7. 530E-15 4.691E-12 4. 380E-11 1.710E-16-1.OOOE+00 7.450E-11 1.620E-10 BREAST 8. 730E-15 4. 636E-12 4. 329E-11 1.690E-16-1.OOOE+O0 1. 630E-il 1. 720E-11 LUNGS 7.180E-15 4.115E-12 3.842E-11, 1.500E-16-1.OOOE+00 2.360E-09 2.400E-12 RED MARR 6. 500E-15 4.005E-12 3. 740E-11 1.460E-16-1.OOOE+O0 2.080E-10 4.660E-11 BONE SUR 2.000E-14 1.O01E-11 9. 349E-11 3.650E-16-1.OOOE+00 2.030E-09 3. 590E-11 THYROID 7.520E-15 4. 197E-12 3.919E-11 1.530E-16-1.OOOE+00 7.620E-12 2.070E-13 REMAINDER 6.760E-15 4.005E-12 3.740E-11 1.460E-16-1.OOOE+O0 9.590E-10 2.770E-09 EFFECTIVE 7.690E-15 4.471E-12 4.175E-11 1.630E-16-1.000E+00 6. 780E-10 8.820E-10 SKIN(FGR) 1.600E-14 7.215E-12 6.737E-11 2.630E-16-1.OOOE+0Q -O.000 E+00 0.OOOE+00 Pu-241 GONADS 7.190E-20 6.653E-17 1. 396E-15 2.310E-21-1.OOOE+00 2.760E-07 5.660E-11 BREAST 8. 670E-20 7. 229E-17 1. 517E-15 2.510E-21-1.OOOE+O0 2. 140E-11 2.790E-15 LUNGS 6.480E-20 4.090E-17 8.584E-16 1.420E-21-1.000E+00 3.180E-06 4.480E-15 RED MARR 5.630E-20 4.003E-17 8.403E-16 1.390E-21-1.000E+00 1.430E-06 2.,780E-10 BONE SUR 2.190E-19 1. 385E-16 2.908E-15 4.810E-21-1.OOOE+O0 1. 780E-05 .3.480E-09 THYROID 6.980E-20 4. 522E-17 9.491E-16 1.570E-21-1.OOOE+00 9. 150E-12 1.010E-15 REMAINDER 6.090E-20 4. 291E-17 9.007E-16 1.490E-21-1.OOOE+00 6.020E-07 1.850E-10 EFFECTIVE 7.250E-20 5.558E-17 1. 167E-15 1.930E-21-1.OOOE+00 1. 340E-06 2.070E-10 SKIN(FGR) 1. 170E-19 2.033E-16 4. 268E-15 7.060E-21-1.000E+00 0.OOOE+O0 OO000E+00 Cm-242 GONADS 7.830E-18 4.893E-14 1.013E-12 1.700E-18-1.,OOE+00 5. 700E-07 5.200E-09 BREAST 1.480E-17 6.159E-14 1.275E-12 2.140E-18-1.000E+00 9.440E-10 8.950E-12 LUNGS 1.130E-18 3.022E-15 6.257E-14 1.050E-19-1.OOOE+00 1. 550E-05 8.840E-12 RED MARR 1. 890E-18 6.562E-15 1. 359E-13 2.280E-19-1.OOOE+00 3.900E-06 3.570E-08 BONE SUR 1.060E-17 4.231E-14 8.759E-13 1.470E-18-1.000E+00 4.870E-05 4.460E-07 THYROID 4.910E-18 1. 261E-14 2.610E-13 4.380E-19-1.000E+00 9.410E-10 8.820E-12 REMAINDER 2.270E-18 1 079E-14 2. 235E-13 3.750E-19-1.OOOE+00 2.450E-06 4. 020E-08 EFFECTIVE 5.690E-18 2. 751E-14 5.697E-13 9.560E-19-1.000E+00 4.670E-06 3. 100E-08 SKIN(FGR) 4. 290E-17 2. 700E-13 5.589E-12 9.380E-18-1.OOOE+00 0.OOOE+00 0. 000E+00

ML093160590

Text

Title:

SUMMARY

2.0 METHODOLOGY

4.0 ASSUMPTIONS

7.0 CALCULATIONS

SUMMARY

9.0 REFERENCES

Navigation menu

Search